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Introduction
Infertility should be considered one of the major health problems of the 21st century. 
It is commonly defined as 'any form of reduced fertility with prolonged time of 
unwanted non-conception'.1 The worldwide prevalence of infertility is estimated to 
range from 4 to 30%, affecting approximately 80 million couples around the globe.2,3 In 
industrialized countries, the lifetime prevalence of infertility is described to range from 
16-26%, thus affecting almost 1 out of every 4 couples.4
This thesis focuses on studying the quality of current fertility care in the Netherlands 
and the implementation of the guidelines developed in the Dutch guideline 
programme on fertility care. This introductory chapter will start with a description of 
the prevalence of infertility in the Netherlands and the treatment options that are 
currently available. The impact on the Dutch society and healthcare system is 
discussed. Next, the quality of care and the potential role of clinical practice guidelines 
and quality indicators in the assessment and improvement of current care, will be 
addressed. The chapter concludes with a set of research questions that led to the 
studies performed within this thesis and a brief outline of the thesis chapters.
Infertility in the Netherlands
In the Netherlands, the number of new cases of infertility in general practice is 
estimated as two per 1000 couples per year.5 In total, this concerns a referral to 
secondary or tertiary care for about 15 percent of couples of reproductive age.5,6 After 
one year of unwanted non-conception, an initial assessment of fertility is performed, 
roughly consisting of three parts: an assessment of ovulation, an assessment of tubal 
patency and a semen-analysis.
The cause of the fertility problem is attributable to the male partner in roughly 30% of 
cases and to the female partner in another 30% of cases. A combination of both 
partners accounts for another 30% of identified causes, whereas it remains idiopathic 
for about 10% of couples. Depending on the identified cause of the fertility problem, 
the woman's age and duration of infertility, either an expectant regimen will be agreed 
upon, or a treatment plan will be formulated. Treatment can encompass fertility 
enhancing surgery or assisted reproductive technologies (ART) like ovulation induction 
(OI), Intra Uterine Insemination (IUI) with or without ovarian stimulation, In Vitro 
Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) with either ejaculated or 
surgically retrieved semen. If these methods fail or are not suitable to the couple, 
alternative ways of conceiving or parenthood could be discussed, for instance, the use 
of donor gametes or opting for a surrogate parent or adoption.
In the Netherlands, fertility care is coordinated and mainly provided by gynaecologists 
and fertility clinicians, although general practitioners and urologists can, prior to 
referral to a gynaecologist, already start an initial assessment of fertility. Gynaecology 
departments in all clinics deliver primary fertility care, covering the initial assessment 
of fertility, surgery, OI and IUI. Performing a complete IVF or ICSI treatment (i.e. 
secondary fertility care) is limited to licensed clinics with highly specialized and 
accredited laboratories, of which there are 13 in the Netherlands. However, these 13 
licensed clinics have affiliated regional clinics where the stimulation phase of the IVF or 
ICSI treatment can take place, respectively up to ovum pick-up (i.e. in 'satellite clinics') 
or including ovum pick-up (i.e. in 'transport clinics'). Thanks to these affiliations, a total
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of 42 clinics in the Netherlands can offer their patients an IVF or ICSI treatment. The 
licensed clinics thus occupy a central position in regional fertility care. Tertiary fertility 
care comprises techniques like ICSI in combination with surgically retrieved epididymal 
or testicular semen; this care still remains restricted to a few of the licensed clinics and 
is partially performed in a research setting.
When compared to other countries, the accessibility to ART in the Netherlands is 
fortunately rather good. The basic Dutch health insurance covers the initial assessment 
of fertility, and the medical and medication costs of OI, IUI and three cycles of IVF or 
ICSI. As a result of this rather good accessibility to clinical care, 1 out of every 39 Dutch 
children born in 2007 was conceived by means of an IVF- or ICSI-treatment.7 Taking all 
other forms of ART into account, this number might very well be even larger. However, 
infertility and its treatment is not to be taken lightly; it is associated with a large 
physical, social and psychological burden for the patients involved.8-13 Apart from this 
impact on patients' lives, infertility claims an important position in health care due to 
the extensive use and costs of healthcare resources for diagnostics and treatment as 
well as for emotional and psychological support.
Quality of health care and the role of clinical practice guidelines
Considering this vast extent of psycho-social burden and resources needed, it is of 
great importance that delivered infertility care is of high quality. The Institute of 
Medicine defines quality of health care as "The degree to which health services for 
individuals and populations increase the likelihood of desired health outcomes and are 
consistent with current professional knowledge". As simple and obvious as this 
definition may sound, defining and operationalizing the concept 'quality' for different 
fields of health care or specific clinical conditions, is refractory. In 1992, the first 
educational paper on evidence-based medicine (EBM) was published14, which initiated 
a shift from intuitive and opinion led medicine towards EBM. This resulted in a 
plethora of papers on EBM, and the evidence base of existing treatment methods 
became subject to research. Subsequently, a multitude of large randomized controlled 
trials (RCT's) and meta-analyses were performed, which are still considered the 'gold 
standard' to compose a solid evidence base for clinical problems. It is therefore not 
surprising that institutions like the Cochrane Collaboration were founded15, who made 
it their prime purpose to review existing evidence and systematically gather and 
disseminate this knowledge. To date, it is widely accepted that health care is only 
considered of high quality when it is, amongst other dimensions, based on the best 
available scientific knowledge.16 However, medical literature from several countries 
suggests that approximately 30-40% of patients still do not receive care based on the 
best available scientific evidence. The quality of health care is moreover reported to 
vary between different settings17 and an estimated 20-25% of provided health care is 
even considered unnecessary or even potentially harmful.18-20 In the case of infertility, 
this could mean the use of unnecessary and expensive diagnostic tests and assisted 
reproductive technologies (ART) or the realization of complicated high-order 
pregnancies. This may have substantial physical and psychological consequences for 
the patients involved.
In an effort to provide clinicians easily with information regarding optimal health care, 
clinical practice guidelines (CPG's) were introduced to bridge the gap between best
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available evidence and the daily care delivered in the consulting room. These CPG's, 
based on solid research and valuable clinical experiences, are increasingly seen as one 
of the crucial tools for improving quality of care.20,21 They may help to increase the 
efficiency of care and reduce variation in performance between different professionals 
and hospital settings.
For reproductive medicine, several large professional organizations have developed 
clinical guidelines for fertility care in the past few years. Among those are the World 
Health Organization (WHO)22, the European Society for Human Reproduction and 
Embryology (ESHRE)23, the National Institute of Clinical Excellence (NICE)24, the 
American Society of Reproductive Medicine (ASRM)25, as well as several smaller 
country-specific fertility societies, like in Denmark and Austria26, and even third-party 
initiatives like the Institute for Clinical Systems Improvement (ICSI)27. In the 
Netherlands, the Dutch Society of Obstetrics and Gynaecology (NVOG) was one of the 
first medical specialist organizations to issue a broad guideline programme. To date, 
the NVOG guideline programme contains a total of 72 evidence- and consensus-based 
guidelines, all developed by a systematic NVOG-procedure (www.nvog.nl). For 
infertility, nine guidelines were developed and afterwards authorized in the general 
assembly. They comprise the entire spectrum of comprehensive fertility care, from the 
initial assessment of fertility and diagnostics to treatment possibilities and 
complications. In addition, the Dutch Ministry of Health, Welfare and Sport published a 
model protocol of the Dutch Embryo Act (http://www.vsop.nl/pdf/embryowet.pdf), 
which incorporates a diversity of clinical recommendations concerning IVF/ICSI 
treatment, and which is therefore considered a clinical guideline as well. The studies in 
this thesis will mostly focus on a set of national infertility guidelines in the 
Netherlands, which is shown in table I.
Table I ; T h e  Dutch infertility guidelines used for the studies in this thesis
Guideline Issued by Year of publication
Initial Assessment of Fertility NVOG 2005
Anovulation and Childwish NVOG 2004
Male Infertility NVOG 1998
Tubal Pathology NVOG 2005
Endometriosis NVOG 2001a
Premature Ovarian Failure (POF) NVOG 2001
Intra Uterine Insemination (IUI) NVOG 2000
Indications for In Vitro Fertilization treatment NVOG 1998
Ovarian Hyper Stimulation Syndrome (OHSS) NVOG 1998b
Embryo Act VWS 2002
a revised in 2006; b revised in 2008; both revisions not considered for the studies within this thesis 
NVOG=Dutch Society of Obstetrics and Gynaecology 
VWS= Ministry of Health, Welfare and Sports
Assessing the quality of healthcare by quality indicators
However, development and dissemination of guidelines does not warrant their 
implementation in daily practice.28 Former experience from NICE29 and a multicentre 
study in the Netherlands directed at the use of the NVOG guideline on IUI care, has 
learned that current infertility guideline adherence is not optimal (unpublished data).
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It can be assumed that this is also true for the remaining Dutch infertility guidelines, as 
they concern not only largely the same patient group, but are also used by exactly the 
same professionals.
A crucial first step towards improving guideline adherence is to gain insight into the 
application of clinical guidelines in daily practice, i.e. the current care. To estimate such 
quality of current care, valid quality indicators are necessary instruments.30 A Quality 
indicator can be defined as "a measurable element of practice performance for which 
there is evidence or consensus that it can be used to assess the quality of care provided, 
and hence change the quality of care provided".31. Such quality indicators should 
preferably be developed by means of a systematic approach.32 In general, three types 
of quality indicators can be distinguished, referring respectively to process and 
structure of medical care and the outcome of delivered care.33 Indicators are 
constructed of a numerator (the cases in which a recommendation is followed) and 
denominator (all cases in which the recommendation is applicable). For fertility care, 
an example of each of these three types is given in table II.
Table II; Examples of three types of quality indicators for fertility care
Indicator type Example of indicator construct
Process
Number of transfers in which no more than two embryos are transferred
Number of embryotransfers performed
Structure
Number of departments performing IUI who evaluate results annually
Number of departments performing IUI
Outcome
Number of started cycle of IVF/ICSI treatment that result in a life birth
Number of started cycles of IVF/ICSI treatment
Although the increasing need for evidence-based quality indicators in reproductive 
health care is recognized internationally, the search for the most suitable clinical 
indicators is still ongoing.34-36 The sparse initiatives taken in this direction are not 
satisfactory yet; they concern either public health oriented initiatives37-39 or lack a 
systematic development methodology.24 Therefore, completing existing infertility 
guidelines with systematically developed quality indicators, would be a valuable step 
forward in quality of care improvement.
Improving the quality of health care by guideline implementation
Nonetheless, even if such systematically developed quality indicators are available, 
improving guideline implementation is a complex and challenging task.
Grol and others propose a stepwise cyclical model to implement change in clinical 
practice.28,40 This model starts off with an assessment of current care, for example by 
means of quality indicators. Based on this, a change proposal can be made, which has 
to be based on available evidence or consensus. Then, barriers and facilitators to 
change should be identified, after which a tailored intervention can be developed. This
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intervention can then be disseminated and implemented. After the implementation 
period, the intervention has to be evaluated, if possible in a RCT or otherwise in a large 
observational study. If the targets set beforehand are not achieved, any of the 
preceding steps can be modified and followed anew. If the targets are indeed 
achieved, it still remains important to keep monitoring current care, as the 
sustainability of change is often questioned.
Regarding the implementation of guidelines in general, literature from several fields of 
healthcare discloses that there is no generic 'magic bullet'.40-42 Implementation 
strategies that appear to be successful and cost-effective in one clinical setting can 
easily fail in another context. Due to the lack of methodologically strong studies on 
guideline implementation strategies, the available evidence base continues to be 
imperfect.41 Moreover, the shortage of publications on process evaluations concerning 
tested strategies, makes it hard to gain further insight into the 'black box' of events 
during implementation43; it thus remains unclear why some interventions do and some 
do not bring about the desired effects.
Multifaceted interventions were previously thought to be more effective than single 
interventions44-46, but recent literature questions this anew41. However, a prospective 
identification of specific barriers to change and tailoring interventions to those barriers 
seems, though sometimes costly and time-consuming, to be still the most suitable way 
to develop an implementation strategy.40,41,47,48 The most frequently tested and 
studied interventions to implement guidelines encompass audit and feedback on 
current practice, dissemination of educational materials, reminders and the 
organization of educational meetings or outreach visits. However, in general, mainly 
organizational aspects and individual professionals are targeted in these 
implementation interventions. It is quite surprising that the role of patients in 
guideline implementation is still rather unexplored.40,49,50 For reproductive medicine or 
fertility care in particular, implementation research is still very rarely performed, 
leading to a lack of experiences and empirical data.
Patients as allies in guideline implementation
The concept of patient-centeredness and active patient participation in health care 
increasingly gains importance.16 This is, for instance, reflected in the development of 
numerous patient surveys on preferences, experiences and satisfaction with care, the 
development of decision aids for diverse clinical problems and the increasing uptake of 
patients as partners in professional guideline development. All these innovations aim 
to empower patients, as there is evidence that active patient participation is 
associated with better medical care and improved health outcomes.49,51-53 Although 
reviews of patient-oriented interventions to change clinical practice so far show mixed 
effects54, there might be a crucial role set aside for patients within guideline 
implementation. As some of the frequently described barriers to guideline 
implementation in reproductive medicine concern the patients themselves55,56, 
implementation of infertility guidelines might benefit from lifting these barriers by 
involving patients in the implementation process. We hypothesize patients could par 
excellence be the allies we need for successful implementation of the Dutch fertility 
guidelines, as fertility patients are, compared to other patient groups, generally young 
and critical towards their care providers. Moreover, Dutch fertility patients are united
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in the large and very active patient association 'Freya', which not only constitutes a 
source of information but also advocates patients rights and viewpoints.
In conclusion, there exists a considerable discrepancy between the worldwide 
development and dissemination of clinical practice guidelines for fertility care on the 
one hand, and the lack of knowledge on implementation of such guidelines on the 
other hand. It is exactly this discrepancy that imposes the necessity to perform more 
research in this field.
Study objectives
This thesis studies the quality of current fertility care and the improvement of the 
implementation of infertility guidelines in the Netherlands, while focusing on the role 
of patients. The research concerning the implementation of the Dutch infertility 
guideline programme, will follow the implementation model of Grol et al.40.
The research questions of the separate studies were as follows:
1. What can be regarded as a valid set of quality indicators for comprehensive fertility 
care? (chapter 2,3,4)
2. What is the quality of current fertility care in the Netherlands, and how is this 
experienced by patients? (chapter 4,5,6)
3. Does a combined professional and patient oriented intervention strategy prove 
more effective for the implementation of a infertility guideline programme than an 
exclusively professional oriented strategy? (chapter 7)
4. What are successful elements of the intervention strategies used? (chapter 7)
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Outline of this thesis
At first sight, infertility may seem one of few fields in health care for which defining 
quality indicators of good clinical care is a really easy task; don't fertility clinicians all 
strive to enable their patients to conceive a healthy newborn? However, taking only 
such an evident outcome measure into account as a predictor of good care, does not 
give us any starting-points for quality improvement programmes. Chapter 2 debates 
this issue and pleads for the development of evidence-based quality indicators for 
reproductive medicine. Chapter 3 subsequently describes the systematic development 
of a set of quality indicators for fertility care, which are based on international 
literature, the 9 Dutch NVOG-guidelines and the Model protocol of the Dutch Embryo 
Act. In chapter 4, this set of quality indicators are submitted to a practice test in 16 
Dutch fertility clinics, to assess several quality criteria per indicator and thus 
investigate their value for monitoring and improvement of clinical performance. A 
second aim, conditional on sufficient quality of the instrument, will be to assess the 
variation in current fertility care in a large sample of clinics. The objective of the study 
described in chapter 5 is to assess another aspect of current care; information 
provision to infertile couples. Adherence to guideline-recommendations on 
information provision will be examined by means of a patient survey. We will also 
assess patient satisfaction with this current practice and analyse to which extent 
variation in adherence is related to certain patient or clinic characteristics. The study 
described in chapter 6 is performed to gain more insight into the factors associated 
with positive patient experiences and satisfaction with fertility care. Furthermore, 
based on the results of the practice test described in chapter 4, two intervention 
strategies are developed to improve the implementation of the Dutch infertility 
guideline programme; a minimal strategy aimed at professionals and a maximal multi­
faceted strategy aimed at both professionals and patients. In chapter 7, we will 
describe the large cluster randomized trial in which these two implementation 
strategies are tested. It also reports on the process evaluation of, and the 
professionals' and patients' experiences with, these implementation strategies.
This thesis concludes with a general discussion in chapter 8, in which we reflect on the 
findings from the previous chapters while discussing the results and methodology. We 
will also present the main conclusions of the studies presented in this thesis, and 
discuss the implications for future practice as well as future research.
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Abstract
Monitoring reproductive health by the Reprostat indicators in Europe will facilitate the 
transparency of reproductive health as well as comparisons over time and between 
countries. However, for the monitoring and improvement of reproductive health care, 
we suggest the systematic development of evidence-based quality indicators, 
especially process and structure indicators.
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Reprostat
In accordance with Jahn et al.1, we agree that monitoring reproductive health in 
Europe by indicators facilitates the transparency of reproductive health as well as 
comparisons over time and between countries. Moreover, insight into actual 
reproductive health may give rise to initiatives to improve reproductive health. 
Therefore, we underwrite the importance of the development of an indicator set for 
reproductive health by 'Reprostat' (http://ec.europa.eu/health/ph_projects/2001/ 
monitoring/fp_monitoring_2001_a1_frep_02_en.pdf). However, the question is: what 
kind of indicators do we need in reproductive health? The Reprostat set contains 
mainly indicators for reproductive health and not for reproductive health care that we 
deliver in our clinics. Only a few of these indicators can be used as proxy measures for 
reproductive health care, such as Reprostat indicator 11: 'the proportion of deliveries 
associated with assisted reproductive technology (ART)'.
Monitoring reproductive health care
In our opinion, monitoring reproductive health care by quality indicators is also 
important, because it gives insight into the overall quality of delivered fertility care, it 
gives the opportunity to compare the delivered care with the recommended care in 
evidence-based guidelines and determination of substandard reproductive health care 
can easily guide improvement of this care. Therefore, to improve reproductive health 
care, a comprehensive set of clinical practice guidelines, valid quality indicators and 
effective strategies to implement the guidelines are needed.
Clinical practice guidelines provide clinicians easily accessible information regarding 
optimal reproductive health care. They are a tool to bridge the gap between evidence 
from the literature and the daily practice. However, clearly, the availability of 
evidence-based clinical guidelines by itself does not result in the delivery of optimal 
patient care.2,3 Implementation of the key recommendations of these guidelines 
requires more than just their publication and dissemination. Well-developed and 
evaluated strategies are necessary to facilitate this implementation. Quality indicators, 
defined as 'measurable elements of practice performance for which there is evidence 
or consensus that they can be used to assess the quality of care' 4, are crucial in this 
field; they measure the application of guidelines in daily practice and provide 
ammunition for feedback and development of implementation strategies (Figure 1).
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Figure 1 ; S c h e m a t i c  representation of the different steps from clinical evidence to the 
implementation in clinical practice.
Different types of indicators
Quality indicators can refer to processes and structures of medical care as well as to 
the outcome of delivered care.5 In the case of reproductive health care, 'the 
proportion of professionals monitoring ovarian stimulation by ultrasound' and 'the 
proportion of professionals informing infertile women about their reduced fertility by 
smoking' are process indicators, 'the proportion of hospitals with a laboratory 
accreditation' is a structure indicator and 'the live birth rate per cycle' and 'the 
proportion of women having been screened for Chlamydia trachomatis before uterine 
instrumentation' are outcome indicators.
Reproductive health care has so far mainly been monitored by outcome indicators 
prompting a recent debate in this journal.6 However, a disadvantage of using outcome 
indicators as a measurement of health care performance is the probability factor in 
health care. That means just the same medical treatment does not always have the 
same outcome and the other way around: an acceptable outcome does not have to be 
caused by a desirable treatment. Differences in outcome may also be due to case mix 
and the way of data collection.7,8 In addition, one of the potential risks to report 
quality of medical care in terms of outcome measurements only is the refusal to treat 
patients with a poor prognosis. The solution for these problems is to rely more on 
process and structure than on outcome indicators.
Process indicators tend to be more sensitive and rarely confounded by other factors, if 
properly designed.7,8 Moreover, process indicators can steer plans towards directed 
improvement activities.9 Of particular value are process or structure indicators that 
have been demonstrated to have a link with reproductive health-care outcome. The 
better this association, the stronger the benefits of applying the quality indicators are 
in terms of, for example, improved ongoing pregnancy rates and reduced multiple 
pregnancy rates.
Process and structure indicators should be based ideally on evidence-based guidelines, 
literature and experts' opinions. Moreover, such a set of indicators should be
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developed systematically and carefully, accepted by the target group and be sensitive 
to changes in the quality of care.10,11 
A need for process and structure indicators
However, despite growing recognition of the importance of increased transparency 
and more rigorous monitoring of health-care performance to decrease the delivery of 
inappropriate medical care, there have been only a few process or structure indicators 
suggested for reproductive health care.
For example, the clinical guideline about fertility assessment and treatment for people 
with fertility problems developed by the National Institute for Clinical Excellence 
contains five measures that could be used.12 Recently, we developed process and 
structure indicators for all national fertility guidelines of the Dutch Society for 
Obstetrics and Gynaecologists in two Dutch multicentred studies: (i) the Quality study 
on Intrauterine insemination in the Netherlands among Gynaecologists (KING study) 
and (ii) the study about fertility guidelines: Patient-Related Implementation in the 
Netherlands among Gynaecologists (SPRING study; description and trial protocol can 
be found at http:// clinicaltrials.gov/show/NCT00119925).
Role of ESHRE?
Last year, some new clinical guidelines were published by the European Society of 
Human Reproduction and Embryology (ESHRE) about, e.g. endometriosis, 
preimplantation genetic diagnosis and recurrent miscarriage.13-15 Although these 
evidence-based guidelines were well developed, unfortunately they were not 
accompanied by a set of quality indicators.
Recently, after an exploration of all national guidelines about intrauterine insemination 
in Europe, we suggested the establishment of a central body for reproductive medicine 
in Europe with expertise in up-to-date guideline development methodology to improve 
the scientific validity and the international consensus and to reduce the inefficient use 
of resources.16 We would argue for incorporating this central guideline development 
with a central indicator development to facilitate the evaluation of reproductive health 
care over time and between countries. The issue of whether or not ESHRE, e.g. under 
the auspices of the special interest group in Quality and Safety in ART, will act here as a 
central body should be discussed.
In conclusion, we welcome the Reprostat indicators for monitoring reproductive health 
in Europe and see it indeed as an important part of a quality control system. However, 
for the monitoring and improvement of reproductive health care, we suggest the 
central and systematic development of process and structure indicators that are based 
on evidence-based clinical guidelines.
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Abstract
Background: Internationally, several organizations have developed clinical guidelines 
for fertility care to supply patients with the best possible care. However, to improve 
the implementation of such guidelines, we first need to gain insight into the 
application of clinical guidelines in daily practice. Valid quality indicators are necessary 
to estimate actual guideline adherence. However, none of the existing fertility 
guideline programmes is accompanied by a satisfactory set of quality indicators. In this 
study, we develop a set of valid guideline-based quality indicators for fertility care.
Methods: A systematic RAND-modified Delphi method was used to develop a set of 
key recommendations based on 10 national Dutch fertility guidelines, international 
literature, and existing international indicators. Experts' opinions were used to 
appraise recommendations regarding specific criteria such as efficacy, level of health 
gain, applicability, and potential for care improvement.
Results: A representative set of 39 key recommendations was selected from 303 initial 
recommendations. The recommendations covered two structural and 37 procedural 
aspects, the latter encompassing 'indications for treatment', 'diagnostic procedures', 
'treatment procedures', and 'patient information'.
Conclusions: This study describes the systematic, stepwise method used to develop 39 
process and structure indicators that can be used to monitor fertility care.
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Introduction
The worldwide prevalence of infertility is estimated to range from 4% to 30%, affecting 
approximately 80 million couples around the globe.1,2 Infertility should therefore be 
considered one of the major health problems of the 21st century; it has great societal 
impact. Even if sufficient fertility services are available (as is the case in most western 
countries), they are not necessarily accessible for all couples nor is the quality 
necessarily satisfactory. The available diagnostic tests and assisted reproductive 
technologies (ART) are expensive and can have substantial physical and psychological 
consequences for the patients involved.3,4 Pregnancies after ART are more often 
complicated, particularly due to higher multiple pregnancy rates.57 Therefore, optimal 
organization of care should be strived for in order to supply patients with the best 
possible care and a minimum of complications at minimal costs. However, the question 
rises whether the current organization of fertility care serves this goal satisfactorily, 
and to what extent patients effectively receive such 'best care'.
To help physicians standardize fertility care and improve health outcomes, several 
large professional organizations have developed clinical guidelines for fertility care in 
the past few years. These include the National Institute of Clinical Excellence (NICE), 
the American Society of Reproductive Medicine (ASRM), the European Society for 
Human Reproduction and Embryology (ESHRE), as well as several country-specific 
fertility societies. In the Netherlands, the Dutch Society for Obstetrics and Gynaecology 
(NVOG) has issued nine national guidelines for fertility care. In general, clinical practice 
guidelines, preferably based on solid research and valuable clinical experience, are 
increasingly seen as one of the crucial tools for achieving high quality of care. 8 
Guidelines can easily provide clinicians with information regarding optimal health care, 
and they aim at increasing the efficiency of care and reducing variation in performance 
between different professionals and hospitals. Regarding fertility care, adherence to 
guidelines can decrease unnecessary diagnostics and treatments, which reduces the 
number of complications and expenditures. However, publication and dissemination of 
guidelines is not automatically followed by a change or improvement of health care9; 
guidelines do not implement themselves10. From our own experience in a multicentre 
quality study of intrauterine insemination (IUI) in the Netherlands, we have learned 
that current guideline adherence is not optimal (unpublished data). The first step 
toward improving adherence is to gain insight into the application of clinical guidelines 
in daily practice, i.e. the actual care. To estimate such quality of actual care, valid 
quality indicators are necessary11 because they are the missing link in connecting 
evidence from guidelines to practice. Three types of quality indicators can be 
distinguished referring to the process and structure of medical care and the outcome 
of delivered care. Such quality indicators should preferably be developed by means of 
a systematic method.12 The increasing need for evidence-based quality indicators in 
reproductive health care is recognized internationally as well, but the search for the 
most suitable indicators is still ongoing.13-15 Unfortunately, none of the existing fertility 
guidelines is accompanied by a satisfactory set of systematically developed quality 
indicators. In our current study, we therefore aimed to develop a set of valid quality 
indicators covering all aspects of fertility care.
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Materials and methods
Setting
A systematic RAND-modified Delphi method16,17, including independent expert ratings 
and repetitive feedback, was used to develop a set of key recommendations suitable 
for transcription into quality indicators. We based our study on international literature 
and the nine NVOG fertility guidelines: initial assessment of fertility, anovulation and 
child wish, male infertility, tubal pathology, endometriosis, premature ovarian failure 
(POF), intra uterine insemination (IUI), indications for in vitro fertilization (IVF) 
treatment and ovarian hyperstimulation syndrome (OHSS) (http://www.nvog- 
documenten.nl, in Dutch). These guidelines are consensus or evidence based and were 
systematically developed according to NVOG standards and issued between 1998 and 
2005. In addition, the Dutch Ministry of Health, Welfare and Sport published a model 
protocol of the Dutch Embryo Act (http://www.vsop.nl/pdf/embryowet.pdf, in Dutch), 
which incorporates a diversity of clinical recommendations concerning IVF treatment, 
and which is considered a clinical guideline as well. The invited expert panels consisted 
of a representative diversity of clinical experts and guideline users18, working at 
various types of fertility clinics ranging from small regional hospitals to tertiary 
university clinics. Among them were gynaecologists, fertility clinicians (medical doctors 
who specialize in assisted reproduction, but who do not have a postgraduate 
specialization in obstetrics and gynaecology), gynaecologists in training, and members 
of the original guideline development workgroups.
Procedure for indicator development
The procedure for quality indicator development consisted of six steps, which were 
completed consecutively as shown in Figure I: 1) literature search, 2) selection of 
recommendations, 3) written questionnaire, 4) consensus meeting, 5) critical 
evaluation, and 6) consultation with guideline developers:
1. Literature search
We searched Medline for existing indicators for reproductive health and specifically 
fertility care. The key words used were 'subfertility', 'infertility', and 'reproductive 
health care' combined with 'guidelines' or 'clinical guidelines' and 'quality indicators'. 
Furthermore, we searched the Internet for potential sources of quality indicators, e.g. 
governmental reports, reports from national and international fertility societies, and 
commercial initiatives. We paid specific attention to existing guidelines concerning 
reproductive health or infertility. For this purpose we used the Websites of the 
National Guideline Clearinghouse (www.guidelines.gov) and the Geneva Foundation 
for Medical Education and Research (www.gfmer.ch).
2. Selection of recommendations
Firstly, four authors (SM, RH, WN, and JK) separately selected all the recommendations 
from the nine NVOG guidelines and the Dutch Embryo Act. To take international 
consensus and solid evidence into account as well, we added all the recommendations 
with A-level evidence from the NICE fertility guideline that did not have an exact 
equivalent in the Dutch set of recommendations. The collected recommendations 
were edited in three different questionnaires for the consensus panel method in step
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3. Questionnaire 1 covered 'endometriosis', 'anovulation', and 'IUI' (131 items); 
questionnaire 2, 'initial assessment of fertility', 'male infertility', and 'tubal pathology' 
(110 items); and questionnaire 3, 'indications for IVF', 'OHSS', 'POF' and the 'Embryo 
Act' (99 items).
3. Written questionnaire
Questionnaires were sent to 63 experts who were divided into three expert panels of 
21 members each, and the panels appraised the questionnaires according to a RAND- 
modified Delphi method12. Each panel received the questionnaire corresponding to the 
area of interest of its members. Whenever available in the guidelines, international 
evidence levels were provided to facilitate the decision making. Experts were asked to 
score the key recommendations on a nine-point Likert scale ranging from 1 (hardly 
relevant) to 9 (extremely relevant), with respect to their impact on both 'health gain' 
,i.e. health as 'physical, mental, and social well-being' 19, and 'overall efficacy', i.e. 
prevention of unnecessary medical treatment and promotion of cost-effectiveness. 
Moreover, the experts were asked to provide for each guideline a top-five ranking of 
recommendations they considered 'most important' and 'representative' to assess the 
quality of clinical performance. They were also offered an opportunity to provide 
comments and suggest additional items. First, we analysed the data from the returned 
questionnaires and calculated median scores for 'health gain' and 'overall efficacy' for 
each recommendation. The selected recommendations were rated as valid if they 
matched the criterion described by Campbell20: an overall panel median score of 8 or 
9. To rate a recommendation as valid, there also had to be 'agreement' between the 
ratings of the independent panellists. Agreement was defined as 75% or more of 
ratings within a panel being in the lowest tertile (1, 2, 3) or the highest tertile (7, 8, 9), 
so that items that were mainly in the unequivocal tertile (4, 5, 6) were excluded.
Second, we scored the recommendations rated valid by means of the Campbell criteria 
by awarding them points according to the expert's top-five ranking. For each number- 
one ranking by an expert, we awarded a recommendation 5 points, for each number- 
two ranking, we awarded 4 points, and so on. This way, we created a list of scores 
reflecting the weight that experts assigned to each recommendation. For each 
guideline, the recommendations with a value of three points or more were listed top­
item down. Next, a consensus meeting took place with these listings as feedback.
4. Consensus meeting
All participants in the questionnaire round were invited to a consensus meeting, where
a discussion about the results of step 3 was initiated. The participants were divided
into three panels, each assessing separate guidelines. Each panel was asked to discuss
and reconsider the previous rankings and aim at a new top five; selected
recommendations had to be 'applicable' for indicator development and had to have
'potential for improvement' as well. The panels were allowed to suggest additional
recommendations. The discussions lasted approximately 2 hours and were chaired by
four of the authors (SM, RH, WN, and JK), who are experienced in performance
measurement. This resulted in a final consensus-based top five for each guideline,
ready for consideration in step 5.
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5. Critical evaluation
Four authors (SM, RH, WN, and JK) critically evaluated the top-five rankings from step
4. The recommendations were once more appraised with regard to both 'improvement 
potential' and 'applicability' after operationalization for the clinical setting. Some items 
were excluded or combined due to overlap between guidelines or pragmatic reasons 
concerning operationalization.
6. Consultation with guideline developers.
As a sixth and final step, we presented the final top-five rankings in a third feedback 
round to 12 gynaecologists who had participated in the development of these 
guidelines, and are therefore considered opinion leaders in the field.
Results
Step 1
The online search of Medline and the additional Internet search revealed that several 
national and international organizations issued specific guideline programmes in the 
field of reproductive health or infertility. Nevertheless, even widely distributed 
programmes, such as the ASRM and ESHRE programmes, are usually unaccompanied 
by quality indicators. However, programmes that are indeed accompanied by indicator 
sets21-24 focus mainly on a public health perspective. They aim, for example, at 
monitoring prevalences of contraceptive use, Chlamydia infections, and induced 
abortions to describe current reproductive health care, but are clearly not specifically 
developed for the extensive domain of clinical outpatient fertility care. In contrast, the 
National Institute of Clinical Excellence (NICE) issued their Clinical Guideline (CG) 11 
concerning infertility25 , and it was accompanied by seven 'key priorities for 
implementation'. Because of the lack of other suitable and systematically developed 
infertility indicators for clinical care, we decided to include all 28 level-A-evidence 
recommendations from the CG11 for appraisal in our selection procedure (Figure I). 
Step 2
Altogether, 275 recommendations extracted from the NVOG guidelines were added. 
This resulted in a total of 303 recommendations for appraisal by the experts.
Step 3
Initially, 63 questionnaires were sent to the experts, of which 47 (75%) were returned 
fully completed. The response rates were 71% (n=15) for questionnaire 1, 76% (n=16) 
for questionnaire 2, and 76% (n=16) for questionnaire 3. The 303 preselected 
recommendations were reduced to 139 items in this selection round, while 36 new 
items were suggested. This resulted in 175 items for appraisal during the consensus 
round.
Step 4
Eleven experts attended the consensus meeting: 3 guideline developers, 6 
gynaecologists, 1 fertility clinician, and 1 gynaecologist in training. They discussed and 
prioritized the 175 items, resulting in a new selection of 53 recommendations.
Step 5
Critical evaluation of the 53 recommendations led to the exclusion of 6 items, and 
another 16 were combined to 8 new items. A semifinal set of 39 key recommendations 
was offered to the guideline developers for approval.
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Step 6
All the guideline developers approved of the set of 39 key recommendations, which 
was thus finalized (Table II).
Final set
These 39 key recommendations were transcribed into 39 quality indicators concerning 
either structural or procedural domains of fertility care. Table I reflects for each 
guideline the selection of key recommendations within the various domains. Both 
structural (n=2) and procedural (n=37) aspects were selected. The latter encompass 
'indications for ART' (n=7), 'diagnostic procedures' (n=6), 'treatment procedures' 
(n=20) and 'patient information' (n=4). In expert rounds 3 and 4, 8 of 16 patient 
information items (50%) were selected, as were 24 of 132 treatment procedure items 
(18%) and 11 of 91 diagnostic items (12%).
Furthermore, 2 of 5 structure items (40%) concerning the annual evaluation of IUI and 
the accreditation of IVF laboratories were selected (Table II). Only one of the 36 newly 
suggested items (regarding lifestyle advice) was included in the final set. Of the 28 
level-A-evidence recommendations from the NICE guideline that were initially added in 
the first step, only 2 were included in the final set. Another 9 (non-level-A evidence) 
recommendations were common to both the NICE and the NVOG guidelines (Table II).
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Figure I a stepwise RAND-modified Delphi method to develop quality indicators for fertility care
Step 1 Step 2
Step 3
Step 4
Step 5
Step 6
Table I: Different domains of key recommendations per guideline
Guidelines OFO Anovulation Male
factor
Tubal
pathology
Endo­
metriosis
POF IUI Indications 
for IVF
OHSS Embryo
Act
Domains after 
Steps 3 and 4
Domains in 
final set
Type of recommendation 
Process (total) 37
Diagnosis
mro_ (23) 3 (20) 1 (3) 3 (5) (5) (1) - (1) - 11 (91) 6
(Contra-) Indications 
for ART
— (3) - (2) 1 (1) 1 (1) 3 (5) 3 (19) - - 8 (31) 7
Treatment procedures (5) 5 (37) 2 (8) 4 (16) 1 (4) 1 (2) 6a (24) 1a 3 (21) 1 (15) 24b (132) 20b
Patient information 1c 2 (4) - (1) - 4 (5) - (1) (4) 1 (1) 8c (16) 4c
Structure - - - - - - 1 (3) - (1) 1 (1) 2 (5) 2
Total selected 
recommendations
5 (38) 7)
lg_ 5 (28) 5 (22) 5 (10) 6 (13) 10 (33) 4 (20) 3 (27) 3 (17) 53 (275) 39
Total indicators formed 5 6 3 4 3 3 5 4 3 3 39
Every column per guideline shows the amount of key recommendations selected by the consensus-procedure; between parentheses is the total amount of recommendations eligible for selection. 
OHSS, ovarian hyper stimulation syndrome; OFO, initial assessment of fertility; POF, premature ovarian failure. 
a An item deriving from NICE guideline CG11. 
b 2 items deriving from NICE guideline CG11. 
c An item newly suggested by the expert panel.
Table II: Final set of key recommendations eligible for indicator transcription per guideline, indicator-type and origin
Guideline Type of indicator Guideline of origin
Initial assessment o f fertility
The initial fertility assessment should result in both a diagnosis and a prognosis. Process
The initial fertility assessment should consist of three parts: semen analysis, tuba-passage and cycle-analysis. Process
Couple's history-taking should cover at least: age of both partners, duration of infertility, type of couple's infertility Process
(primary or secondary).
Woman's physical examination should include assessment of the body mass index. Process
Life-style advice concerning bodyweight, smoking and alcohol and drug use should be part of the counselling regarding Process
pregnancy-probabilities.
Anovulation and childwish
Patients with overweight should, with regard to their fertility-treatment and overall health, be informed of the Process
importance of weight reduction by means of life-style changes.
The goal of ovulation-induction should be mono-ovulation. Process
The ovarian response to hormonal stimulation should be performed by regular transvaginal ultrasound (frequency of 1 - Process
3 times/week).
Women with WHO Group II anovulatory infertility should be given anti-oestrogen as first-choice medication for Process
ovulation induction.
Before starting ovulation induction treatment, the patient should be informed about specific side-effects of medication, 
the need for regular intensive follow-up during treatment, the increased risks of multiple pregnancy, OHSS syndrome Process
and spontaneous abortion.
In case of three or more follicles >16 mm and/or more than five follicles >12 mm during an ovulation-induction Process
treatment cycle, the patient has to be informed that coitus is prohibited or contraception has to be used.
Male factor infertility
In case of normospermia (WHO-criteria), semen-analysis should not be repeated, and no additional andrological tests Process
should be performed.
In case of an abnormal semen-analysis (WHO-criteria), the physician should perform an andrological anamnesis, a Process
physical examination and at least one extra semen-analysis.
In case of an idiopathic oligoasthenoteratozoospermia, no hormones, vitamins or non-steroidal anti-inflammatory drugs Process
should be prescribed to improve semen-quality.
Tubal pathology
In case of IVF because of inoperable tubapathology, salpingectomy shoud be performed when bilateral hydrosalpinges Process
are visible by ultrasound.
NVOG
NVOG
NVOG
NVOG
Panel,NICE
NVOG,NICE
NVOG
NVOG
NVOG
NVOG
NVOG
NVOG
NVOG,NICE
NVOG,NICE
NVOG
Guideline Type of indicator Guideline of origin
In case of tubal pathology, both diagnostic laparoscopy and complementary examination of the endosalpinx 
(hysterosalpingogram or salpingo-scopy) should be performed to decide in favour of tubal surgery.
The indication for tubal surgery in a patient should be made by the future surgeon himself (i.e. videomaterial or by 
performing a diagnostic laparoscopy).
Except for refertilization, the female age limit for tubal surgery should be 40 years.
Endometriosis
Prior to laparoscopy intended to diagnose endometriosis, at least an anamnesis should be performed for those with a 
suspect history, a vaginal and speculum examination.
Women with peritoneal endometriosis and infertility should not be given hormonal treatment to improve fecundicity.
In case of unexplained infertility and peritoneal endometriosis, IUI with ovarian stimulation should be given as primary 
treatment to improve fecundicity.
Premature ovarian failure (POF)
Patients with POF, should not be offered any treatment to pursue pregnancy, except for oocyte donation.
In case POF is diagnosed, the following should be discussed with the patient: possibilities to receive psychological 
support, oocyte-donation, the probabilities of a spontaneous conception, the option of assessing karyotype (POF, Fragile 
X, Auto-immune diseases) and the (dis-)advantages of hormone replacement therapy
In every patient with POF who chooses not to have hormonal supplementation therapy, bone-densitrometry should be 
performed.
Intra uterine insemination (IUI)
In case of unexplained infertility, stimulated IUI should not be offered, even though it is associated with higher 
pregnancy rates than unstimulated IUI, because it carries a risk of multiple pregnancy.
The diagnosis 'cervical factor' is an indication for IUI in the unstimulated cycle.
In case of IUI in the stimulated cycle, ovarian response should be monitored by transvaginal ultrasound.
Each department performing IUI should evaluate their results annually.
IUI should not be performed in case of more than three follicles .16 mm or more than five follicles .12 mm. In both 
cases, the use of contraceptives should be advised as well.
Indications fo r  IVF/ICSI
In case of severe endometriosis and decreased tubal function (but no bilateral occlusion), there is an indication for IVF 
after 2 years of infertility.
In case of male infertility with volume x concentration x motility < 1 x10 /ml (before capacitation) there is a direct 
indication for ICSI-treatment.
In case of unexplained infertility in a woman < 36 years, there is an indication for IVF after 3 years of infertility.
Routine use of hCG for luteal support after IVF is not recommended.
Process
Process
Process
Process
Process
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Process
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Guideline Type of indicator Guideline of origin
Ovarian hyper stimulation syndrome (OHSS)
• In case of ovulation-induction with gonadotropins, no ovulatory HCG dose should be given and protected intercourse 
should be advised in case of the presence of three or more dominant follicles > 18 mm or five or more follicles > 15 mm 
and/or a serum-estradiol level > 3.0 nmol/l.
Process NVOG
• In case of OHSS with haemoconcentration > 45%, the patient should be admitted to the hospital. Process NVOG
• In case of severe OHSS and hospital admission, patients should be given thrombosis-prophylaxis (low molecular weight 
heparin).
Embryo act
Process NVOG
• IVF-laboratories should be accredited by the CCKL (Dutch Coordinating Committee for maintenance of Quality Standards 
in Laboratory research).
Structure NVOG
• Per embryo transfer no more than two embryos should be transferred at the same time. Process NVOG,NICE
• During an intake prior to IVF-treatment, the following should be discussed:
• The risks of hyperstimulation, poor response and accompanying consequences, complications such as infection and 
bleeding, the laboratory procedure and the risk of swapping-and laboratory-mistakes.
• The chances of success, pregnancy after SET and DET, the chances of congenital diseases/malformations, ectopic 
pregnancy, multiple pregnancy and spontaneous abortion and possible unknown long-term risks.
• The emotional aspects of the treatment, how patients can communicate that they are in need of extra emotional 
support and the existence of the patient association for infertility to share experiences and gain information from 
the patient's perspective.
• How hospital care during treatment is organized and which caretakers are involved in the treatment procedure, how 
patients should contact the fertility team in case of problems or complaints and how the fertility team can be 
contacted, especially outside daytime-hours.
Process NVOG
WHO, World Health Organization; NVOG, derived from a guideline of the Dutch Society for Obstetrics and Gynaecology; NICE, (partially) derived from the Clinical Guideline 11 regarding infertility of NICE; 
Panel, item that was additionally suggested by the expert panel; SET, single embryo transfer; DET, double embryo transfer; VCM, volume x concentration x motility.
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Discussion
When we consider our final set, it appears that 40% of the structure items and 50% of 
patient-information items were selected, which suggests that professionals 
acknowledge the importance of an accurate quality framework and complete patient 
information as conditions for 'best possible care'. Furthermore, the panellists 
suggested 36 new items before step 3, but only one of them was included in the final 
set (Table II). Experts apparently consider the current guideline contents as possibly 
incomplete, but still sufficiently satisfactory regarding clinical relevance.
The fact that the quality indicators in our set refer mainly to the process of care, a few 
to structure, and none to outcome reflects the ratios of these types of 
recommendations in guidelines. The lack of evidence for the best outcome measures 
in clinical care explains the absence of outcome-related recommendations in 
guidelines that are consensus and evidence based. Nevertheless, outcome indicators 
(e.g. 'live birth rate per treatment cycle') are the mean criterion used for judging 
professionals and hospitals in daily practice.13 Outcome measures, on the one hand, 
have the disadvantage of being sensitive to case mix and the methods of data 
collection.26,27 In addition, they may affect our judgment of the quality of care 
provided because good outcomes do not necessarily mean that care was delivered 
well. Process indicators, on the other hand, assess the process of care and reveal 
exactly where changes can be made, while structure indicators provide us with the 
framework to do so. Therefore, process and structure indicators are more valuable in 
quality improvement programmes because, unlike outcome measures, they offer a 
concrete starting point for improvement. This is especially true when process 
measures have been proven to relate to outcome measures.
In reproductive health care, choosing the best outcome measures to define the
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standards of success is currently being discussed internationally. ' ' '  A comparison 
of this ongoing discussion and activity about outcome measures with the almost 
complete lack of initiatives for developing and measuring process and structure 
indicators, highlights a striking discrepancy. Apparently, little effort has been made to 
bridge the gap between the evidence we make available in our guidelines and the 
supposedly evidence-based care we deliver in practice.
The literature search revealed one similar initiative of indicator development for 
clinical fertility care, the NICE fertility guideline.25 NICE used a systematic approach 
similar to ours to develop their auditable standards (http://www.nice.org.uk). 
However, a comparison of the contents of our final indicator set with NICE's seven key 
priorities shows that only one indicator is common to both sets: 'no more than two 
embryos should be transferred per embryotransfer' (Table II). Aside from similarities in 
guideline contents and health systems in both countries, different stakeholders and 
slightly different selection criteria have probably influenced the composition of both 
final sets. Especially the NICE criterion 'make efficient use of National Health Service 
resources', already curtails potential indicators because the lack of suitable resources 
would render indicators ineligible. In addition, NICE explicitly tries to include between 
5 and 10 key priorities in their guidelines. This upper limit is in line with most quality
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measure projects currently being realized.30 Regarding fertility care, having many 
indicators would, in our opinion, better suit such a wide guideline programme that 
encompasses several different domains. However, before cutting back our set of 39 
indicators, we recommend to perform a practice test.
There are some methodology limitations that could be considered with respect to the 
range of our final set. Comparable combined RAND-modified Delphi techniques have
20,31,32proven effective in several indicator-development initiatives. However, the
limitations and validity of such procedures have been questioned regularly.33 In 
particular, the accuracy and validity is suggested to depend on several expert 
characteristics.34 Questions may arise about whether the group of experts is 
heterogeneous enough and whether the individual expert contributions are of equal 
value. However, the group of experts in a small country like the Netherlands (which 
has only 13 licensed IVF clinics including eight university centres) is limited. We 
therefore think that the level of professional participation in our expert panels does 
reliably reflect the country's overall level of expertise. Moreover, a consensus-based- 
panel approach has the advantage of directly involving the target group of 
professionals in the procedure. By obtaining their consent during the selection process, 
we founded a substantial supporting base for our set of quality indicators, and 
consequently, for any national measurement programme or guideline-implementation 
strategy that may follow.
The systematic approach and panel composition underline how face and content 
validity are accounted for in this study. However, content validity alone is not enough 
to entitle indicators as valid. As already stated, improvement programmes in health 
care should preferably be tailor-made and therefore based on adequate 
measurements of performance. Although we have already considered selected criteria 
for operationalization (e.g. measurability and potential for improvement) during the 
selection rounds, the suggested quality indicators need to be submitted to a practice 
test. Then certain clinimetric characteristics, such as measurability, feasibility, 
reliability, and improvement potential, can be properly assessed. Furthermore, efforts 
should be made to try to relate indicator scores to outcome measures in order to 
assess the clinical importance of the separate quality indicators. Ultimately, this 
practice test will show whether these indicators will hold up in the future. 
Independently of any future adjustments, the complete indicator set presented in this 
paper complements the existing guidelines and can still serve as a benchmarking 
instrument for educational or quality-improvement activities in fertility centres.
This study took international literature into account, but still took place within the 
framework of the Dutch fertility guidelines. This implies that some of the selected 
indicators are particularly valuable in the Dutch situation and less suitable 
internationally. For example, the recommendation 'no more than two embryos should 
be transferred per embryotransfer' would probably not withstand the selection if the 
panellists were from the United States. Still, the topic of this indicator. e.g. 'the 
maximum number of embryos transferred' could be maintained for international 
application when adapted to specific national standards.
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We strongly encourage the development of international fertility guidelines based on 
both international evidence and consensus, in initiatives like the one ESHRE is currently 
undertaking (www.eshre.com). However, we suggest that all such initiatives be 
accompanied by the simultaneous development of quality indicators by an 
international panel. Such quality indicators should be tested in practice first, and 
should preferably match the health-care systems and ethics of the various countries 
involved. Suitable data resources should be appointed or adapted to match the 
demands of proper indicator measurement. The consensus method and the domains 
of fertility care described in this paper could serve as a framework for further work in 
this field.
In conclusion, we have described a systematic procedure of developing a complete set 
of process and structure indicators based on an entire national fertility guideline 
programme. These 39 quality indicators can be used to monitor fertility care. However, 
their potential to do so accurately must first be proven in a proper practice test.
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Abstract
Background: About 30-40% of patients do not receive care based on available 
scientific evidence. For infertility, this may imply unnecessary and expensive diagnostic 
tests and treatments. It is therefore important to identify gaps in performance by 
monitoring current fertility care. A set of 39 guideline-based quality indicators was 
previously developed for this purpose. This study aimed to assess several quality 
criteria of the indicator-set and to use the set to assess current fertility care.
Methods: A historic cohort study was performed in 16 Dutch fertility clinics; 2698 
couples were invited to participate. Indicator data were gathered by medical record 
extraction, and patient and professional questionnaires. Quality criteria for each 
indicator (measurability, reliability, applicability, improvement potential, 
discriminatory capacity, complexity and case-mix stability) were assessed. Current 
practice was measured as adherence to the separate indicators.
Results: One thousand four-hundred and ninety-nine (56%) couples participated. All 
indicators were measurable, but the results for the other quality criteria varied. In 
total, 14 of the 39 indicators scored <50% adherence. Variation in performance 
between the clinics was up to 100%. The highest median adherence (86%) is found 
within the guideline 'indications for IVF-treatment'. The lowest median adherence is 
found within the guideline 'initial assessment of fertility' (43%), followed closely by the 
guideline 'anovulation' (44%).
Conclusions: This study shows the quality of the developed indicator-set for 
monitoring clinical fertility care. A first assessment in the Netherlands reveals large 
variation between clinics and ample room for improvement of care.
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Introduction
According to medical literature, ~30-40% of patients do not receive care based on 
available scientific evidence.1 On top of this, an estimated 20-25% of provided health 
care is unnecessary.2-4 In the case of infertility, this could mean the use of unnecessary 
and expensive diagnostic tests and assisted reproduction technologies (ART) or the 
realization of complicated high-order pregnancies. Subsequently, this may have 
substantial physical and psychological consequences for the patients involved.5-9 
Patients should receive the best achievable care with a minimum of complications and 
at minimal costs. To improve both outcome and process of health care, clinical practice 
guidelines have been developed summarizing the best available evidence.10 However, 
such guidelines do not implement themselves.11 Efforts to monitor actual health care 
and to identify gaps in performance show where improvement is needed. Guideline- 
based quality indicators are useful tools for monitoring health care.12 Consequently, 
they can be used to assess changes in clinical practice as well, which makes them 
indispensable instruments within clinical improvement programmes.
We reported previously on the development of a guideline-based set of 39 process and 
structure indicators for the entire spectrum of clinical fertility care by means of a 
systematic six-step RAND-modified Delphi method.13 The selected indicators focus on 
process and structure of fertility care rather than outcome. Although current 
international debate focuses mainly on outcome measures14,15, process indicators are
valuable instruments within performance assessment and improvement programmes
13 16 21
because they reveal exactly where changes in care might be necessary. ' - This does 
not mean, however, that clinical outcomes are unimportant, but to change outcomes, 
it is necessary to first initiate changes in the process and structure of care. The primary 
aim of this study was to test the indicator-set for several quality criteria.22 Such a 
practice test is necessary to demonstrate its value as an instrument for monitoring and 
improvement of clinical performance.23-27 The second aim, conditional on sufficient 
quality of the instrument, was to assess the variation in current fertility care in a large 
sample of clinics.
Materials and Methods
Study design and study population
We conducted a retrospective cohort study in 16 Dutch clinics using medical record 
and questionnaire data. The study was approved for all clinics by 'the Regional Review 
Board for Human Research (CMO) Arnhem-Nijmegen (CMO no. 2004/193)'. To assess 
current clinical fertility care in the Netherlands, we aimed at including a broad patient 
cohort from the participating clinics. The clinics' characteristics varied to ensure that 
delivered care was representative for Dutch standards. There was one academic and 
one tertiary care clinic and seven clinics offered secondary care (IVF/ICSI-treatment). 
These clinics were all also teaching clinics and of large or intermediate size; the other 
seven clinics were smaller, non-teaching facilities. In total, 15 clinics were national 
health, and one of the smaller secondary care clinics was a private clinic.
To include a representative patient group, potential participating couples were 
randomly selected by means of each clinics' financial DBC (Diagnosis/Treatment 
Combination code) registration database. In this national registration, patients 
undergoing diagnostics or treatment for infertility are identified with a specific
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Fertility-code (F-code). Couples were apt for inclusion if they had an active F-code 
anytime between 1 April and 30 June 2005. The assessment focused on the care they 
received in the period 1 January-30 June 2005. In each clinic, a random sample of 
eligible couples (50-500 depending on the size of the clinic) was invited to participate 
in the study. They were sent an informed consent form and a questionnaire: the 
former included consent to use their medical data from the clinic. Couples who had 
insufficient knowledge of the Dutch language or did not visit the fertility clinic in the 
study period were excluded. In total, 2698 couples were invited.
The clinical quality indicators
We used a set of 39 clinical quality indicators for fertility care, which was developed 
using a rigorous and systematic six-step approach. The set was based on literature, 
existing international guidelines and indicators and 10 Dutch (evidence and consensus 
based) fertility guidelines.13 The latter includes the Dutch Embryo Act and nine fertility 
guidelines of the Dutch Society of Obstetrics and Gynecology (NVOG): initial 
assessment of fertility, anovulation and child wish, male infertility, tubal pathology, 
endometriosis, premature ovarian failure (POF), intrauterine insemination (IUI), 
indications for IVF treatment and ovarian hyperstimulation syndrome (OHSS).
The indicator-set encompasses 37 process indicators and 2 structural indicators, and 
comprises the entire spectrum of fertility care: the initial assessment of fertility, 
diagnostics, treatments and possible complications. Indicators were operationalized by 
the construction of a numerator and denominator, each consisting of several variables. 
The numerator is formed by the proportion of patients in which there is adherence to 
a recommendation and the denominator by the proportion of patients in which the 
recommendation is applicable. The indicators within the guideline 'initial assessment 
of fertility' are shown in Table I. The remaining indicators, ranked per guideline, are 
shown in Supplementary Table Ia-e.
Data collection to assess quality criteria and current practice
Data for indicators regarding indications for ART (n=7), diagnostic procedures (n=6) 
and treatment procedures (n=20) were extracted from the individual medical records 
by three trained investigators. Data for indicators regarding information provision to 
patients (n=4) were collected by means of a patient questionnaire and data for 
indicators regarding the structure of care (n=2) by a short professional questionnaire. 
The patient questionnaire was piloted in a group of 30 infertile couples and this led to 
minor adjustments in formulation of the questions before it was used in the total study 
population.
Definitions and analysis
The application of a systematic and rigorous consensus method for indicator 
development results in high face and content validity of this indicator-set. We 
measured the following quality criteria of all indicators in the set, in order to
12 23-25 27-30demonstrate its value as an instrument for assessment of fertility care. ' " ' 
Interested readers are referred to Supplementary Table II in the web-based version of 
this article which contains a list of suggested additional reading on the use and validity 
of (process) indicators in clinical quality and performance assessment.
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(i) Measurability: an indicator is considered measurable if data to fill the numerator 
and denominator of the indicator can be made available through data collection 
(e.g. medical records, complication or treatment databases or a survey).23
(ii) Reliability: if the measurement of indicator data by two different data-collectors 
is reliably comparable, there is high reliability.23 Two independent reviewers 
abstracted a random sample of 10% (n=32) of medical records from two 
participating clinics. The extent of agreement between these data reviewers on 
the level of process indicator scores, corrected for chance, was calculated using 
Cohen's kappa coefficient of inter-rater reliability. Coefficients of 0.4-0.6 
represent moderate inter-rater reliability, coefficients of 0.61 or higher are 
considered very good.31
(iii) Applicability: for accurate performance assessment, an indicator is preferably 
applicable to a substantial proportion of reviewed patients (>10 cases); this is 
referred to as applicability.12
(iv) Improvement potential: when an indicator is used to detect changes in clinical 
performance, it is a prerequisite that improvement is possible at all; if overall 
performance for a certain indicator is already very high, the indicator has no 
improvement potential. We defined improvement potential as an overall 
performance score of <90%.27
(v) Discriminatory capacity: the discriminatory capacity indicates whether an 
indicator is able to discriminate practice performance between different 
hospitals. High discriminatory capacity is therefore present when the range in 
scores between the lowest- and highest-scoring clinics is >20%.12
(vi) Complexity: the concept of complexity was used for the number of variables 
needed to fill the numerator and denominator of an indicator. Complexity is thus 
a measure that reflects the amount of investments needed to assess an 
indicator; the higher the complexity the more effort it takes to measure an 
indicator. The maximum value for complexity was beforehand set at five 
different variables; in the case of complexity scores of more than five variables, 
subdivision of the indicator was considered. Variables relating to the inclusion of 
patients were not counted because those variables can vary per clinic and 
depend on design of the medical records. For the indicators measured by 
medical record extraction, two researchers (W.L.D.M.N. and S.M.M.) counted 
independently the number of variables to fill the numerator and denominator of 
each indicator. For the indicators measured by means of a professional or patient 
questionnaire, we counted the number of answers needed to determine the 
indicator. If there was disagreement between the two researchers' findings, 
discussion took place to reach an agreement.
(vii) Case-mix stability: case-mix stability is an important asset that enables the 
application of an indicator for monitoring within a specific hospital over time or 
to compare hospitals of different sizes and settings.23 Therefore, the relationship 
between certain patient-characteristics that may vary considerably between 
clinics ['woman's age', 'type of infertility (primary or secondary)' and 'duration of 
infertility'] and the indicator scores was analysed to decide whether correction 
for case mix is necessary.
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Analysis
Collected data were entered in a database using the Statistical Package for the Social 
Sciences (SPSS 14.0 for Windows, SPSS Inc., Chicago, IL, USA). Descriptive analyses 
were performed for each indicator, and current practice was expressed as percentage 
of adherence to an indicator. The median adherence of each separate clinic was 
calculated, as well as the adherence of all clinics together.
Table I. Adherence to indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Initial assessment of fertility Range and median adherence for 16 clinics (%) Median adherence 
(43a)
Range n  patients
The initial fertility assessment should result in both a 
diagnosis and a prognosis.
The initial fertility assessment should consist of three 
parts: semenanalysis, tubal patency assessment. and 
cycle-analysis.
Couple's history-taking should cover at least:
1. age of both partners,
2. duration of infertility,
3. type of couple's infertility (primary or 
secondary)
Woman's physical examination should include 
assessment of the Body Mass Index.
Life-style advice concerning bodyweight, smoking, 
and the alcohol and drug use should be part of the 
counselling regarding pregnancy-probabilities.
23
31
98
72
30
0-100
0-83
83-100
0-95
0-63
428
179
361
333
295
median adherence of all indicators within one guideline
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Table II. Baseline characteristics of the participating couples (n=1499)
Characteristics % of couples
Mean age in years (SD)
Female 32.8 years (4.1)
Male 35.1 years (5.0)
Ethnic backgrounda
Dutch 98.1
Non-Dutch 1.9
Gross monthly family income (euros)b
<1100 1.6
1100-1760 4.6
1760-2750 22.2
>2750 71.6
Education level per couplec
Low 6.4
Intermediate 40.7
High 52.9
Type of infertilityd
Primary 72.8
Secondary 27.2
Mean duration of infertility in months (SD)e 38.4 (22.5)
BMI of the woman
Low (<18) 14.0
Normal (18-25) 53.9
High (>25) 32.0
Ethnic background of the couples was determined by the origin of both partners: Dutch, one or both partners are of Dutch 
origin; non-Dutch, both partners are not of Dutch origin.
Gross monthly family income was categorized according to social security standards and modal income in euros: ,1100 less 
than Dutch modal income; <1100-1760 Dutch modal income; 1760-2750 up to 1.5 x Dutch modal income; .2750 more than 
Dutch modal income.
Education level of the couples was determined by the highest education level of both partners: low, primary or lower 
vocational education; intermediate, secondary or intermediate vocational education; high, higher professional education or 
university.
Type of fertility was determined for the couple.
Duration of infertility was defined as the period between the start of regular unprotected sexual intercourse and 1 January 
2005, the beginning of the study period.
Table III. Quality criteria of guideline-based indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Initial assessment of fertility Applicability
(n patients )
Improvement
potential
Discriminatory 
capacity (%)
Complexity
(n variables)
Case mix 
stability
Data source
The initial fertility assessment should result in both a diagnosis 
and a prognosis.
428 Y 100 2 Y Medical record
The initial fertility assessment should consist of three parts: 
semen-analysis, tubal patency assessment. and cycle-analysis.
179 Y 83 3 Na Medical record
Couple's history-taking should cover at least:
1. age of both partners,
2. duration of infertility,
3. type of couple's infertility (primary or secondary)
361 N 17 5 Y Medical record
Woman's physical examination should include assessment of 
the Body Mass Index.
333 Y 95 2 Y Medical record
Life-style advice concerning bodyweight, smoking, and the 
alcohol and drug use should be part of the counselling 
regarding pregnancy-probabilities.
295 Y 63 4 Na Patient
questionnaire
Quality indicators of the guideline “Initial assessment of fertility"; N=no, Y=yes, NA= not applicable 
acase mix correction is necessary for 'duration of infertility'.
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Results
Response
The mean participation rate was 56% (1499 of 2698 invited couples), varying between 
47% and 72% per clinic. Demographic characteristics of the participating couples are 
shown in Table II. Mean female age was 33 years and male age 35 years. Forty-seven 
couples (3.2%) were of non-Dutch origin. Of the participating couples, 73% suffered 
from primary infertility. The median duration of infertility was 38 months. A total of 
53% had a high education level and 72% had a more than modal income (gross > € 
2750/month).
Assessment of quality criteria of the indicator-set
Table III shows the quality criteria of the indicators, within the guideline 'initial 
assessment of fertility'. Supplementary Tables IIIa-i show these criteria for the 
remaining guidelines. All indicators were measurable and made available through 
either medical record extraction, or a patient or professional questionnaire. The 
reliability is high for questionnaire data, because it is first-hand information. For 
medical record data, reliability was substantial, reflected in an average Cohen's kappa 
coefficients of 0.86 (range 0.48-1.0). In total, 18 indicators were inapplicable (<10 
patients). For these indicators, the other quality criteria could not be assessed. A total 
of eight indicators had adherence scores of 90% or more, and therefore possess too 
little room for improvement. Regarding discriminatory capacity, a total of 11 indicators 
scored <20%. This understandably includes the eight indicators that had no room for 
improvement. None of the indicators required more than one data source. Complexity 
values ranged mostly from 1 to 5. An exception was the indicator concerning 'the 
items that should be discussed during an intake prior to IVF/ICSI-treatment'. This 
indicator encompassed many topics and concerned 18 variables and was therefore 
subdivided into five different parts for accurate analysis. Assessment of case-mix 
stability revealed that the following three indicators are in need of correction for 
'duration of infertility': (i) 'the initial fertility assessment should consist of three parts: 
semen-analysis, tubal patency assessment and cycle analysis', (ii) 'life-style advice 
concerning bodyweight, smoking and the alcohol and drug use should be part of the 
counseling regarding pregnancy-probabilities' and (iii) 'in the case of IUI in the 
stimulated cycle, ovarian response should be monitored by transvaginal ultrasound'. 
The indicator 'in the case of unexplained infertility in a woman, 36 years, there is an 
indication for IVF after 3 years of infertility' needs correction for 'duration of 
infertility', 'woman's age' and 'type of infertility' when the analysis takes place. All 
other indicators showed equal distribution of these patient-characteristics. The overall 
results of this quality criteria assessment are summarized in Table IV.
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Table IV. Overall scores of the indicators (n=39) for each quality criterion.
Quality criteria Number of indicators that met the criterion
Measurability 39
Reliability 39
Applicability 21
Improvement potential 31
Discriminatory capacity 28
Complexity 38
Case-mix stability 35
Current practice: adherence to indicators
Table I shows the median clinical performance and the range of performance of the 
clinics for each indicator within the guideline 'initial assessment of fertility'. 
Supplementary Table Ia-e contains the results for the remaining indicators. The 
indicators regarding endometriosis, OHSS, tubal pathology and POF 13 were applicable 
to too few patients (n<10) in this sample and are therefore not shown in Table I. From 
Table I and Supplementary Table Ia-e, it can be concluded that the median adherence 
of 14 indicators was <50%. Of those, six indicators even scored <25%. The median 
adherence to the separate indicators varied from 0% (e.g. 'in the case of abnormal 
semen-analysis, a complete andrological history taking, physical examination and one 
extra semen-analyses should be performed') up to 100% (e.g. 'Each department 
performing IUI should evaluate their results annually').
The variation between clinics differed widely and is reflected in the range of adherence 
within one indicator. We found, for example, on the one hand exactly equal adherence 
between all clinics (e.g. all clinics scored 100%) for the indicator 'routine use of hCG for 
luteal support after IVF is not recommended' and on the other hand a 100% difference 
between the clinics (e.g. two clinics scoring 0% and 100%, respectively) for the 
indicator 'initial fertility assessment should result in a prognosis and a diagnosis'.
Finally, the results show that the highest median adherence (86%) is found within the 
guideline 'indications for IVF-treatment'. The lowest mean adherence is found within 
the guideline 'initial assessment of fertility' (43%), followed closely by the guideline 
'anovulation' (44%).
Discussion
This study demonstrates several quality criteria of a set of 39 guideline-based process 
and structure indicators for comprehensive clinical fertility care. Moreover, a first 
assessment of current fertility care in the Netherlands discloses a large variation in the 
performance between clinics.
During the original indicator-selection procedure, the expert panels were asked to take 
five criteria into account when selecting key recommendations from the guidelines.13 
In this practice test, we assessed additional quality criteria of the proposed indicators. 
We can conclude that most of them meet these criteria, with several remarkable 
results. Improvement potential and applicability were not always high. Apparently, a 
considerable discrepancy exists between the experts' estimate of these criteria on the 
one hand and currently provided care on the other hand. This underlines that even a 
rigorous indicator-development procedure should be complemented with a practice
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test. On the basis of the results of our practice test, particularly applicability and 
improvement potential (Tables III and IV and Supplementary Table IIIa-i), we can 
distinguish three subsets within our original set of 39 quality indicators. Indicators 
within the 'first subset' score highly for applicability and improvement potential and 
can therefore be used for quality monitoring purposes and as a baseline measurement 
for improvement programmes in the involved clinics. A 'second subset' contains 
indicators with low improvement potential, which makes them useless for 
improvement programmes, but with high applicability, which makes them still suitable 
for monitoring purposes, namely to ensure that adherence continues to be high in the 
future. Within the 'third subset', we find indicators with low applicability. They 
concern relatively rare conditions or complications (e.g. POF and severe OHSS), so 
inclusion numbers within our random patient sample were too small for adequate 
indicator assessment. This does not mean, however, that this subset needs to be 
discarded immediately for any future use; but the inclusion of enough cases for such 
indicators requires a more specific patient sample, e.g. drawn from separate 
complication registrations or large (national) databases.
The question arises whether this set of indicators is also suitable for countries other 
than the Netherlands. Only 2 out of the 39 indicators (e.g. laboratory accreditation by 
a Dutch committee and the maximum number of two embryos transferred per cycle) 
may be more or less specific for Dutch practice, but both can be easily adapted for 
international use by judging not the content but the topic of the indicator. 
Generalizability is thus not a barrier for international adaptation of the presented 
indicator-set.
Adherence to the guideline recommendations
Our study shows that adherence to guideline-based indicators ranged widely per clinic, 
per guideline and per individual indicator. Adherence to the indicators is relatively 
poor; 14 indicators score below 50% adherence. This means there is ample room for 
improvement of clinical fertility care. Professionals should be urged to improve the 
implementation of those guideline-recommendations that showed poor adherence in 
their clinic. A 100% adherence score may not always be a viable goal, because there 
can in specific cases be good reasons to divert from guideline-recommendations. 
However, professionals should at least aim to rival the best scoring clinic, which is a 
realistic benchmark. The lowest adherence (less than 50%) is found within the 
guidelines 'initial assessment of fertility' and 'anovulation'; priority should therefore be 
given to implementation of these guidelines. It is furthermore important to realize that 
a low score on an indicator does not automatically mean that there is a problem in the 
quality of care; it is, however, a signal to further estimate the matter in order to try to 
understand underlying causes and processes.
There are some results that stand out in particular. Several of the critical indicators 
with low adherence relate to communication and patient information. Again, the 
broad variation in adherence to these indicators and the fact that some clinics do score 
highly, illustrate that these results cannot be simply disregarded or attributed to recall 
bias.32,33 These findings are in line with previously conducted qualitative and 
quantitative research, identifying physicians' 'lack of self-efficacy regarding
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communication' and 'low outcome expectancy' as main barriers for adherence to a 
fertility guideline.34 However, this is plainly disturbing from the perspective of patient­
centred care, as former research clearly discloses infertile patients' preferences for 
comprehensible and complete information.35-38 Increased awareness among 
careproviders of these patient preferences and feedback on low indicator scores 
should lead to an improvement in information provision and transparency of care. 
Another low-scoring indicator is the one recommending unstimulated over stimulated 
IUI, in the case of unexplained infertility, to prevent multiple pregnancies (15% 
adherence, range between clinics 0-48%). This perfectly reflects the situation where 
consensus on a specific topic is lacking. None of the clinics score 100% adherence, 
meaning this recommendation is far from consistently followed. This might be because 
both patients and professionals are apt to change their treatment policy and are 
willing to take more risks, e.g. after previous unsuccessful cycles of unstimulated IUI. 
This probably also explains the poor adherence to the recommendation 'mono­
ovulation should be the result of ovulation-induction'. However, it is the responsibility 
and moral duty of the professional to guard patient safety during any treatment, and 
0% scores should therefore be taken very seriously. Fortunately, more reticence is 
seen in the high adherence (79%) of the recommendation 'IVF-treatment in women 
<36 years is only indicated after 3 years of infertility'. This reflects the professionals' 
commitment to prevent over-treatment and strive for cost-effectiveness and efficacy 
of this expensive and intensive type of infertility treatment, by respecting the 
possibility of less invasive approaches and treatment-independent pregnancies.39,40
This study also has some limitations. Indicator measurement turned out to be quite a 
laborious exercise, including widely distributed questionnaires and an extensive 
medical record search to complete indicator data. Poor availability of medical data and 
the lack of adequate data resources are common problems in performance assessment 
efforts41,42, but this should never be the sole reason to discard rigorously selected 
quality indicators. On the contrary, care-providers and policy-makers should undertake 
efforts to overcome these barriers. The ongoing introduction of electronic patient 
records offers great opportunities for collaboration with clinical improvement 
programmes. It is therefore important to conduct further research to uncover which 
relatively small investments or adjustments to existing databases are necessary to 
facilitate monitoring of current care.
In conclusion, we demonstrated the quality of a developed set of guideline-based 
indicators for comprehensive clinical fertility care. A practice test in the Netherlands 
revealed large variation and ample room for improvement of fertility care. Such 
objective assessment of care can help professionals to identify and subsequently 
target the domains of care in need of improvement. The next step will be the 
translation of indicator results into appropriate implementation strategies that aim to 
bridge the gaps between the best available evidence we present in our guidelines and 
the care we deliver in daily practice.
Table la. Adherence to indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Range and median adherence for 16 clinics
(%)
Median
adherence
Range n  patients
Anovulation and Childwish
Patients with overweight should, with regard to their 
fertility-treatment and overall health, be informed of the 
importance of weight reduction by means of life-style 
changes.
The goal of ovulation-induction should be mono-ovulation.
The ovarian response to hormonal stimulation should be 
performed by regular transvaginal ultrasound (frequency of 
1-3 times / week).
Women with WHO group II anovulatory infertility should be 
given anti-oestrogen as first-choice medication for 
ovulation induction.
Before starting ovulation induction treatment, the patient 
should be informed about:
1. the specific side-effects of medication
2. the need for regular intensive follow-up during treatment
3. the increased risks of multiple pregnancy
4. the ovarian hyper stimulation syndrome
5.a spontaneous abortion.
In case of 3 or more follicles >16mm and/or more than 5 
follicles>12mm during an ovulation-induction treatment 
cycle, the patient has to be informed that coitus is 
prohibited or contraception has to be used.
NA
NA
27
43
86
NA
19
NA
0-53 126
5-63 52
86 30
NA
0-50 202
NA
2
9
Table Ib. Adherence to indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Range and median adherence for 16 clinics
(%)
Median
adherence
Range n  patients
Male factor infertility 65 '
In case of normospermia (WHO-criteria), semen-analysis 
should not be repeated, and no additional andrological 
tests should be performed.
In case of an abnormal semen-analysis (WHO-criteria), the 
physician should perform:
1. a complete andrological history-taking
2. a physical examination
3. at least one extra semen-analysis.
(In case of partial andrological history-takingf
In case of an idiopathic oligoasthenoterato-zoospermia, no 
hormones, vitamins or NSAID's should be prescribed to 
improve semen-quality.
95 86-100 78
59
100 179
0 0
0
median adherence of all indicators within one guideline; NA= not applicable; WHO = World Health Organisation; NSAID= non steroidal anti-inflammatory drugs
Table Ic. Adherence to indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Range and median adherence for 16 clinics
(%)
Median
adherence
Range n  patients
Intra uterine insemination (IUI) 60
In case of unexplained infertility, stimulated IUI should not 
be offered, even though it is associated with higher 
pregnancy rates than unstimulated IUI, because it carries a 
risk of multiple pregnancy.
The diagnosis 'cervical factor' is an indication for IUI in the 
unstimulated cycle.
In case of IUI in the stimulated cycle, ovarian response 
should be monitored by transvaginal ultrasound.
Each department performing IUI should evaluate their 
results annually.
IUI should not be performed in case of more than 3 follicles 
> 16 mm or more than 5 follicles > 12mm. In both cases, the 
use of contraceptives should be advised as well.
NA
2□ 4
h-H
0 6 8
I
100
Ï
Q •0 D G
1 1
j  SO 100
H
1 1
20 40 6
I I
0 80 100
I
100
15
26
98
100
NA
0-48 138
21-31 41
90-100 173
16
NA
0
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Table Id. Adherence to indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Range and median adherence for 16 clinics
(%)
Median
adherence
Range n  patients
Indications for IVF/ICSI
In case of severe endometriosis and decreased tubal 
function (but no bilateral occlusion), there is an indication 
for IVF after 2 years of infertility.
In case of male infertility with VCM<1x10*6/ml (before 
capacitation) there is a direct indication for ICSI-treatment
In case of unexplained infertility in a woman <36 years, 
there is an indication for IVF after 3 years of infertility.
Routine use of hCG for luteal support after IVF is not 
recommended.
NA
50
NA
50
0
24
79 67-92 43
100 100 16
median adherence of all indicators within one guideline 
NA= not applicable, VCM=volume*motility*concentration
Table le. Adherence to indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Range and median adherence for 16 clinics
(%)
Median
adherence
Range n  patients
Embryo Act
IVF-Laboratories should be accredited by the CCKL (Dutch 
Coordinating Committee for maintenance of Quality 
Standards in Laboratory research ).
Per embryo-transfer no more than 2 embryos should be 
transferred at the same time.
During an intake prior to IVF/ICSI-treatment, the following 
should be discussed:
1.The risks of hyperstimulation, poor response and 
accompanying consequences, complications such as 
infection and bleeding, the laboratory procedure and the 
risk of swapping- and laboratory-mistakes.
2.The chances of success, pregnancy after SET and DET.
100 100
100 NA 265
12 0-26 270
88 67-100 300
2
Range and median adherence for 16 clinics
(%)
Median
adherence
Range n  patients
Embryo Act 58
3.the chances of congenital diseases/malformations, 
ectopic pregnancy, multiple pregnancy and spontaneous 
abortion and possible unknown long-term risks.
4.The emotional aspects of the treatment, how patients 
can communicate that they are in need of extra 
emotional support and the existence of the patient 
association for infertility to share experiences and gain 
information from the patient's perspective.
5 .How hospital care during treatment is organised and 
which caretakers are involved in the treatment 
procedure, how patients should contact the fertility team 
in case of problems or complaints and how the fertility 
team can be contacted, especially outside daytime-hours.
!
0 2
|_
4
1
60 8 
1 1
o— O_ O
r
20 4
1
0 60 8 
1 1
1
0 100
15
46
66
0-32 256
15-67 280
40-79 264
a median adherence of all indicators within one guideline; NA= not applicable
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Table IIIa. Quality criteria of guideline-based indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Anovulation and Childwish Applicability
(n patients )
Improvement
potential
Discriminatory 
capacity (%)
Complexity
(n variables)
Case mix 
stability
Data source
Patients with overweight should, with regard to their fertility- 
treatment and overall health, be informed of the importance 
of weight reduction by means of life-style changes.
126 Y 53 3 Y Patient
questionnaire
The goal of ovulation-induction should be mono-ovulation. 52 Y 58 2 Y Medical record
The ovarian response to hormonal stimulation should be 
performed by regular transvaginal ultrasound (frequency of 1­
3 times / week).
30 Y 0 2 NA Medical record
Women with WHO group II anovulatory infertility should be 
given anti-oestrogen as first-choice medication for ovulation 
induction.
2 NA NA 1 NA Medical record
Before starting ovulation induction treatment, the patient 
should be informed about:
1.the specific side-effects of medication
2.the need for regular intensive follow-up during treatment
3.the increased risks of multiple pregnancy
4.the ovarian hyper stimulation syndrome
5.a spontaneous abortion.
202 Y 50 5 Y Patient
questionnaire
In case of 3 or more follicles >16mm and/or more than 5 
follicles>12mm during an ovulation-induction treatment cycle, 
the patient has to be informed that coitus is prohibited or 
contraception has to be used.
9 NA NA 3 Y Medical record
Quality indicators of the guideline 'Anovulation and Childwish'.
Table IIIb. Quality criteria of guideline-based indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Male factor infertility Applicability
(n patients )
Improvement
potential
Discriminatory 
capacity (%)
Complexity
(n variables)
Case mix 
stability
Data source
In case of normospermia (WHO-criteria), semen-analysis 
should not be repeated, and no additional andrological tests 
should be performed.
78 N 14 2 Y Medical record
In case of an abnormal semen-analysis (WHO-criteria), the 
physician should perform:
1. a complete andrological history-taking
2. a physical examination
3. at least one extra semen-analysis.
59 Y 36 4 Y Medical record
In case of an idiopathic oligoasthenoterato-zoospermia, no 
hormones, vitamins or NSAID's should be prescribed to 
improve semen-quality.
179 N 0 4 NA Medical record
Quality indicators of the guideline 'Male factor infertility'.
a case mix correction is necessary for 'duration of infertility'; b case mix correction is necessary for 'duration of infertility', 'female age' and 'type of infertility for the couple'; N=no, Y=yes, NA= not applicable, 
NSAID=non steroidal anti-inflammatory drugs, WHO = World Health Organisation
Table IIIc. Quality criteria of guideline-based indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Intra uterine insemination (IUI) Applicability
(n patients )
Improvement
potential
Discriminatory 
capacity (%)
Complexity
(n variables)
Case mix 
stability
Data source
In case of unexplained infertility, stimulated IUI should not be 
offered, even though it is associated with higher pregnancy 
rates than unstimulated IUI, because it carries a risk of 
multiple pregnancy.
138 Y 48 1 NA Medical record
The diagnosis 'cervical factor' is an indication for IUI in the 
unstimulated cycle.
41 Y 10 1 Y Medical record
In case of IUI in the stimulated cycle, ovarian response should 
be monitored by transvaginal ultrasound.
173 N 10 1 Na Medical record
Each department performing IUI should evaluate their results 
annually.
IUI should not be performed in case of more than 3 follicles >
16c N 0 1 NA Professional
questionnaire
16 mm or more than 5 follicles > 12mm. In both cases, the use 
of contraceptives should be advised as well.
9 NA NA 4 NA Medical record
Quality indicators of the guideline 'Intra uterine insemination'.
Table IIId. Quality criteria of guideline-based indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Indications for IVF/ICSI Applicability
(n patients )
Improvement
potential
Discriminatory 
capacity (%)
Complexity
(n variables)
Case mix 
stability
Data source
In case of severe endometriosis and decreased tubal function 
(but no bilateral occlusion), there is an indication for IVF after 
2 years of infertility.
0 NA NA 4 NA Medical record
In case of male infertility with VCM<1x10*6 /ml (before 
capacitation) there is a direct indication for ICSI-treatment
24 Y 0 3 Y Medical record
In case of unexplained infertility in a woman <36 years, there 
is an indication for IVF after 3 years of infertility.
43 Y 25 5 Nb Medical record
Routine use of hCG for luteal support after IVF is not 
recommended.
16 N 0 1 NA Medical record
Quality indicators of the guideline 'Indications for IVF/ICSI'.
a case mix correction is necessary for 'duration of infertility'; b case mix correction is necessary for 'duration of infertility', 'female age' and 'type of infertility for the couple'; c this indicator applies to clinical 
departments, not patients; N=no, Y=yes, NA= not applicable; VCM=volume*motility*concentration
Table IIIe. Quality criteria of guideline-based indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Embryo Act Applicability
(n patients )
Improvement
potential
Discriminatory 
capacity (%)
Complexity
(n variables)
Case mix 
stability
Data source
IVF-Laboratories should be accredited by the CCKL (Dutch 
Coordinating Committee for maintenance of Quality Standards 
in Laboratory research ).
2d N 0 1 NA Professional
questionnaire
Per embryo-transfer no more than 2 embryos should be 
transferred at the same time.
During an intake prior to IVF/ICSI-treatment, the following 
should be discussed:
265 N 0 2 NA Medical record
I.The risks of hyperstimulation, poor response and 
accompanying consequences, complications such as 
infection and bleeding, the laboratory procedure and the risk 
of swapping- and laboratory-mistakes.
270 Y 26 4 NA Patient
questionnaire
2.The chances of success, pregnancy after SET and DET 300 Y 33 2 NA Patient
questionnaire
3.the chances of congenital diseases/malformations, ectopic 
pregnancy, multiple pregnancy and spontaneous abortion 
and possible unknown long-term risks.
256 Y 32 5 NA Patient
questionnaire
4.The emotional aspects of the treatment, how patients can 
communicate that they are in need of extra emotional 
support and the existence of the patient association for 
infertility to share experiences and gain information from the 
patient's perspective.
280 Y 52 3 Y Patient
questionnaire
5. How hospital care during treatment is organised and which 
caretakers are involved in the treatment procedure, how 
patients should contact the fertility team in case of problems 
or complaints and how the fertility team can be contacted, 
especially outside daytime-hours.
264 Y 39 4 Y Patient
questionnaire
Quality indicators of the 'Embryo Act'.
acase mix correction is necessary for 'duration of infertility'
bcase mix correction is necessary for 'duration of infertility', 'female age' and 'type of infertility for the couple' 
d this indicator applies to clinics with an IVF laboratory, not patients
N=no, Y=yes, NA=not applicable, SET=single embryo transfer, DET=double embryo transfer
Table IIIf. Quality criteria of guideline-based indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Tubal Pathology Applicability
(n patients )
Improvement
potential
Discriminatory 
capacity (%)
Complexity
(n variables)
Case mix
stability
Data source
In case of IVF because of inoperable tubapathology, 
salpingectomy shoud be performed when bilateral 
hydrosalpinges are visible by ultrasound.
0 NA NA 4 NA Medical record
In case of tubal pathology, both diagnostic laparoscopy and 
complementary examination of the endosalpinx 
(hysterosalpingogram or salpingo-scopy) should be performed 
to decide in favour of tubal surgery.
1 NA NA 3 NA Medical record
The indication for tubal surgery in a patient should be made by 
the future surgeon himself (i.e. videomaterial or by performing 
a diagnostic laparoscopy).
0 NA NA 2 NA Medical record
Except for refertilisation, the female age limit for tubal surgery 
should be 40 years.
4 NA NA 3 NA Medical record
Quality indicators of the guideline 'Tubal pathology'.
Table IIIg. Quality criteria of guideline-based indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Endometriosis
Applicability
(n patients )
Improvement
potential
Discriminatory 
capacity (%)
Complexity
(n variables)
Case mix 
stability
Data source
Prior to laparoscopy intended to diagnose endometriosis, 
there should be done at least an history-taking with a suspect 
history, a vaginal and speculum examination.
9 NA NA 5 NA Medical record
Women with peritoneal endometriosis and infertility should 
not be given hormonal treatment to improve fecundicity.
0 NA NA 3 NA Medical record
In case of unexplained fertility and peritoneal endometriosis, 
IUI with ovarian stimulation should be given as primary 
treatment to improve fecundity.
0 NA NA 5 NA Medical record
Quality indicators of the guideline 'Endometriosis'.
a case mix correction is necessary for 'duration of fertility'; b case mix correction is necessary for 'duration of infertility', 'female age' and 'type of infertility for the couple'; N=no, Y=yes, NA= not 
applicable
Table IIIh. Quality criteria of guideline-based indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Ovarian Hyper Stimulation Syndrome (OHSS) Applicability
(n patients )
Improvement
potential
Discriminatory 
capacity (%)
Complexity
(n variables)
Case mix 
stability
Data source
In case of ovulation-induction with gonadotropins, no 
ovulatory hCG dosis should be given and protected intercourse 3 NA NA 6 NA Medical record
should be advised in case of:
1. the presence of 3 or more dominant follicles > 18mm or
2. the presence of 5 or more follicles > 15mm and/or
3. A raise in serum-estradiol levels >3,0 nmol/l.
In case of OHSS with hemoconcentration > 45%, the patient 2 NA NA 2 NA Medical record
should be admitted to the hospital.
In case of severe OHSS and hospital admission, patients should 
be given trombosis-profylaxis (lowmolecularweight heparin). 2 NA NA 4 NA Medical record
Quality indicators of the guideline 'Ovarian Hyper Stimulation Syndrome'.
Table IIIi. Quality criteria of guideline-based indicators for clinical fertility care: an assessment in 16 Dutch fertility clinics.
Premature Ovarian Failure Applicability
(n patients )
Improvement
potential
Discriminatory 
capacity (%)
Complexity
(n variables)
Case mix 
stability
Data source
Patients with premature ovarian failure, should not be offered 
any treatment to pursue pregancy, except for oocyte donation.
0 NA NA 1 NA Medical record
In case premature ovarian failure is diagnosed, the following 
should be discussed with the patient:
1. Possibilities to receive psychological support, oocyte- 
donation,
2.the probabilities of a spontaneous conception, the option of 
assessing karyotype (Premature Ovarian Failure, Fragile X, 
Auto-immune diseases)
3. the (dis-)advantages of hormone replacement therapy.
0 NA NA 5 NA Patient
questionnaire
In every patient with premature ovarian failure who chooses 
not to have hormonal suppletion therapy, a bone- 
densitrometry should be performed.
0 NA NA 3 NA Medical record
Quality indicators of the guideline 'Premature ovarian failure'.
acase mix correction is necessary for 'duration of infertility'; b case mix correction is necessary for 'duration of infertility', 'female age' and 'type of infertility for the couple'; N=no, Y=yes, NA= not applicable
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Abstract
Background: Adequate information provision is a crucial dimension of high-quality 
fertility care. Clinical practice guidelines containing consensus-based recommendations 
may standardize practice between settings. This study was designed for three 
purposes: (i) to assess actual adherence to recommendations on information 
provision, (ii) to measure patient satisfaction with current practice and (iii) to analyse 
how variation in adherence relates to the characteristics of patients and clinics.
Methods: All recommendations concerning patient information were extracted from 
10 national fertility guidelines and edited into a patient questionnaire. Additional 
questions concerning patient satisfaction and potential determinants of information 
provision at patient level were included. A total of 2698 couples from 16 clinics were 
invited to participate. A professional's questionnaire was sent to all gynaecologists to 
gather potential determinants at clinic level. Multilevel regression analysis was 
performed to identify the determinants of information provision.
Results: A total of 1499 couples (56%) participated. The percentage of couples who 
reported to have received complete information varied between recommendations 
from 10 to 96% (mean 57%). Overall, 94% of couples were satisfied with fertility 
services. The use of checklists for information provision, the presence of 
obstetrics/gynaecology residents and specialized nursing personnel, and higher patient 
anxiety scores were significantly associated (P < 0.05) with higher levels of information 
received.
Conclusions: Despite the possibility of recall bias in questionnaire studies and 
observed high patient satisfaction with fertility services, we conclude that information 
provision for infertile couples is currently poor and in need of improvement. This could 
easily be procured by, for example, the use of information checklists.
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Introduction
Adequate information provision is a crucial dimension of patient-centred and high- 
quality care. Good communication and full comprehension of information have been 
reported as important prerequisites for obtaining informed consent and achieving 
patient satisfaction, hence improving compliance with doctor's advice and treatment 
outcomes.1-3 Providing patient information should therefore not merely be intended to 
prepare patients on the actual course of their treatment, but more importantly, it 
should enable them to participate actively and be well informed in the agreed 
treatment plan.4-8 The importance of information provision is acknowledged by diverse 
international organizations, such as the European Patient Federation and the World 
Health Organization (WHO), who make a clear statement on the topic within the 
'declaration on the promotion of patients' rights in Europe':
'Patients have the right to be fully informed about their health status, 
including the medical facts about their condition; about the proposed 
medical procedures, together with the potential risks and benefits of each 
procedure; about alternatives to the proposed procedures, including the 
effect of non-treatment; and about the diagnosis, prognosis and progress 
of treatment'.4
In fertility care, a patient's decision on commencing treatment could signify 
considering elective surgery, assisted reproductive technologies or even the use of 
donor gametes. These are weighty choices and it is therefore not surprising that 
infertile couples rate information provision as one of the most important aspects of 
good clinical care.9-12
Unfortunately, there is no evidence for which information exactly should be provided 
to different patient groups. Based on the cited universal WHO statement, however, 
consensus-based recommendations on information provision can be formulated per 
practice topic and included in wide-spread clinical practice guidelines. For fertility care, 
such recommendations are, for instance, already included in selected guidelines of the 
European Society of Human Reproduction and Endocrinology, the National Institute of 
Clinical Excellence and the Dutch Society of Obstetrics and Gynaecology (NVOG). 
Recommendations concern, for example, the provision of general treatment 
information, but also of information regarding risks and complications of treatment. 
Clinical practice guidelines can thus facilitate individual physicians to standardize 
information provision in the consulting room.
The question remains, however, whether these guideline recommendations are 
actually followed, as guidelines are not self-implementing.13 The objectives of this 
study were therefore first to assess actual adherence to such guideline 
recommendations on information provision. Second, we measured patient satisfaction 
with this current practice, to evaluate its correspondence with the level of information 
provision. Since understanding current practice by the recognition of potential 
determinants is an important first step towards achieving optimal care14, for our third 
objective we analysed the extent to which variation in adherence was related to 
certain patient or clinic characteristics.
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Materials and Methods 
Setting
We conducted a cross-sectional postal survey study, consisting of a questionnaire and 
two reminder rounds. The study was approved for all clinics by the 'Regional Review 
Board for Human Research (CMO) Arnhem-Nijmegen (CMO no. 2004/193)' and is part 
of a larger research project on which we previously published.15 The NVOG issued nine 
national fertility guidelines to facilitate professionals in providing effective and 
evidence-based care. Guidelines encompass both diagnostics and treatment of fertility 
problems. The model protocol of the Dutch Embryo Act is in daily practice also used as 
a complementary national guideline on in vitro fertilization (IVF). These 10 documents 
describe the minimal degree of patient information that should be given prior to or 
during fertility treatment. All recommendations concerning patient information were 
extracted from these national guidelines by four of the authors (S.M., W.N., R.H. and 
J.K.). Selected recommendations (n=18) comprised several domains: general 
information about treatment, risks of treatment, possible complications, lifestyle 
change, psychosocial and medical follow-up. Because data on information provision is 
hard to extract reliably from medical records16, all 18 recommendations were edited 
into a patient questionnaire.
Study population
We included a representative Dutch patient group, visiting 16 participating clinics for 
diagnosis or treatment of infertility. These clinics vary in size, offer different treatment 
options (e.g. including IVF/intra-cytoplasmic sperm injection (ICSI) or not) and are both 
teaching and non-teaching, primary, secondary and tertiary referral clinics. Potential 
participating couples were selected by means of each clinic's diagnosis treatment 
combination code registration database; in this national financial registration, fertility 
patients are identified with a specific fertility-code (F-code). An F-code could mean 
either an initial assessment of fertility, diagnostics for fertility, fertility treatment (e.g. 
surgery, ovulation induction, intra-uterine insemination or IVF) or only counselling. 
Couples were apt for inclusion if they had an F-code anytime in April, May or June 
2005. In each clinic, a random group of infertile couples was invited to take part in the 
study and was sent an informed consent form and a questionnaire. The patient sample 
size was chosen according to the clinic size (50, 150 or 550 eligible patients); a total of 
2698 couples were invited. Couples who completed both the questionnaire and 
informed consent forms were included for analysis. Couples who did not have enough 
knowledge of the Dutch language to fill out the questionnaire or turned out not to 
have visited the clinic in the requested period were excluded.
Questionnaire development
The patient questionnaire was constructed to address the three objectives of this 
study:
Part 1: actual adherence to recommendations on information provision 
Questions were carefully formulated to detect a couple's direct experience of care; 
they were asked whether they had received specific information from their own care- 
providers (as opposed to a formulation directed at testing their knowledge of specific 
topics). For example: 'did your clinic provide you with information about the risk of
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ectopic pregnancy before you started an IVF/ICSI treatment?' Questions were 
composed of four closed response categories, 'yes', 'no', 'cannot remember'and 
'irrelevant'.
Part 2: patients' satisfaction with information provision
Satisfaction ratings of the female partner were measured by a Dutch translation of 
Souter's 'questionnaire on patient satisfaction with the management of infertility'.10
Part 3: determinants of information provision
We searched for potential determinants of information provision from the literature
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regarding fertility as well as other fields of health care. '
These potential determinants were hypothesized to be found in three groups, which 
are shown in Supplementary Table 1a:
(1) Patient characteristics (at individual and couple level, e.g. female age, couple's 
education level, female's anxiety for treatment)
(2) Clinic's organization of fertility care (e.g. clinic size, IVF/non-IVF facilities, 
presence of trained fertility nurses).
(3) Clinic's organization of information provision (e.g. availability of a lifestyle 
change programme, organization of an informative meeting, use of information 
checklists).
Questions regarding demographic characteristics and potential determinants based on 
patient characteristics (both at the level of individual partners as well as the couple) 
were added to the patient questionnaire. The female partner was asked to fill out 
additional questions on anxiety and depression. Anxiety was measured by a 10 item 
short version of the state trait anxiety index (STAI)23,24 and n=12 additional infertility- 
related anxiety items, e.g. 'anxiety for treatment outcome, both on a four-point scale 
("almost never", "sometimes", "frequently" and "almost always")'. Depression was 
measured by the Beck Depression Index for primary care (BDI-PC) that uses a four- 
point scale for varying utterances.25
When completing the questionnaire, patient couples were asked to describe their 
experiences during the study period (1 January 2005 to 1 July 2005). Because a fertility 
problem affects both partners who are frequently seen in a joint consultation, couples 
were asked to fill out part I of the questionnaire (regarding the information 
recommendations) preferably together. The patient questionnaire was piloted in a 
group of 30 infertile couples recruited through the website of the Dutch Patients' 
Association for Infertility 'Freya'. This pilot led to minor adjustments in formulation of 
some questions before the questionnaire was used in the study group.
A professional questionnaire was composed of questions regarding potential 
determinants based on a clinic's organization of fertility care and organization of 
information provision, and sent to a gynaecologist of each of the 16 participating 
clinics.
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Statistical analysis
We used the Statistical Package for the Social Sciences (SPSS 14.0 for Windows, SPSS 
Inc., Chicago, IL, USA) for most analyses. If a single guideline-derived recommendation 
encompassed several topics, it was discussed in the study group (S.M., W.N., J.K. and 
R.H.) until consensus was reached. If considered appropriate, it was subdivided for 
further analysis. This procedure resulted in 28 recommendations for analysis. 
Descriptive analysis was performed to assess frequencies of adherence to the 
recommendations. If a recommendation was applicable to less than 10 patients, it was 
excluded from further analysis.
We applied univariate analysis (cross tabulations, Wilcoxon's rank sum test, 
independent samples t-test and X2 test) to examine the associations between several 
patient's or clinic's characteristics (independent variables) on the one hand, and 
adherence to information recommendations (dependent variables) on the other hand. 
Before applying this analysis, a confirmatory factor analysis and reliability assessment 
was performed for the questions of the STAI (Cronbach's a=0.91) and BDI-PC 
(Cronbach's a=0.82); both showed good internal consistency within our study 
population and thus the sumscores 'depression' and 'state anxiety' were carried 
forward as potential determinants. Exploratory factor analysis was performed on the 
additional questions regarding anxiety to reduce the number of potential 
determinants. Regarding this, the following two factors were identified: anxiety for 
treatment (Cronbach's a=0.73) and anxiety for treatment outcome (Cronbach's 
a=0.76). Remaining anxiety items that did not belong to a factor were 'anxiety for 
financial consequences' and 'anxiety for relationship with partner'; these were also 
treated as potential determinants.
All independent variables were subsequently analysed for colinearity. If a correlation 
between two independent variables was detected (correlation coefficient > 0.4), the 
most relevant candidate variable with respect to content was carried forward. All 
independent variables, which were found to be univariately significantly associated 
with adherence to the information recommendations (P < 0.10) and showed enough 
variation between the different clinics, were included in a multilevel stepwise logistic 
regression analysis to explain difference in adherence. If variation between clinics was 
nil, a regular multivariate regression analysis was performed. For the multilevel 
analysis, a random coefficient model was composed using two levels (clinic and 
patient) in a Glimmix procedure in SAS (SAS for Windows V8.2). Significance for both 
multivariate as well as multilevel analysis was set at P < 0.05.
Results
Response
A total of 1499 couples (=56%) completed the questionnaire and gave their consent to 
join the study. In only 24%, the couple did fill out the questionnaire together; in 76% it 
was completed exclusively or mainly by the woman (i.e. sporadically asked her partner 
for an answer). Socio-demographic characteristics of the participating couples are 
shown in Table I.15 Mean female age was 32.8 years and male age 35.1 years. Only 
1.9% (n=27) of couples were of non-Dutch origin (i.e. both partners were non-Dutch). 
Of the participating couples, 73% suffered from primary infertility and the median 
duration of infertility was 38 months. A total of 53% had a high education level (more
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than secondary school) and 94% had a more than modal income (per household > 
1760 euro/month gross).
Actual adherence to information provision recommendations
Information recommendations on 'premature ovarian failure' and 'cancellation criteria 
for intra-uterine insemination' were excluded from analysis because ,10 patients were 
eligible for analysis. The percentage of couples who reported to have received 
complete information for one of the recommendations ranged from 10 to 96% (mean 
57%) and is shown in Supplementary Table 2a. The information recommendation that 
scored lowest, with 10%, concerns the risk and symptoms of ectopic pregnancy after 
tubal surgery, closely followed by the recommendation 'to discuss risks of an IVF/ICSI 
treatment prior to actual treatment' with 14%. The best scoring recommendations 
were 'having an evaluative consultation when IVF/ICSI treatment is terminated' (96%) 
and 'to discuss the assessment of tubal patency both pro- and retrospectively' (95%). 
Regarding the different content domains, the information concerning complications 
(e.g. ovarian hyper stimulation syndrome, OHSS) was received in 32% of appropriate 
cases, information concerning risks (e.g. ectopic pregnancy) in 41% of cases, followed 
by lifestyle advise (e.g. weight loss) in 46%. Higher scores of 72% were found for both 
general information (e.g. accessibility of the clinic within and outside office hours) and 
information concerning additional emotional or psychological support (e.g. contact 
information of the patient association).
Patient satisfaction with information provision
In total, 35% of the couples mentioned information provision as the most important 
aspect of care compared with: waiting time in clinics, doctor's attitude, the way 
investigations are done and emotional support. However, 26% of couples wished to 
have had more written information, whereas 68% reported to have received any 
written information on diagnostics, background and treatment of their infertility. 
Overall, 94% of the couples were satisfied or very satisfied with their current fertility 
services. Couples who achieved pregnancy in the study period were significantly more 
satisfied (P=0.000) than those who did not. Satisfaction was however not significantly 
associated (P= 0.515) with pregnancy outcome.
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Table I. Baseline characteristics of the participating couples (n=1499)
Characteristics % of couples
Mean age in years (SD)
Female 32.8 yrs (4.1)
Male 35.1 yrs (5.0)
Ethnic backgrounda
Dutch 98.1
Non-Dutch 1.9
Gross monthly family income (euros)b
<1100 1.6
1100-1760 4.6
1760-2750 22.2
>2750 71.6
Education level per couplec
Low 6.4
Intermediate 40.7
High 52.9
Type of subfertilityd
Primary 72.8
Secondary 27.2
Median duration of subfertility in months (SD)e 38.4 (22.5)
a Ethnic background of the couples was determined by the origin of both partners: Dutch = one or both partners are of Dutch 
origin; non-Dutch = both partners are not of Dutch origin. 
b Gross monthly family income was categorized according to social security standards in 2005 and modal income in euros:<1100 
less than Dutch modal income; 1100-1760 Dutch modal income; 1760-2750 up to 1,5 times Dutch modal income; >2750 more 
than twice Dutch modal income.
c Education level of the couples was determined by the highest education level of both partners: low = primary or lower 
vocational education; intermediate = secondary or intermediate vocational education; high = higher professional education or 
university.
d Type of subfertility was determined for the couple.
e Duration of subfertility was defined as the period between the start of regular unprotected sexual intercourse and 1 January 
2005, the beginning of the study period.
Determinants of information provision
As hypothesized, we found univariate significant associations within the three groups 
of determinants: patient's characteristics, clinic's organization of fertility care and 
clinic's organization of information provision (data not shown). Of the 28 information 
recommendations, 7 showed sufficient variation between the clinics to be analysed 
subsequently in a multilevel procedure. The results of these multilevel analyses are 
shown in Table II. At patient level, there was a positive association between, on the 
one hand, high education level (P=0.0064) and high treatment-related anxiety scores 
(P=0.0275, P=0.0050, P=0.0289 and P=0.0070), and on the other hand, a higher level of 
received information concerning 'lifestyle advice' about weight, alcohol and drug use 
and 'emotional consequences of treatment'. At the level of a clinic's organization of 
fertility care, the presence of obstetrics/gynaecology residents in the fertility 
department positively influenced 'information provision on lifestyle advice concerning 
weight' (P=0.0017) and 'emotional consequences of treatment' (P=0.0375). Moreover, 
the presence of trained fertility nurses positively influenced 'information provision on 
prevention of OHSS' (P=0.0390) and 'lifestyle advice concerning tobacco use' 
(P=0.0023). A clinic's higher number of consultations per year was positively associated 
with information concerning alcohol use (P=0.0277). At the level of a clinic's 
organization of information provision, the use of checklists for information provision
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was positively associated with a higher level of information provision on 'prevention of 
OHSS' (P=0.0294 and P=0.0024) and 'lifestyle advice on alcohol use' (P=0.0241).
Discussion
In this study, we observed that for Dutch patients information provision according to 
national fertility guideline recommendations is currently poor and in need of 
improvement. Patient couples are deprived of essential information on diagnostics, 
causes of their condition and treatment risks. Determinants of high information 
provision are, e.g. patients' high education level, the presence of trained fertility 
nurses and the use of information checklists for professionals.
However, the majority of patients view the information they receive as sufficient, and 
patient satisfaction with treatment is high.
Adherence to information recommendations
We showed that the percentage of couples who received complete information varied 
widely per guideline recommendation. It is especially alarming that the majority of the 
patient couples are deprived of essential information concerning complications and 
risks of treatment; only 32 and 43% of couples, respectively, actually received this 
complete information. It is thus disputable whether these couples have really been in 
the position to make informed decisions before starting treatment. In general, an 
observed lack of information can be attributed to two main factors, i.e. limited 
information provision by healthcare professionals and defective memorization or 
comprehension by patients.26 If the former is the main problem, professionals should 
be confronted with their inadequate performance to enable them to improve. 
However if the latter is the main problem, professionals should also be alert to 
recognize when information is not sufficiently understood. Furthermore, providing 
information on complications and risks of fertility treatment can be complicated by the 
fact that couples perceive treatment merely as a positive thing, i.e. a solution for their 
problem. They could therefore ignore warnings and downplay any negative or 
frightening information about the much desired treatment.
In general, infertile patients comprise a relatively young, actively participating and, in 
our sample, even well-educated patient group.
Several studies in oncology and primary care showed that younger patients and 
patients striving for active involvement in their treatment have higher intrinsic needs 
for information; this makes our observed lacunas in information provision, particularly 
alarming.21,27 The fact that clinicians incorrectly associate a younger patient age with 
better understanding of information or with better abilities to gather information 
themselves, might be a serious pitfall in daily practice.
Healthcare professionals should therefore be attentive to patient's preferences and 
perspectives and should ensure that information, particularly on patient safety, is 
actually taken in and fully understood.
Satisfaction
To deliver patient-centred healthcare, professionals should put effort into collecting, 
as well as acting upon, patients' preferences on a regular basis. The results of our 
survey showed that the vast majority (94%) of participating couples were satisfied with
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their fertility services, with even higher ratings when pregnancy was achieved. Likewise
10 12 28 29high ratings of patient satisfaction are known from the literature. However,
such high ratings may mask still existing shortcomings in actual care, especially as 
ratings were shown to be influenced by desired outcome (i.e. pregnancy). For example, 
a patient who is unaware that information provision is incomplete has no reason to be 
critical and is therefore likely to be content with the information he or she received. It 
is important to realize that a patient satisfaction assessment is only an indirect, and 
therefore insufficient, method to monitor current practice; it should be completed 
with more care-related and preferably evidence-based evaluations of actual 
performance, such as the current study.
Determinants of information provision
In each of the three hypothesized domains (Supplementary Table 1a), determinants 
were found to be significantly related to information provision levels after multilevel 
analysis. Within the domain 'clinic's organization of fertility care', the presence of 
specialized fertility nurses and residents was found to be associated with better 
information provision on selected topics, as was the use of information checklists from 
the domain 'clinic's organization of information provision'.
This probably reflects the typically more systematic working methods of both groups in 
comparison with the more autonomous and routine practice of, for example, 
established gynaecologists. It also means that a simple and systematic approach, such 
as the introduction of information checklists for professionals, can compensate for 
organizational characteristics such as a clinic's small size, low number of fertility 
consultations or the lack of specialized nursing personnel.
The observed association between higher levels of information received and higher 
treatment-related anxiety scores raises the question that a causal connection could 
exist. Are more anxious patients craving for information and thus better informed, or 
does an overload of warning information make patients confused and more anxious, 
even affecting memorization? This controversy is previously described in the 
literature30-34, and further research is needed to try to unravel the underlying 
mechanisms. In the meanwhile, special attention should be paid to anxiety levels of 
infertile patients.
Table II. Significant determinants of information provision after multi-level analysis
Recommendation Determinant of high information provision P-value
In case of actual mild OHSS, patients should be given the following information to monitor signs Use of checklists for information provision 0.0294
of OHSS
Increase fluid intake
Check colour of urine
Daily monitoring of body weight in the morning
In case of actual mild OHSS and an increase in body weight of >1 kg/day, patients should be Presence of trained fertility nurse 0.0390
advised to contact the clinic for ultrasound and laboratory tests Use of checklists for information provision 0.0024
During an intake prior to IVF/ICSI-treatment, the following should be discussed: High level of anxiety for relationship with partner 0.0275
Emotional aspects of the treatment Presence of Ob/Gyn residents 0.0375
How patients can communicate that they are in need of extra emotional support
The existence of the subfertility patient association 'Freya' for the possibility to share
experiences and gain information from the patients perspective
Patients with anovulation and overweight should, with regard to their fertility treatment and High level of anxiety for treatment outcome 0.0050
overall health, be informed of the importance of weight reduction by means of life-style
changesa.
Lifestyle advice regarding tobacco, should be part of the counselling regarding pregnancy Presence of trained fertility nurses 0.0023
probabilitiesa. High level of anxiety for treatment 0.0289
Lifestyle advice regarding alcohol should be part of the counselling regarding pregnancy Couple's high education level 0.0064
probabilitiesa. High number of fertility consultations/year 0.0277
Use of checklists for information provision 0.0040
Lifestyle advice regarding a healthy weight should be part of the counselling regarding High level of State anxiety 0.0289
pregnancy probabilitiesa. High level of anxiety for treatment outcome 0.0070
Presence of Ob/Gyn residents 0.0017
Ob/Gyn=Obstetrics and Gynaecology; OHSS=ovarian hyper stimulation syndrome. Significance was set at p<0.05.
a patients were only included for analysis of this recommendation when they respectively used alcohol, tobacco or had a BMI <20 or >25 kg/m2
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Advantages and disadvantages of the study
An advantage of this study is that the investigated content domains of information in 
this study are universal for fertility care and not unique to the Dutch situation, which 
makes the reported results also of considerable interest to other countries. It shows 
that the existence of best practice guidelines does not automatically coincide with 
actual best practice. Acknowledging this gap between current and best practice will be 
the first important step towards optimal information provision.
Adequate ways should be found to guide clinicians in taking the next steps. The 
attitude towards patient participation in guideline development could, for example, 
precipitate the development of patient information as a regular addendum to each 
newly developed guideline, as suggested before by Coulter et al.5 .
This study also has some limitations. First, recall bias should be considered whenever 
analysing patient questionnaires. A 100% adherence score per recommendation might 
not be feasible due to incomplete patient recall.35-37 However, the large differences in 
adherence scores between the recommendations as well as between the participating 
hospitals (data not shown) illustrate that recall bias might not be the most important 
nor the sole explanation for the reported low adherence scores, as each 
recommendation is a priori at comparable risk for this recall bias. We tried to minimize 
the effect of possible recall bias by choosing a study design with a questionnaire aimed 
at couples. It is certainly possible that one of the partners cannot correctly recall the 
information provided, but the other partner may be able to compensate this lack of 
recall. We hypothesized that addressing the couple instead of the individual will give 
us a more reliable representation of actual practice. Conversely, the questions 
concerning anxiety, depression and satisfaction were exclusively aimed at the female 
partner. The literature, however, shows that gender differences can be present for
12 38 39these scales. ' ' Future research would therefore benefit from a design directed at 
distributing separate questionnaires to the individual partners. Such an adjusted 
design would make it possible to compare scores from both partners, thus shedding 
more light on the role of the male partner as well as couple dynamics regarding the 
issue of patient information in fertility care.
Secondly, the use of an extensive written questionnaire may have caused a sample 
bias; Non-Dutch or low-literacy couples are less apt to participate because of 
insufficient Dutch language skills. It is important to realize that the level of received 
information in these patient groups will be even less than our reported findings, i.e. 
our results could be an under-estimation of reality. Both groups already tend to ask 
fewer questions during consultation and are therefore at risk to understand less of the
21 22 40provided information. ' ' Supplemental written information to consolidate oral 
information is known to improve recall41,42, but has no effect in these distinctive 
patient groups. Further research should therefore aim at identifying, acknowledging 
and acting upon specific informational needs of certain patient subgroups. This could 
result in more tailored information provision, e.g. using pictograms for low-literacy 
patients43,44, or providing translated information material for non-native speakers.45 
Thirdly, some patient characteristics known from the literature to be related to 
transmission of information (e.g. ethnicity, social class, age and income)17 were not 
found to be significant in our analysis. A possible explanation is that our sample of 
infertile couples was a relatively homogenous group compared with, for example,
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patient groups in oncology or primary care; the age-range was relatively small and 
ethnicity, social class and income showed a skewed distribution. Sufficient data 
variation between the clinics is necessary to analyse all potential determinants in a 
multilevel procedure. Future research in a larger multicentre study should be 
performed to overcome this lack of inter-patient, inter-couple and inter-clinic 
variation. In conclusion, we found that information provision in fertility care in the 
Netherlands is currently poor. This is despite the effort of professional organizations 
such as the NVOG and the Dutch Ministry of Health, Welfare and Sport to describe the 
minimal informational needs of infertile patients in official nationwide guidelines and 
even an act of law. Nevertheless, we reported high ratings of patient satisfaction, 
suggesting that such ratings alone are insufficient to assess actual care. Information 
provision could easily be improved by, for example, the use of information checklists.
O
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Table 1a Potential determinants of information provision
Determinant domain Level Determinant
Female age (years)
Male age (years)
Alcohol use (yes/no) both partners 
Tobacco use (yes/no) both partners 
Individual Drug use (yes/no) both partners 
State anxiety a female partner 
Anxiety for treatmenta female partner 
Patient Anxiety for treatment outcomea female partner
Anxiety for financial consequencesa female partner 
Anxiety for relationship with partnera female partner 
Depressiona female partner
Type of subfertility (primary/secondary) 
Duration of subfertility (months)
Couple Ethnicity (Dutch/non-Dutch)
Education level (low, intermediate, high) 
Gross monthly family income (euros) 
Attained pregnancy (yes/no)
Clinic size (new patients/year)
Clinic type (1-16)
Number of subfertility consultations/year 
IVF facilities (yes/no)
Teaching facility (yes/no)
Presence of separate subfertility outpatient clinic (yes/no) 
Clinic: Presence of separate subfertility consulting hours (yes/no)
organization of fertility Presence of trained subfertility doctors (yes/no)
care Number of trained subfertility doctors
Presence of trained subfertility nurses (yes/no)
Number of trained subfertility nurses 
Presence of Ob/Gyn residents (yes/no)
Number of professionals within subfertility team 
Local fertility protocols available (yes/no)
National fertility protocols available (yes/no)
Lifestyle alteration programme available (yes/no)
Clinic: Locally developed patient-information available (yes/no)
organization of Nationally developed patient-information available (yes/no)
information provision National patient association information available (yes/no)
Organization of informative meetings (yes/no)
Use of checklists for information provision (yes/no)
a Anxiety and Depression were reflected in sumscores, as described in the text. 
Ob/Gyn; Obstetrics and Gynaecology
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Table 2a Mean adherence to guideline-based recommendations on information provision
Information domain Adherence
(%)
npatients Guideline
source
General information 72
Before prescribing Metformin for ovulation induction because 59 17 Anovulation
of apparent Clomiphene-resistancy, the following should be and childwish
discussed:
• Possible side effects of Metformin
• The off-label use of Metformin for ovulation-induction
Each step in the initial assessment of fertility should be Initial
discussed with the couple both pro- and retrospectivel; assessment of
• Cycle-analysis 91 337 fertility
• Semenanalysis 85 316
• Tubal patency assessment 95 159
All diagnostics within the initial assessment of fertility should 83 342 Initial
aim at providing the couple insight into their chance of assessment of
spontaneous conception fertility
In case of ovulation induction to improve fecundity and poor 26 61 Embryo act
ovarian response(<3 follicles), IVF should be advised against.
After each unsuccessful cycle of IVF/ICSI, the cycle should be 59 294 Embryo act
evaluated with the couple and a proposal for possible further
treatment should be given.
During an intake prior to IVF/ICSI-treatment, the chances of 86 301 Embryo act
pregnancy in general and after single and double embryo
transfer respectivelyb should be discussed.
During an intake prior to IVF/ICSI-treatment, the following 68 265 Embryo act
should be discussed:
• how hospital care during treatment is organised and which
caretakers are involved in the treatment procedure
• how patients should contact the fertility team in case of
problems or complaints
• how the subfertility team can be contacted, especially
outside daytime-hours
The patient who is candidate for tubal surgery should be 82 55 Tubal
informed about the admittance procedure, the surgery itself pathology
and the post-operative recovery.
The patient who is candidate for tubal surgery should be 68 53 Tubal
informed about the success rate after surgery pathology
The patient who is candidate for tubal surgery should be 57 49 Tubal
informed about the time interval between surgery and pathology
possible conception
Lifestyle 46
Patients with overweight should, with regard to their fertility- 28 128 Anovulation
treatment and overall health, be informed of the importance and childwish
of weight reduction by means of life-style changes.
Lifestyle advice regarding tobacco use should be part of the 57 114 Initial
counselling regarding pregnancy-probabilities.a assessment of 
fertility
Lifestyle advice regarding alcohol use should be part of the 49 192 Initial
counselling regarding pregnancy-probabilities.a assessment of 
fertility
Lifestyle advice regarding drug use should be part of the NA 7 Initial
counselling regarding pregnancy-probabilities.a assessment of 
fertility
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Information domain Adherence
(%)
npatients Guideline
source
Lifestyle advice regarding a healthy weight should be part of 50 145 Initial
the counselling regarding pregnancy-probabilities.a assessment of 
fertility
Complications 32
During an intake prior to IVF/ICSI-treatment, the following 14 271 Embryo act
risks should be discussed:
• Risk of hyperstimulation
• Risk of poor response and accompanying consequences
• Risk of complications such as infection and bleeding
• The laboratory procedure and the risk of swapping- and
laboratory-mistakes
In case of actual mild OHSS, patients should be given the 20 150 OHSS
following information to monitor signs of OHSS:
• Increase fluid intake
• Check colour of urine
• Daily monitoring of body weight in the morning
In case of actual mild OHSS and an increase in body weight of 61 150 OHSS
>1 kilogram/day, patients should be advised to contact the
clinic for ultrasound and lab-tests.
Additional support 72
During an intake prior to IVF/ICSI-treatment, the following 48 280 Embryo act
should be discussed:
• Emotional aspects of the treatment
• How patients can communicate that they are in need of
extra emotional support
• The existence of the subfertility patient association 'Freya'
for the possibility to share experiences and gain
information from the patient's perspective
In case IVF/ICSI-treatment is terminated, an evaluative 96 47 Embryo act
consultation should be held with the couple to determine
whether further follow-up or adjuvant emotional support is
necessary.
In case premature ovarian failure is diagnosed, the following NA 0 Premature
should be discussed with the patient: ovarian failure
• Possibility to receive psychological support
• The possibility of oocyte-donation
• The chances of spontaneous conception
• Family-history, with regard to the option of assessing
karyotype (premature ovarian failure, Fragile X  syndrome,
Auto-immune diseases)
• The (dis-)advantages of hormone replacement therapy
Risks 41
Before ovulation induction treatment, the patient should be 18 204 Anovulation
informed about: and childwish
• Specific side-effects of medication
• The need for regular intensive follow-up during treatment
• The increased risk of multiple pregnancy
• The increased risk of OHSS
• The increased risk of spontaneous abortion
During ovulation-induction, the patient has to be informed 67 46 Anovulation
that coitus is prohibited or contraception has to be used in and childwish
case of 4 or more follicles >12mm.
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Information domain Adherence
(%)
npatients Guideline
source
Intra Uterine Insemination should not be performed in case of 
more than 3 follicles > 16 mm or more than 5 follicles > 12mm. 
In both cases, the use of contraceptives should be advised as 
well.
92 100 Intra uterine 
insemination
During an intake prior to IVF/ICSI-treatment, the following 
risks should be discussed:
• Chance of congenital diseases/malformations
• Chance of ectopic pregnancy
• Chance of multiple pregnancy
• Chance of spontaneous abortion
• Possible unknown long-term risks
16 257 Embryo act
The patient who is candidate for tubal surgery should be 
informed about the risk and symptoms of extra-uterine 
gravidity
10 49 Tubal pathology
patients were only included for analysis of this recommendation when they respectively used alcohol, tobacco or had a BMI 
<20 or >25 kg/m2
b in the Netherlands, a maximum of two embryos are transferred per treatment cycle.
OHSS = ovarian hyperstimulation syndrome;
IVF= in vitro fertilization;
ICSI= intracytoplasmatic sperm injection
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Abstract
Objective: To assess determinants of patients' experiences and satisfaction with 
fertility care.
Design: Cross-sectional questionnaire study.
Setting: Sixteen fertility clinics in The Netherlands.
Patients: A total of 1,499 infertile women in The Netherlands who visited a 
participating clinic in April-June 2005 for diagnostics or treatment.
Main outcome measures: Patients experiences and satisfaction with several aspects of 
fertility care, and the patient and clinic characteristics that are determinants of those 
two concepts.
Results: In general, patients' satisfaction with care was high (94%). Waiting times, 
information provision and emotional support were experienced the least positive 
aspects of care. Determinants of all care aspects were found to be significant at four 
different domains: three at patient level, i.e., demographic characteristics, type of 
received treatment and both general and mental health status, and one at clinic level,
i.e., organization of care.
Conclusions: This study provides an increased understanding of the determinants of 
patients' experiences and satisfaction with fertility care. This enables professionals to 
tailor their care to specific subgroups of patients and adjust their organization of 
fertility care where needed. Moreover, the study underlines the need to investigate 
whether case-mix correction is necessary whenever interpreting patient-surveys on 
care experiences, because both the patient's and the clinic's characteristics can 
influence the way that health care delivery is experienced. Demographic background 
of this regional patient sample was rather homogeneous, which should be taken into 
account when interpreting results.
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Introduction
Traditionally, the quality of health care is rated by technical and physiologic outcome 
measures such as mortality and morbidity.1,2 Regarding fertility care, outcomes are 
thus frequently defined as live birth or complication rate. However, in the last two 
decades there has been an increasing conviction that patients' opinions have to be 
included in the evaluation of health care to achieve a more thorough and patient- 
centered reflection of quality of care.1,3,4 For this purpose, standardized methods, such 
as the Picker Patient Experience questionnaire5 and the Consumer Assessment of 
Healthcare Providers and Systems (https://www.cahps.ahrq.gov) have been developed 
to elicit feedback from patients. Such feedback can thus be used as additional outcome 
measures within quality-of-care assessments, while simultaneously uncovering those 
aspects of care that are in need of attention or improvement.6,7 The current 
disadvantage of such instruments is, however, that they are not always tailored to 
specific patient groups and only scarcely available for outpatient care, let alone fertility 
care. This probably explains why most studies within fertility care have sought to 
develop and validate their own instruments.8-10
The question rises whether measuring experiences and satisfaction alone provides us 
with enough transparency to directly improve care. A logical second step would be to 
assess which determinants influence patients' experiences and satisfaction.11 On the 
one hand, an increased understanding of such determinants enables professionals to 
tailor their care to the preferences and needs of different patient subgroups and to 
develop improvement programs addressing deficits in various settings. On the other 
hand, it might reveal the need to adjust for certain patient or clinic characteristics 
when interpreting patient evaluations, e.g., in the light of performance comparisons of 
health care providers.12,13
The objective of the present study was therefore twofold. First, we aimed to assess 
patients' experiences and satisfaction with fertility care, and second, we explored 
which clinic and patient characteristics are determinants of these two concepts.
Materials and methods 
Setting
We conducted a cross-sectional study by postal questionnaire and two reminder 
rounds.14 The reported results are part of a larger study which was approved by the 
Regional Review Board for Research on Human Subjects (CMO), Arnhem-Nijmegen 
(CMO no. 2004/193).
Study Population
We aimed to include a representative Dutch patient group, visiting 16 participating 
clinics for diagnostics or treatment of infertility. Of the 16 participating clinics, there 
was one university and one tertiary fertility clinic and six additional clinics offered 
IVF/ICSI treatment. These eight clinics were all large- or intermediate-sized teaching 
facilities and national health services funded, except for one smaller nonteaching 
private clinic. The remaining eight clinics were intermediate- or small-sized, and all but 
one nonteaching facilities. Every Dutch citizen has an either privately or publicly 
funded basic insurance coverage, which covered, during the study period, treatment
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costs (but not medication costs) for intrauterine insemination (IUI) and ovulation 
induction (OI), as well as treatment and medication costs of three cycles of IVF/ICSI. 
Potential participants were selected by means of each clinic's Diagnosis-Treatment 
Combination (DBC) registration database; in this nationwide financial registration 
method, infertile couples are identified with a specific F-code. An F-code could mean 
either an initial assessment of fertility, diagnostics, treatment, or counseling. Couples 
were apt for inclusion if they had an F-code any time in April, May, or June 2005. A 
computerized random sample of patients with an F-code was selected and invited to 
participate from each clinic's DBC database. The patient sample size was stratified 
according to clinic size (50, 150, or 550 patients) and encompassed ~75% of the clinic's 
fertility patients during the inclusion period. In total, 2,698 couples were invited. 
Patient couples were asked to complete the questionnaire concerning the study period 
(January 1, 2005-July 1, 2005). Couples were included if they completed both the 
questionnaire and the informed consent.
Questionnaire Development
Part 1: patients' experiences and satisfaction with fertility care
The patient questionnaire was constructed for a larger study on several aspects of 
clinical fertility care.14 The present paper focuses on the questions concerning 
experiences and satisfaction with care, measured by a Dutch translation of Souter et 
al.'s ''questionnaire on patient satisfaction with the management of infertility''.8 The 
original Souter questionnaire was systematically developed based on literature and 
focus group interviews with patients.
Part 2: determinants of patients' experiences and satisfaction with fertility care
The Souter questionnaire was complemented with questions regarding determinants
of patients' experiences and satisfaction. Potential determinants were gathered from10 13 15_22
general and fertility literature ' ' and expected to exist within three groups:
1. Patient's demographic characteristics (e.g., female age, couple's education level): 
Demographic characteristics were gathered from both partners by questions with 
open-end (e.g., ''age'') or categorical (e.g., ''household income'') response 
categories.
2. Patient's health status (e.g., level of anxiety, achieved pregnancy):
The female partner was asked to fill out additional questions on anxiety and 
depression. Anxiety was measured by a 10-item short version of the State-Trait 
Anxiety Index (STAI)23,24 and 12 additional fertility-related anxiety items, e.g., 
''anxiety for treatment outcome,'' both on a 4-point scale (''almost never,'' 
''sometimes,'' ''frequently,'' ''almost always''). Depression was measured by the 
Beck Depression Index for Primary Care (BDI-PC) using a 4-point scale of varying 
utterances25. ''Achieved pregnancy'' was defined as a positive pregnancy test in the 
study period. The questionnaire was piloted among 30 couples recruited by the 
Dutch Patients' Association for Infertility and adjusted where necessary.
3. Clinic's characteristics (e.g., clinic ID [1-16], presence of trained fertility nurses): A 
professional questionnaire regarding clinic characteristics and organization of 
fertility care14 was sent to a coordinating gynecologist of each participating clinic.
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Questions were either open ended (e.g., ''number of fertility consultations/year'') 
or categorical (e.g., ''presence of trained fertility nurses'').
Statistical Analysis
Dependent variables: patients' experiences and satisfaction with fertility care 
Patients' experiences were considered to be dependent outcome variables. For 
reduction of dependent variables, exploratory factor analysis was performed on the 
Souter questionnaire. Five factors were discerned: 1) information provision; 2) 
emotional support; 3) waiting times; 4) doctor's attitude; and 5) organization of 
diagnostics. These five aspects are also mentioned in the Souter questionnaire, where 
patients are asked to rank them by their relative importance. A reliability analysis for 
internal consistency was performed for each factor (Cronbach a = 0.59-0.79). Per 
patient, sum scores were calculated and dichotomized if distributions appeared 
skewed (i.e., categories containing <15% of all answers).
Independent variables: determinants of patients' experiences and satisfaction with 
fertility care
Confirmatory factor analysis and reliability assessment was performed for the 
questions of the STAI (Cronbach a = 0.91) and BDI-PC (Cronbach a = 0.82); both 
showed good internal consistency and ''anxiety'' and ''depression'' were carried 
forward as potential determinants. Exploratory factor analysis was performed on the 
additional anxiety questions, resulting in the factors ''anxiety for treatment'' 
(Cronbach a = 0.73) and ''anxiety for treatment outcome'' (Cronbach a = 0.76). 
Remaining anxiety items outside a factor were ''anxiety for financial consequences'' 
and ''anxiety for relationship with partner.'' All independent variables were checked 
for colinearity. If a correlation coefficient of >0.6 was found, preference was given to 
the variable closest to actual outpatient performance. For example, a strong 
correlation (>0.8) was found between ''clinic size'' and ''having special fertility 
consulting hours,'' and the latter was carried forward as the preferred variable.
All independent variables were then tested in an univariate analysis (cross tabulations, 
Wilcoxon rank sum test, independent-samples t test, and X2-test) with the dependent 
variables concerning patient's experiences. The significantly associated (P<.100) 
variables that showed enough interclinic variation were included in a multilevel 
stepwise logistic regression analysis to explain differences in experiences. For this, a 
random coefficient model was composed using the levels ''clinic'' and ''patient'' in a 
Glimmix procedure in SAS (SAS forWindows v8.2). If no interclinic variation existed, 
regular multivariate regression analysis was performed. Significance for multivariate 
and multilevel regression analysis was set at P<.05.
Results
Response
In total, 1,499 couples (56%, range 47%-72%) completed the questionnaire and signed 
informed consent. Sociodemographic characteristics of the participants are shown in 
Table I (14). Mean female age was 32.8 years and male age 35.1 years. Only 1.9% 
(n=27) of couples were of non-Dutch origin, 53% had a high education level 
(>secondary school), and 94% had a more than modal household income (>1,760
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euros/month gross); 73% suffered from primary infertility, and mean duration of 
infertility was 38 months.
Table I. Baseline characteristics of the participating couples (n=1499).
Characteristic % of couples, or mean (SD)
Mean age
Female 32.8 yrs (4.1 yrs)
Male 35.1 yrs (5.0 yrs)
Ethnic backgrounda
Dutch 98.1
Non-Dutch 1.9 
Gross monthly family income (euros)b
<1,100 1
1,100-1,760 4
1,760-2,750 22
>2,750 71.6 
Education level per couplec
Low 6
Intermediate 40
High 52.9 
Type of infertilityd
Primary 72.8
Secondary 27.2
Mean duration of infertilitye 38.4 mo (22.5 mo)
Ethnic background of the couples was determined by the origin of both partners: Dutch = one or both partners are of Dutch 
origin; non-Dutch = both partners are not of Dutch origin.
Gross monthly family income was categorized according to social security standards in 2005 and modal income in euros: 
<1,100 = less than Dutch modal income; 1,100-1,760 = Dutch modal income; 1,760-2,750 = up to 1,5 times Dutch modal 
income; > 2,750 = more than twice Dutch modal income.
Education level of the couples was determined by the highest education level of both partners: low =primary or lower 
vocational education; intermediate = secondary or intermediate vocational education; high = higher professional education or 
university.
Type of infertility was determined for the couple.
Duration of infertility was defined as the period between the start of regular unprotected sexual intercourse and January 1 
2005, the beginning of the study period.
Patients' experiences with fertility care
Table 2 shows patients' experiences with aspects of fertility care. In total, 38% of 
patients explicitly preferred a fertility clinic as opposed to a mixed clinic. A lack of 
continuity of care (i.e., being seen by more than one doctor) was indicated by 27% of 
patients. The aspects with the lowest amount of positive experiences were ''emotional 
support,'' ''waiting times,'' and ''information provision.'' Emotional support by the 
team or an actual appointment with a social worker or psychologist was offered to 
23% of patients, whereas 13% indicated they would actually want to talk to such 
professionals. Regarding consultations, 43% were held on scheduled time and mean 
waiting time was 18 minutes. However, 77% of patients seen late stated that this delay 
was acceptable. Written information was received by 70% of patients and 26% felt the 
amount was insufficient. Almost two-thirds (65%) of patients never received a clear 
plan for the future. Doctor's attitude was generally rated rather high. The majority of 
patients (>95%) felt that their doctor was listening, friendly, capable, sympathetic, and 
explaining. Approximately one in ten patients (11%) felt their doctor did not involve
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them in decision making, one-fifth (19%) of patients felt that their doctor was not 
really interested in them as a person, and a similar number was not given enough 
opportunity to ask questions.
Ranking of aspects
The five aspects of care were ranked by patients for relative importance; ''Doctor's 
attitude'' was considered to be the most important aspect of care (36%), followed by 
''information provision'' (29%), ''organisation of diagnostics'' (24%), ''waiting time'' 
(8%), and ''emotional support'' (4%).
Table II. Patients' experiences with fertility care, ranked per aspect.
Aspect of care
Response category ''yes'' 
Number of Percentage of 
patients patients
Clinic's organization
Preferred fertility clinic 573/1,459 38
Preferred mixed clinic 201/1,459 14
No preference 685/1,459 47
Experienced lack of continuity of care 348/1,300 27
Information provision
Received written information 1,007/1,447 70
Received sufficient written information 354/1,362 26
Received sufficient explanation of possible causes 1,295/1,428 91
Received sufficient explanation of side-effects of medication 1,051/1,161 91
Received a clear plan for the future 452/1,276 35
Emotional support
Was offered emotional support by the team 332/1,460 23
Was offered appointment with a social worker or psychologist 373/1,460 26
Wanted to talk to a social worker or psychologist at time of 182/1,379 13
filling
out questionnaire
Waiting times
Seen on scheduled time 654/1,459 43
Delay acceptable 1,168/1,432 77
Doctor's attitude
Did the doctor at your most recent visit:
Behave politely 1,423/1,450 98
Appear good at his/her job 1,404/1,433 98
Listen to what you had to say 1,401/1,439 97
Explain things 1,379/1,445 95
Make it easy to ask questions 1,392/1,450 96
Show an interest in you as a person 1,114/1,379 81
Appear sympathetic 1,359/1,435 95
Let you take part in any decisions 1,154/1,299 89
Were there questions you would have liked to ask at the clinic 269/1,470 18
but
did not have the opportunity to do so
Organization of diagnostics
Explained beforehand 1,364/1,410 90
Repeated excessively 84/1,394 6
Took too long to carry out 145/1,393 10
Took too long for results to come through 124/1,395 9
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Determinants of Patients' experiences with care
Multilevel analysis showed significant determinants at four different domains (Table 
III). At patient level, three domains were repeatedly found: demographic 
characteristics (e.g., higher female age), type of received treatment (e.g., IVF), and 
health status. The latter concerned both mental health status (e.g., state anxiety) and 
general health status (e.g., achieved pregnancy). For example, achieving pregnancy 
was associated with positive experiences regarding emotional support (P=.014), 
doctor's attitude (P=.008), and organization of diagnostics (P=.003). At clinic level, only 
the domain ''organisation of care'' (e.g., presence of a separate fertility consultation 
hour) provided significant determinants. For example, having a separate fertility 
consultation hour was associated with positive experiences regarding emotional 
support (P=.019). Clinic size or ID was not associated with experiences.
Patient satisfaction and determinants of satisfaction with fertility care
Overall, 94% of patients were satisfied with current fertility services. Table IV shows 
the determinants associated with high satisfaction: suffering from secondary infertility 
(P=.048), less feelings of depression (P<.001), receiving IVF treatment (P=.016), 
achieving pregnancy (P<.001), and visiting a clinic with specialized fertility nurses 
(P=.019). Pregnancy outcome (e.g., ongoing pregnancy or not) was not significantly 
associated (P=.515) with satisfaction.
Discussion
This study assessed patients' experiences and satisfaction with several aspects of 
fertility care and explored the determinants influencing those experiences. 
Experiences were generally positive, which is similar to findings in a Scottish cohort of 
infertile patients.8 Overall satisfaction with care was very high, which also corresponds
8_IQ 26_28with the literature. Determinants of experiences and satisfaction could be
found in both patient and clinic characteristics. Frequently found determinants were 
mental or general health status. Hall and Dornan29 already described strong evidence 
that health status is a causal determinant of patient satisfaction. Also, higher levels of
17,18,30 16anxiety and depression are frequently found to be associated with
dissatisfaction with care. For fertility care in particular, the role of social attributes,
such as anxiety, about treatment as well as marital stress, has been reported to relate
10,26,27to negative patient experiences and lower satisfaction. We found similar results: 
For each of the five aspects of care studied, lower scores of either anxiety or 
depression related to positive experiences with care. Moreover, lower depression 
scores were significantly associated with increased satisfaction.
The majority of studies on patient satisfaction with care unequivocally report that a 
good self-perceived health status or achieving a desired health outcome (in this case,
12,21,27,31,32pregnancy) is strongly associated with high satisfaction. ' ' '  ' In accordance, we 
showed that achieving pregnancy was indeed associated with more positive 
experiences and higher overall satisfaction. Similarly, when the type of infertility was 
secondary (i.e., pregnancy was achieved before), it was associated with higher 
satisfaction ratings.
The only clinic characteristics found as determinants were the ''presence of trained 
nurses'' and ''specialized fertility consulting hours''. This reflects the fact that specific
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patient-centered attention and tailored care may be accountable for positive
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experiences and high satisfaction. ' '
We assume this is also the reason why specific types of received treatment (i.e., IUI 
and IVF/ICSI treatment) were repeatedly found as a determinant. It might appear 
strange that the most intensive treatment types (as opposed to, e.g., expectant policy) 
were found to be determinants. However, invasive and time-consuming types of 
treatment are provided within specifically designed outpatient care, involving more 
extensive information provision and contact hours with highly specialized personnel. 
Patients' preferences for more continuity and personal care are thus probably
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met. ' ' This is also described by others, who found that emotional support and a 
good relationship between staff and patient was a major determinant of patient 
satisfaction.15,28,33 Considering the high drop-out rates (i.e., 17%-65%) known to exist 
in IVF/ICSI treatment, it would probably prove worthwhile for clinics to invest in better 
emotional support to enable couples to go through treatment cycles confidently.36-42 
Global differences in reimbursement of fertility care could hamper adoption of such 
beneficial organizational elements. However, because clinic characteristics might be 
the only determinants that can be easily influenced by care providers (as opposed to, 
e.g., type of fertility), efforts should be made to adapt these, independent of 
reimbursement systems. Even with limited financial means, small adjustments in 
existing clinic structure could be easily achieved by redesigning current care structure. 
For example, incidental or randomly planned fertility consultations in mixed 
obstetrics/gynecology outpatient clinics could be streamlined by clustering fertility 
patients into separate consultation hours where nursing staff remains of stable 
composition. This nursing staff is preferably extra educated or subspecialized within 
infertility care or, if reimbursement is insufficient, staff can be enabled to get educated 
''on the floor.''
Experiences Versus Satisfaction
The first initiatives at incorporating patients' opinions in health care assessments 
concerned mainly satisfaction ratings. However, these carry the disadvantage of being 
subject to emotions, thus presenting only limited pictures. This generally results in high 
satisfaction ratings, even when patients simultaneously indicate problems with several 
aspects of care.15,43-45 Measuring patients' concrete experiences with specific aspects 
of care (e.g., ''did your doctor give you the opportunity to ask questions?'') rather than 
satisfaction (i.e., ''were you satisfied with your doctor?'') therefore provides a more 
reliable indication of the quality of care delivered, because it provides insight into the 
processes in need of improvement.15,44,46 The same applies to assessing background 
factors of patients' satisfaction with care, as opposed to patients' experiences with 
care.44 The concepts ''experience'' and ''satisfaction,'' however, remain to be 
intertwined.47,48 Ware et al.49 made an early attempt at theoretic work by 
distinguishing satisfaction ''reports'' (i.e., experiences) from satisfaction ''ratings''50, 
and only gradually the term ''experiences'' was introduced to discriminate between 
the two. Still, ''satisfaction'' is used alternately for the same concept; for example, the 
Souter questionnaire is reported by the original authors to assess ''patient 
satisfaction,'' although, in our opinion, it actually assesses mostly experiences while 
also including a single question on satisfaction with care. The high ratings of
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satisfaction and experience described here are in correspondence with other fertility
8_10 26_28literature , However, most of these studies are performed in countries which
also have fairly good ART reimbursement systems. Patients' expectations of fertility 
care might therefore be lower compared with countries where patients have to pay 
directly for treatment, because expectations are assumed to influence the way health 
care delivery is experienced.51
Limitations
There are also some limitations to this study. First, the participants in the study were 
relatively highly educated and belonged to high-income households of primarily Dutch 
origin. This rather homogeneous background could have caused the absence of 
determinants such as age, ethnicity, education, and income, which are known from
12,30,52,53literature to relate to satisfaction. The use of an extensive written
questionnaire could have induced a sample bias, because non-Dutch or lower-class 
couples are less apt to participate owing to inadequate language proficiency. We were 
unable to perform a nonresponder analysis, because of absent demographic 
information on the nonresponder group, although this could have provided 
information on the extent of sample bias. However, the demographic background of 
the study group was similar to those in a previous survey study in the same region, 
which had a higher response rate.44
Second, earlier studies found gender differences in experiences and satisfaction 
assessments.27,54,55 Most of our questionnaire items were exclusively aimed at the 
female partner. Future research could benefit from using separate questionnaires for 
both partners.14
Finally, the major disadvantage of the study is the cross-sectional study design, which 
can only demonstrate associations, not causality. To demonstrate any causality, future 
studies should be longitudinal in design.
Conclusion
In conclusion, the present study provides us with an increased understanding of the 
determinants of patients' experiences and satisfaction with comprehensive fertility 
care. Determinants could be found at both patient and clinic levels. Couples clearly 
seem to prefer continuity of care, including the opportunity to connect with a small 
group of health care providers, versus the ''clinic'' type of care. These results enable 
fertility professionals to tailor their care to specific subgroups of patients and adjust 
their organization of care where needed. Moreover, this study underscores the need 
to investigate whether case-mix correction is necessary when interpreting patient 
surveys on experiences and satisfaction with care, because patient and clinic 
characteristics can strongly influence the way health care delivery is experienced.
Table III. Determinants of patients' positive experiences with several aspects of fertility care—results of a multilevel logistic analysis.
Aspect of fertility care Determinant OR [ 95% CI] P value Determinant associated with positive experiences
Information provision Mental health status (Depression) 0.88 0.84-0.92] < .001 Less depressive feelings
Type of treatment (IUI) 1.88 1.33-2.64] < .001 Received IUI treatment
(IVF/ICSI) 1.82 1.25-2.65] .002 Received IVF/ICSI treatment
Emotional support Health status (Pregnancy) 1.48 1.08-2.01] .014 Achieved pregnancy
Mental health status (Anxiety) 0.93 0.90-0.96] < .001 Less anxious feelings (state anxiety)
(Depression) 0.90 0.85-0.96] .002 Less depressive feelings
Type of treatment (IVF/ICSI) 2.53 1.67-3.85] < .001 Received IVF/ICSI treatment
Organization of care (Consultation hours) 2.12 1.13-3.96] .019 Presence of specialized fertility consultation hours
Waiting times Mental health status (Depression) 0.92 0.88-0.97] < .001 Less depressive feelings
Type of treatment (IUI) 1.43 1.04-1.96] .028 Received IUI treatment
(IVF/ICSI) 1.70 1.12-2.58] .013 Received IVF/ICSI treatment
Doctor's attitude Health status (Pregnancy) 1.51 1.12-2.04] .008 Achieved pregnancy
Mental health status (Anxiety) 0.97 0.95-0.99] .024 Less anxious feelings (state anxiety)
Type of treatment (IVF/ICSI) 1.53 1.05-2.24] .028 Received IVF/ICSI treatment
Organization of 
diagnostics Demographics (Female age) 1.57 1.03-2.38]
.010 Younger female age
Health status (Pregnancy) 1.85 1.19-2.94] .003 Achieved pregnancy
Mental health status (Anxiety) 1.79 1.22-2.56] < .001 Less anxious feelings(financial consequences)
Type of treatment (IVF/ICSI) 1.03 1.01-1.11] .007 Received IVF/ICSI treatment
Table IV. Determinants of patients' satisfaction with fertility care—results of a multilevel logistic analysis.
Determinant OR 95% CI] P value Determinant associated with higher satisfaction
Satisfaction Demographics (Type of subfertility) 1.97 [1.01-3.87] .048 Secondary subfertility
Health status (Pregnancy) 3.70 1.85-7.38] <.001 Achieved pregnancy
Mental health status (Depression) 0.88 0.82-0.95] <.001 Less depressive feelings
Type of treatment (IVF/ICSI) 2.79 [1.21-6.39] .016 Received IVF/ICSI treatment
Organization of care (Trained nurses) 2.08 [1.13-3.85] .019 Presence of trained fertility nurses
CI = confidence interval; IUI = intrauterine insemination; IVF/ICSI = in vitro fertilization/intracytoplasmatic sperm injection; OR = odds ratio.
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Abstract
Introduction: Proper use of clinical practice guidelines can decrease variation in care 
between settings. However, actual use of fertility guidelines is suboptimal and in need 
of improvement. Hence, a cluster-randomized controlled trial was designed to study 
the effects of two strategies to implement national Dutch guidelines on 
comprehensive fertility care.
Materials and methods: Design: Sixteen fertility clinics participated in the trial. A 
minimal, professional oriented implementation strategy of audit and feedback was 
tested versus a maximal multi-faceted strategy that was both professional as well as 
patient-oriented.
Outcome measures: The extent of adherence to guideline-recommendations, reflected 
in quality indicator scores. To get insight into unwanted side-effects, patient anxiety 
and depression scores were gathered as secondary outcomes. Data collection 
encompassed medical record search, patient and professional questionnaires.
Results: 1499 couples were included at baseline and 1396 at after-measurement. No 
overall significant improvement in indicator scores was found for either strategy. 
Secondary outcomes did not differ for both groups, selected anxiety scores were lower 
in the maximal intervention group. Process evaluation of the trial revealed positive 
patient experiences with the intervention material. Professionals' appreciation of 
intervention elements varied, and execution of the multi-faceted strategy appeared 
incomplete.
Discussion: Absence of an intervention effect may be due to the nature of the 
strategies, incomplete execution or flaws in study design. Process evaluation data 
raises the question whether professionals should be the only actors responsible for 
guideline implementation. This study therefore contributes to an increased 
understanding of fertility guideline implementation in general, and the role of patients 
in particular.
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Introduction
The burden of infertility weighs heavily on approximately 80 million couples 
worldwide.1,2 For western Europe, this affects around 10-15% of couples of 
reproductive age3-6, of which an estimated 50% seeks medical assistance.4 Providing 
those infertile couples with best available health care, i.e. consensus and evidence- 
based diagnostic tests and treatment options, is the common aim of several national 
and international societies of fertility professionals. For this purpose, they developed 
clinical practice guidelines to guide health care providers during daily practice, while at 
the same time decreasing variation in care between settings. However, the mere 
existence of such guidelines does not automatically imply that they are widely spread 
nor commonly used. Dissemination of new guidelines should therefore ideally be 
followed by robust implementation efforts. However, research on the implementation 
of fertility guidelines in particular is scarce. This is remarkable, as the diagnostics and 
treatment commonly used for infertility, lead to an extensive use of healthcare 
resources and are associated with substantial physical and psychological consequences 
for the patients involved.7-11
It is commonly known in guideline implementation research that there is no 'magic 
bullet' for successful implementation of every clinical problem or in every practice 
setting. For example, literature is still inconclusive regarding the effects of multifaceted 
versus single interventions for guideline implementation.12-16 The most frequently 
studied interventions encompass audit and feedback on current practice, 
dissemination of educational materials, reminders and the organization of educational 
meetings or outreach visits, which all seem to have only small to moderate effects on 
the improvement of professional performance.17-19 However, mainly individual 
professionals are targeted in these interventions. The role of patients in guideline 
implementation is, surprisingly, still rather unexplored and evidence is therefore 
scarce.20-22 As fertility patients are generally young, critical towards their care 
providers and thus sometimes regarded by professionals as one of many barriers to 
guideline implementation23, we hypothesize patients could be just the allies we need 
for successful implementation of fertility guidelines.
Hence, we designed a cluster-randomized controlled trial (c-RCT) to study the effects 
of two different strategies to improve the use of recommendations in national Dutch 
fertility guidelines on comprehensive clinical fertility care. Literature was reviewed to 
identify barriers for the implementation of clinical practice guidelines in reproductive 
medicine and fertility care in particular23-31, as a prospective identification of barriers is 
still assumed to lead to better adaptation of interventions.32 Based on this literature, 
barriers were expected to be found in the contexts of the guideline itself, 
organizational aspects of care, patient characteristics and professional characteristics. 
Our strategies were subsequently tailored to these barriers. We hypothesized that a 
maximal implementation strategy consisting of a multi-faceted intervention, tailored 
to barriers from literature and directed at both professionals as well as patient 
couples, would prove to be more effective than a minimal implementation strategy 
consisting of a single, professional-oriented intervention of audit and feedback. We 
assume these effects can be seen at cluster level. To increase our understanding of
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factors influencing the impact of the implementation strategies, a process evaluation 
of the trial was also performed.
Material and methods 
Study design
We performed a cluster-randomized controlled trial in 16 fertility clinics from the 
Fertility Network East, a knowledge and clinical experiences exchanging network of 
fertility clinics in the eastern region of the Netherlands. The study was approved for all 
clinics by 'the Regional Review Board for Research with Human Subjects (CMO) Region 
Arnhem-Nijmegen' (CMO no. 2004/193), as well as two local research ethics 
committees. The trial was registered with ClinicalTrials.gov (ID NCT00119925) and 
results are reported according to the CONSORT-statement for cluster-randomized 
trials.33
Randomization
Fertility clinics instead of couples were the unit of randomization to avoid cross-over 
contamination of both intervention strategies; clinics were assigned to either a 
minimal or a maximal implementation strategy. Prior to randomization to one of the 
implementation strategies, participating clinics were stratified according to clinic size 
(small, medium large) and treatment facilities (with or without IVF/ICSI facilities) (see 
figure 1). Two independent research associates performed the randomization 
procedure by drawing blinded envelopes. Allocation sequence was concealed until the 
interventions were assigned. Usual care measured at baseline served as a control for 
both groups. Figure 1 shows a flow-chart of clinics and included patients.
Blinding
All patients and professionals were blinded to group assignment and remained 
unaware of intervention contents. The research group, but not the trained data 
extraction personnel was aware of group assignment.
Participants
Clinics
In total, sixteen clinics of the Fertility East Network were invited and agreed to 
participate. There was one academic and one tertiary care clinic, both running a 
licensed IVF laboratory, of which there are only 13 in total in the Netherlands. Seven of 
the sixteen clinics offered secondary care, as an autonomous, satellite (i.e. performing 
an IVF/ICSI cycle up to the ovarian stimulation phase) or transport IVF/ICSI clinic 
satellite (i.e. performing an IVF/ICSI cycle up to the oocyte pick-up phase). These clinics 
are also teaching clinics and of large or intermediate size; the other seven clinics are 
smaller, non-teaching facilities. In total, 15 clinics are in the national health system, 
and one of the smaller secondary care clinics is a private clinic. The different types of 
clinics were chosen to reflect average national fertility care.
Patients
To include a representative patient group, potential participating couples were 
retrospectively selected in each clinic by means of the clinics' financial registration 
database (Diagnosis Treatment Combination code). In this nation-wide registration
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system, patients undergoing diagnostics or treatment for infertility are identified with 
a specific Fertility-code (F-code). A baseline measurement was performed which 
included a random sample of 1499 couples that had an active F-code anytime between 
the 1st of April 2005 and July 1st 2005 and concerned the fertility care these couples 
received in the period between the 1st of January 2005 and July 1st 2005. For the 
after-measurement, couples were apt for inclusion if they had an active F-code 
anytime between the 1st of December 2007 and March 1st 2008. The after­
measurement focused on the care these couples received in the period between the 
1st of September 2007 and March 1st 2008. From each clinic, a random sample of 
eligible couples (n=50, 150 or 500, stratified according to clinic size) was invited to 
participate in data-collection for the study (postal survey). Patients in each study arm 
were included according to the 'intention to treat' principle, i.e. independent from 
diagnosis or treatment type. This procedure was followed for both the baseline and 
after-measurement. Eligible couples were sent a questionnaire which included an 
informed consent form concerning the use of both medical data from patient records 
as well as from the questionnaire.
Study Interventions
Minimal strategy; Audit and Feedback
The minimal implementation strategy was entirely directed at professionals, and in 
June 2007 introduced in each of the eight clinics in the minimal intervention arm. This 
strategy consisted of professional audit and feedback. Audit encompassed results of 
the baseline assessment of the clinics' scores to previously developed quality 
indicators34, regarding care provided in the period January 2005-July 2005. Based on 
these indicator scores, clinic-specific feedback reports regarding current care were 
formulated by the study group. Each of these minimal strategy clinics was sent a 
sufficient number of these feedback reports for dissemination among its fertility 
professionals (i.e. gynaecologists, fertility doctors, nurses, physician assistants). An 
instruction letter for interpretation was enclosed in each report. Per quality indicator, 
feedback on current care was given by means of a bar-chart showing the total range of 
performance on a scale from 0%-100% including the median adherence of all 
participating clinics. Feedback was kept anonymously and each individual clinic 
received a feedback report with a clear marking in the bar chart of their own 
performance. After sending these feedback reports, no further contact was established 
with the minimal intervention clinics until the data collection for the after­
measurement was started up.
Maximal strategy; multi-faceted intervention
The maximal implementation strategy was multifaceted of nature, and tailored to 
barriers known from literature as well as to baseline performance; the strategy was 
directed at both professionals and patient couples.
The strategy included the following four professional oriented elements:
i) Audit and feedback discussions
Similar to the minimal strategy, clinic-specific feedback reports on current care were 
developed and sent to the eight maximal intervention clinics in May 2007. After circa
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three weeks, a multidisciplinary (e.g. addressing gynecologists, fertility doctors, 
residents, fertility nurses, quality officers) one hour meeting was organized in each 
clinic, where the feedback report was presented and commented on by one of the 
authors (S.M.). During each meeting, the clinic's performance was discussed in the 
light of the other 15 clinics' performances, and possibilities for quality improvement 
were highlighted.
Moreover, professionals in each of the maximal strategy clinics were provided with the 
following implementation tools:
i) List of suggested tools for implementation of the guidelines at local level
Per indicator, a specific tool or action was provided to improve performance. For 
example, the proposed action to improve 'history-taking of the couple' consisted of 
'the development and introduction in the outpatient record of a systematic history- 
taking form'.
Besides these professional oriented interventions, a patient oriented intervention was 
introduced in these maximal strategy clinics:
ii) Leaflet on Shared Decision Making (SDM) in the fertility consultation
The leaflet on SDM explained the general principles of SDM and contained a suggested 
literature list. It also provided practice examples for fertility care in which patient 
preferences do not always match guideline contents, and how SDM could be helpful to 
reach bilateral agreement in policy (e.g. concerning single versus double embryo 
transfer or the need for an expectant period before start of assisted reproduction).
iii) Patient information checklists
Checklists for the provision of patient-information were disseminated for professionals 
to use in the consultation room. These checklists consisted of laminated sheets that 
contained patient information items to be discussed with patients and recommended 
in the guidelines (e.g. the chances of pregnancy after transfer of one versus two 
embryos, the side-effects of medication for ovulation induction).
iv) Educational patient leaflets
Based on the fertility guidelines and accompanying quality indicators, three 
educational patient leaflets were developed concerning; 1) the initial assessment of 
fertility, male infertility, endometriosis, tubal pathology and idiopathic infertility; 2) 
ovulation induction, intra uterine insemination and ovarian hyper stimulation 
syndrome; 3) IVF/ICSI treatment and ovarian hyper stimulation syndrome. These 
leaflets explained the background and contents of the professional guidelines in lay 
language. The text moreover aimed to encourage patients to start a dialogue with 
their doctor regarding diagnostic testing, treatment plan and treatment itself, while 
promoting the concept of shared decision making. The leaflets contained a prompt 
sheet for questions during consultation and also referred to the national fertility 
guidelines published on the website of the Dutch Society for Obstetrics and 
Gynaecology. Professionals were asked to distribute the relevant leaflets among the 
infertility patients consecutively visiting their (outpatient) clinic in the implementation 
period (June 2007-January 2008).
Outcomes
The effectiveness of both implementation strategies was reflected in the scores on a 
pre-developed set of guideline based quality indicators34. The studied guidelines
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included nine fertility guidelines of the Dutch Society for Obstetrics and Gynaecology 
(NVOG): Initial assessment of fertility, anovulation, male infertility, tubal pathology, 
endometriosis, premature ovarian failure (POF), intra uterine insemination (IUI), 
indications for in vitro fertilization (IVF) treatment, ovarian hyperstimulation syndrome 
(OHSS). Moreover the model protocol of the Dutch embryo Act was considered, which 
includes clinical statements on the provision of IVF treatment. The indicators were 
systematically developed structure and process indicators for comprehensive clinical 
fertility care. They cover topics like 'indications for treatment', 'diagnostic procedures', 
'treatment procedures' and 'patient information'. Indicators are scored dichotomously, 
in which the value '1' reflects 'adherence' and value '0' reflects 'non-adherence' to a 
defined guideline recommendation. All indicators were tested during the baseline 
measurement for several quality criteria (i.e. measurability, reliability, applicability, 
improvement potential, discriminatory capacity, complexity and case-mix stability, 
thus exploring their value as instruments for monitoring and improving clinical 
performance.34 After the baseline measurement indicators with high applicability were 
considered adequate primary outcome measures to reflect the degree of adherence to 
guideline recommendations for the c-RCT.35 Indicators which also have high 
improvement potential are suitable to assess changes in adherence, whereas 
indicators with low improvement potential are only suitable to monitor adherence in 
time. To get insight into any unwanted side-effects of the applied strategies, we 
included at patient level 'anxiety' and 'depression' as secondary outcome measures.
Data collection
Data collection to calculate quality indicator scores was performed from either medical 
records (e.g. process indicators concerning treatment aspects), a professional 
questionnaire (e.g. structure indicators concerning clinic's structure) or a patient 
questionnaire (e.g. process indicators concerning patient information provision).36 
Medical record extraction was performed by three trained data collectors who entered 
data in digital forms, specifically designed to enhance systematic and complete data 
collection by using computerized algorithms for data entry. Data collectors followed an 
intensive one-month training and reliably assessed a series of 30 test records before 
starting official data collection. During data-collection, two independent reviewers 
abstracted a random sample of 10% (n=32) of medical records from 2 participating 
clinics. The extent of agreement between these data reviewers on the level of process 
indicator scores, corrected for chance, was calculated using Cohen's kappa 
coefficient37. Reliability among the data collectors was substantial, reflected in average 
Cohen's Kappa-coefficients of 0.86 (baseline) and 0.82 (after-measurement) (range 
0.48 -1.0).
Data for the secondary outcome measures were gathered by the patient 
questionnaire. Anxiety was measured by a 10 item short version of the State Trait 
Anxiety Index (STAI)37,38 and n=12 additional infertility-related anxiety items, e.g. 
'anxiety for treatment outcome, both on a 4-point scale ('almost never', 'sometimes', 
'frequently', 'almost always'). Depression was measured on a 4 point scale by the Beck 
Depression Index for Primary Care (BDI-PC)40.
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Process evaluation of intervention elements
We applied the process-evaluation framework described by Hulscher et al.41 to 
evaluate both exposure to as well as each stakeholder's experience with the several 
elements of the interventions. This was done by means of a professional questionnaire 
and an addendum to the patient questionnaire in the after-measurement.
Sample size
The study was designed to provide at least 80% power in order to detect a difference 
of 15% in guideline adherence between the two study arms (70% for the minimal 
strategy and 85% for the maximal strategy) at the 0.05 two-sided significance level. 
Considering an intracluster-correlation coefficient (ICC) of 0.15 and assuming an 
average 30 infertile couples seen per professional and an average 2 a 3 professionals 
per clinic (43 professionals in total), 1290 couples (43*30) were needed for both the 
baseline measurement as well as the after-measurement.
Analysis
To analyze the effectiveness of the two implementation strategies, we assessed the 
proportion of patients that was treated in accordance with the guidelines, which is 
reflected in quality indicators scores before and after the implementation period in 
both intervention arms. The difference in indicator scores was analyzed with 
adjustment for clustering of patients within clinics. Therefore, for each indicator, multi­
level logistic regression analyses were performed in which 'intervention arm' acted as 
the independent variable and 'indicator score' as the dependent variable. Analyses 
were based on the modified intent to treat principle, meaning all participants were 
included in the arm to which they were originally assigned, regardless of whether they 
completed the intervention given to the arm. Chi2 statistic and Crosstabs were used to 
determine differences in scores within either baseline or the after-measurement. If 
significant differences (set at p<0.05) existed at baseline level for either specific 
indicator scores or demographic characteristics, these differences were corrected for 
by taking baseline scores up as a covariate in the final multi-level model composed to 
assess differences between the two intervention arms. The statistical programme SAS 
for Windows V8.2 was used to compose a multi-level model correcting for clustering in 
the different clinics.
Results
Participant flow
At baseline, 726 couples were included for the maximal implementation strategy and 
773 for the minimal implementation strategy, for the after-measurement these 
numbers were 697 and 696 respectively (see figure 1).
Comparability of data at baseline
Demographic characteristics of both intervention arms at both measurement periods 
are shown in table I. For most characteristics, the arms were comparable.
There were significant differences between the minimal and maximal intervention 
arms at baseline, for the variables 'type of infertility' (68% versus 77% primary 
infertility; p=0.000) and 'duration of infertility' (35 versus 41 months; p=0.000).
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Figure 1
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Table I demographic characteristics of the participating couples
Baseline measurement After-measurement
(n=1499 )__________________ (n=1393 )
Characteristics Minimal arm 
(n=726)
Maximal arm 
(n=773)
Minimal arm 
(n=696)
Maximal arm 
(n=697)
Mean age in years (SD)
Female 32.48 32.85 33.06 33.37
(SD 4.1) (SD 4.2) (SD 4.5) (SD 4.7)
Male 35.11 35.56 35.53 36.31*
(SD 4.9) (SD 5.1) (SD 5.1) (SD 6.1)
Ethnic background (%)a
Dutch 98.4 97.8 98.5 98.4
Non-Dutch 1.6 2.2 1.5 1.6
Gross monthly family income in € (%) b
<1100 1.3 1.9 0.8 1.5
1100-1760 4.4 4.8 2.3 4.3
1760-2750 20.9 23.4 14.8 15.5
>2750 73.3 69.9 82.1 78.6
Education level per couple (%)c
Low 7.1 6.1 3.1 5.7
Intermediate 41.1 40.2 36.6 36.4
High 51.9 53.6 60.3 57.9
Type of infertility (%)d
Primary 68.4 77.0* 67.8 69.5
Secondary 31.6 23.0* 32.2 30.5
Mean duration of infertility in months 34.7 41.4* 35.8 38.7*
S ) e (SD 20.4) (SD 24.2) (SD 23.7) (SD 26.1)
* significant difference between both arms at the p=0.05 level.
a Ethnic background of the couples was determined by the origin of both partners: Dutch = one or both partners are of Dutch 
origin; non-Dutch = both partners are not of Dutch origin.
g Gross monthly family income was categorized according to social security standards in 2005 and modal income in euros:<1100 
less than Dutch modal income; 1100-1760 Dutch modal income; 1760-2750 up to 1,5 times Dutch modal income; >2750 more 
than twice Dutch modal income.
c Education level of the couples was determined by the highest education level of both partners: low = primary or lower 
vocational education; intermediate = secondary or intermediate vocational education; high = higher professional education or 
university.
d Type of infertility was determined for the couple.
e Duration of infertility was defined as the period between the start of regular unprotected sexual intercourse and the beginning 
of the study period: respectively January 1 2005 (for the baseline measurement) or September 1 2007(for the after­
measurement).
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Outcomes and estimation
Pr im a r y  o u tc o m es
Table II shows the indicator scores for both the baseline as the after-measurement. 
The indicators with low improvement potential at baseline showed in the after­
measurement the same high adherence percentages, meaning care remained of high 
standards. This is for example true for the indicator 'Couple's history-taking should 
cover at least: age of both partners, duration of infertility, type of couple's infertility'. 
The remaining indicators with high improvement potential at baseline, showed mixed 
effects in the after-measurement (table II).
Only for two indicators, concerning 'the aim of the initial assessment of fertility to 
result in a diagnosis and prognosis' and 'lifestyle advice concerning smoking', there 
was a significant surplus value of the maximal intervention compared to the minimal 
intervention arm. For one indicator, concerning the monitoring of ovarian response by 
transvaginal ultrasound in case of IUI in the stimulated cycle, there was a significant 
less decrease in adherence to the guideline when comparing minimal and maximal 
intervention arms.
SECONDARY OUTCOMES
Both at baseline as well as in the after-measurement, there were no significant 
differences in BDI-PC and STAI scores for the minimal and maximal intervention arms 
(data not shown). Regarding the infertility-related anxiety items at baseline, women in 
the maximal arm were more fearful of definitive childlessness (p=0.033). This 
difference did not exist in the after-measurement. At after-measurement, women in 
the minimal arm had significantly higher anxiety scores regarding the effect of stress 
on the physical relationship with their partner (p=0.013) as well as higher anxiety 
scores for the presence of a twin pregnancy (p=0.006).
Process evaluation of study interventions
Patients
Of the 696 patients included in the maximal intervention arm in the after­
measurement, 260 (37%) unique patients reported to have received one or more of 
the patient leaflets. The majority of those patients appeared highly satisfied with the 
leaflets (97%). They reported an increased knowledge of potential causes (71%), 
treatment procedures (90%) and guidelines (51%), an increased understanding of their 
doctor's treatment policy (61%), an increased ability to ask questions about the 
treatment (61%. The scores for an improved communication with the doctor (22%), as 
well as perceived increased empowerment for decision making during consultations 
(22%) were lower. In total, 83% would want to receive comparable leaflets in the 
future and 97% would recommend the leaflets to peers.
Table II; indicator scores at baseline and after-measurement
Indicator Minimal intervention 
Baseline After
Change Maximal intervention 
Baseline After
Change a • aA min-max
Initial assessment of fertility % % % % % % 2-tailed
(n) (n) (n) (n) p-value
The initial fertility assessment should result in both a 45.2 34.6 - 10.6 14.1 26.4 +12.3 p<0.0001 *
diagnosis and a prognosis. (231) (165) (197) (178)
The initial fertility assessment should consist of three parts: 32.3 38.8 +6.5 37.7 32.0 -5.7 NS
semenanalysis, tubal occlusion and cycle-analysis. (100) (116) (79) (100)
Couple's history-taking should cover at least: age of both 97.0 99.4 98.0 98.0 0 NS
partners, duration of infertility, type of couple's infertility (209) (178) +2.4 (152) (148)
(primary or secondary).
Woman's physical examination should include assessment 74.1 92.6 +18.5 70.7 76.6 +5.9 NS
of the Body Mass Index. (193) (176) (140) (141)
Life-style advice should be part of the counselling regarding 50.8 75.0 +25.8 65.3 68.8 +3.5 p=0.0436*
pregnancy-probabilities. (65) (68) (49) (48)
Advice concerning smoking
Advice concerning alcohol 45.2 67.8 +22.6 54.6 68.1 +13.5 NS
(115) (121) (77 (116
Advice concerning bodyweight 48.9 53.9 +5 52.7 51.4 -1.3 NS
(90) (78) (55) (70)
Anovulation
Patients with overweight should, with regard to their 20.3 25.6 +5.3 38.6 27.9 -10.7 NS
fertility-treatment and overall health, be informed of the (69) (78) (57) (43)
importance of weight reduction by means of life-style
changes.
The ovarian response to hormonal stimulation should be 86.1 96.7 +10.6 88.1 93.8 +5.7 NS
performed by regular transvaginal ultrasound (frequency of (72) (61) (59) (32)
1-3 times / week).
Before starting ovulation induction treatment, the patient 13.8 19.6 +5.8 23.7 21.4 -2.3 NS
should be informed about: specific side-effects of (109) (143) (93) (84)
medication, the need for regular intensive follow-up during
treatment, the increased risks of multiple pregnancy,
hyperstimulation syndrome and spontaneous abortion.
Indicator Minimal intervention Change Maximal intervention Change A min-maxa
Baseline After Baseline After
Male factor infertility % % % % % % 2-tailed
(n) (n) (n) (n) p-value
In case of normospermia (WHO-criteria), semen-analysis 89.8 72.5 -17.3 66.7 51.6 -15.1 NS
should not be repeated, and no additional andrological (48) (40) (30) (31)
tests should be performed.
In case of an abnormal semen-analysis (WHO-criteria), the 6.9 2.5 -4.4 21.4 31.0 +9.6 NS
physician should perform: (30) (40) (29) (29)
1. andrological history-taking
2. a physical examination
3. at least one extra semen-analysis.
In case of an idiopathic oligoasthenoterato-zoospermia, no 100 100 100 100 NS
hormones, vitamins or NSAID's should be prescribed to (88) (86) (91) (76)
improve semen-quality.
Intra uterine insemination (IUI)
In case of unexplained infertility, stimulated IUI should not 8.3 15.2 +6.9 28.0 17.2 -10.8 NS
be offered, even though it is associated with higher (89) (46) (49) (29)
pregnancy rates than unstimulated IUI, because it carries a
risk of multiple pregnancy.
The diagnosis 'cervical factor' is an indication for IUI in the 11.1 13.3 +2.2 22.7 11.8 -10.9 NS
unstimulated cycle. (18) (15) (23) (17)
In case of IUI in the stimulated cycle, ovarian response 58.3 26.5 -31.8 66.7 61.0 -5.7 p= 0.0451*
should be monitored by transvaginal ultrasound. (103) (68) (51) (59)
Each department performing IUI should evaluate their 100 100 - 100 100 - NS
results annually (8) (8) (8) (8)
Indications for IVF/ICSI
In case of male infertility with VCM<1x10*6 /ml (before 13.6 56.7 +43.1 24.0 73.6 +49.6 NS
capacitation) there is a direct indication for ICSI-treatment. (44) (30) (50) (19)
In case of unexplained infertility in a woman <36 years, 61.5 70.0 +8.5 83.3 81.3 -2.0 NS
there is an indication for IVF after 3 years of infertility. (13) (10) (30) (16)
The routine use of hCG for luteal support after IVF is not 100 100 - 100 100 - NS
recommended (8) (8) (8) (8)
Indicator Minimal intervention Change Maximal intervention Change a • aA min-max
Baseline After Baseline After
Embryo Act % % % % % % 2-tailed
(n) (n) (n) (n) p-value
During an intake prior to IVF-treatment, the following
should be discussed:
The risks of hyperstimulation, poor response and 13.0 12.9 +0.1 14.2 11.6 -2.6 NS
accompanying consequences, complications such as (115) (155) (155) (138)
infection and bleeding, the laboratory procedure and the
risk of swapping- and laboratory-mistakes.
The chances of success, pregnancy after SET and DET. 82.4 90.7 +8.3 89.1 88.0 -1.1 NS
(125) (161) (175) (142)
The chances of congenital diseases/malformations, ectopic 6.4 8.1 +1.7 23.8 12.1 -11.7 NS
pregnancy, multiple pregnancy and spontaneous abortion (109) (149) (147) (132)
and possible unknown long-term risks.
The emotional aspects of the treatment, how patients can 41.2 53.5 +12.3 52.2 55.2 0 NS
communicate that they are in need of extra emotional (119) (144) (161) (143)
support and the existence of the patient association for
infertility to share experiences and gain information from
the patient's perspective.
How hospital care during treatment is organised and which 66.4 74.0 +7.6 70.0 63.6 -6.4 p=0.0336 **
caretakers are involved in the treatment procedure, how (104) (146) (160) (129)
patients should contact the fertility team in case of
problems or complaints and how the fertility team can be
contacted, especially outside daytime-hours.
a = corrected for baseline differences; * = significant difference in favor of the maximal intervention;
** = significant difference in favor of the minimal intervention; NS = non significant
A d d e n d u m  to  ta b le  II: Some patient numbers or percentages shown in table II regarding the baseline measurement may slightly differ from those reported in table I in chapter 4. Increased insight during the 
study period did the researchers decide to make minor adjustments in the complex algorithms behind some indicators. This encompassed for example adding stricter exclusion criteria and loosening 
assessment of history-taking items by including only recommendations with high-grade evidence to the algorithm. Some indicators that concerned more than one treatment cycle per patient, were 
operationalized anew by formulating indicator adherence as a dichotomized score per patient instead of indicator adherence per cycle separately; this way, the care assessment by indicators approximates 
daily practice more closer, as professionals may have legitimate reasons to defer from guidelines in specific cases. Adjustments were done to include as many cases as reasonably possible without loosening 
inclusion criteria or deviating from the guideline recommendation contents. Indicators of both baseline as well as after-measurement in table II were calculated using the exactly the same indicator 
algorithms, and are thus comparable over time.
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Professionals
Professionals from both intervention arms rated the feedback report as easily 
accessible, comprehensible and reported that the report actually contributed to the 
implementation of the guidelines in their clinics. In the maximal intervention arm, the 
feedback meeting was rated of equal value. In those maximal intervention clinics, the 
'List of suggested tools for implementation of the guidelines at local level' was 
moreover highly appreciated, whereas professionals were indifferent to the leaflet on 
Shared Decision Making and the patient information checklists. One remarkable 
reason that came up frequently for not using the offered intervention material for 
fertility guideline implementation, was that it was considered to be "not my job 
responsibility" to initiate practice changes.
Discussion
To our knowledge, we report the first trial to evaluate the implementation of a set of 
fertility guidelines, and one of few trials in general that searches to influence 
professional behavior by a patient oriented intervention. However, both the minimal 
professional directed strategy and the maximal tailored, multifaceted patient and 
professional oriented strategy did not improve the overall use of recommendations in 
our national guidelines on comprehensive fertility care. For only two indicators 
significant effects were seen in favor of the maximal intervention, compared to the 
minimal intervention.
Not having found a sustainable effect of either strategy for the entire guideline 
programme, raises the question whether these specific strategies are ineffective in 
itself, or whether ineffectiveness is largely caused by flaws in study design or 
incomplete execution of the intervention strategies. We will further elaborate on these 
possibilities.
Rationale of the tested interventions
From the reviews of the Cochrane Effective Practice and Organisation of Care Group 
(EPOC), we learned that the impact of different interventions to promote healthcare 
interventions is largely variable. Both 'audit and feedback' and 'educational outreach 
visits' are reported to have a small to modest effect on improving professional practice 
and the effect of 'printed educational materials' seems to be only beneficial when 
compared to 'no intervention'.19 In the field of reproductive healthcare, a recent 
review of evidence-based strategies for implementing guidelines in obstetrics42, 
showed especially positive effects for interventions including audit and feedback, 
reminders, as well as multifaceted strategies. It also clearly demonstrated that the 
prospective identification of barriers to change leads to better adaptation of 
interventions. Recent studies on barriers to implementation in reproductive medicine 
identified mainly organizational barriers.23,25,27,29,30,43 As the professionals involved in 
obstetric, gynaecological and fertility care are largely similar, and evidence for 
implementation within fertility care is very scarce, an extrapolation of these results 
may be assumed to be reasonable. However, we have to keep in mind that the major 
pitfall in implementing change into practice lies therein that previously successful 
interventions may prove worthless in other settings. This assumption to extrapolate
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and rely on previously performed barrier research and interventions, might be one 
explanation why the tested strategies in our c-RCT did not prove to be successful.
Study Design
We choose to perform a c-RCT to evaluate the effect of the tested interventions, as 
this is considered the 'gold standard' in implementation research.44 Randomization 
was performed at clinic rather than professional or patient level to avoid any risk of 
contamination of both study arms. However, such a clustered design requests more 
patients to achieve an appropriate study power, which can be done by either 
increasing the number of clusters or the number of patients per cluster. However, as 
the patient sample was randomly selected from electronic databases for financial 
purposes in which treatment or diagnosis type was not indicated, sufficient inclusion 
per indicator could not be guaranteed beforehand. Incomplete inclusion unfortunately 
made it very hard to achieve statistical power for some of the less frequently 
applicable indicators. Proving changes in effect of the interventions was moreover 
complicated because effect-sizes in implementation research are in general only small 
to moderate (5%-15%).15,21,45,46
Choosing a complete set of guidelines with a large number of concrete 
recommendations for practice as a study subject was an ambitious and challenging 
task. The same professionals are involved in providing diagnosis and treatment of the 
various types of infertility, so interventions were aimed at these professionals 
irrespective of background characteristics of their patients (i.e. diagnosis or treatment 
type). If the interventions would have had an overall positive effect on guideline 
adherence, a large group of patients could thus have benefitted from an increase in 
health gain and overall efficacy of care. This in return, would have had a substantial 
beneficial impact on cost-effectiveness of the strategies. However, taking the lack of 
observed effects for the comprehensive set of recommendations into account, and the 
difficulties of including enough patients of some of the indicators, some side remarks 
should be made for future studies. We recommend to exert a future c-RCT with a more 
strictly specified subgroup of patients, for example with the shared diagnosis 'male 
infertility and a more limited set of recommendations'. This would have several 
advantages. First, the patient sample could be easier identified by either clinical or 
laboratory registrations. Second, when enrolling the intervention, professionals only 
have to focus on a distinct patient group and limited clinical care pathways, thus 
probably increasing their awareness to the provided interventions.
Incomplete execution of the intervention
The patient leaflet was received by only 37% and read by 30% of intended patients 
from the maximal intervention clinics. The vast majority of leaflet recipients read the 
material (87%, 92% and 87% respectively for each of the leaflets) and highly 
appreciated it. We learn from these results that patients on the one hand are 
amenable to this innovative type of implementation strategy, whereas the 
professionals on the other hand either appeared to be quite indifferent to the 
execution of this intervention, or did not consider it their job to do so. Subgroup 
analysis of patients that actually received the patient information leaflets was 
unfortunately not possible because of low numbers per indicator. Obviously the
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success of a maximal intervention as described in this paper depends on optimal 
dissemination of intervention materials, for example due to the presence of local 
opinion-leaders who commit themselves to the project. We moreover recommend to 
search for alternative ways of implementing such interventions, for example direct 
automated mailing of material through identification of patients from e.g. EPF's, 
systematic dissemination on the floor through specialized nurses or, perhaps quite 
unorthodox, even by bypassing the already busy professionals by entrusting the 
patients associations alone with this task.
As the feedback report and meeting were generally rated as the most valuable 
intervention elements by the professionals, it could very well be possible that the 
surplus value of the maximal implementation strategy was limited. This is in 
accordance with literature, which recently questions the previously reported 
advantages of multi-faceted over single interventions.16 Change needs time, certainly 
when it concerns effectuating a change in the communication and decision-making 
process by patient-education and empowerment. It could be a slow process requiring a 
redefinition of traditional roles and a paradigm shift in doctor-patient interaction. As 
stated above, the challenge of implementing a comprehensive set of guidelines by 
addressing all dimensions of fertility care at the same time is a huge one. A longer 
implementation period (e.g. 12 or even 24 months) might have been more justified to 
uncover intervention effects, especially as the interventions were introduced just 
before the regional summer holiday season.
Patient involvement
So far, most evidence from literature on guideline implementation strategies, concerns 
professional-oriented and to a lesser extent organisational interventions. The patient is 
seldom directly involved in introducing change and improvement. However, individual 
preferences of the patient can indeed have major impact on decisions about which 
health care is delivered.47,48 Although this c-RCT did not proof any beneficial effect of 
either of the tested strategies, we think that the role of patients in influencing and 
improving health care provision should be a continued focus of attention in future 
research on fertility care. Negative effects of the interventions, such as an increase of 
anxiety or depression scores, were not observed. Patients from the maximal 
intervention arm were even found to be less anxious for twin pregnancy or the effect 
on the physical relationship with their partner, which could be caused by more open 
communication with their care providers. Regarding the infertility-related anxiety 
items, women in the maximal arm were more fearful of definitive childlessness 
(p=0.033) at baseline than at the after-measurement. This could be caused by positive 
ascertainment from their doctors our from increased understanding of their problem 
due to the patient leaflets, however, it might also be explained by longer duration of 
infertility and higher frequency of primary infertility at baseline.
Summarizing, the results of our study, although not evidently effective, can contribute 
to an increased understanding of the potential role of patients in clinical guideline 
implementation, as the process evaluation data on the patient oriented intervention 
showed promising results; patients did feel empowered to act as a partner in the 
diagnostic and treatment process and experienced an improvement in communication.
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Whether professionals are also prepared to accept patients as equal partners in clinical 
decision-making, remains another challenging focus for further research.49 Similarly, 
the role of leadership, team climate, and local 'culture for change' could be interesting 
subjects for future research50,51, particularly because some professionals indeed felt 
and reported that 'initiating practice changes' was not their responsibility.
In conclusion, in this c-RCT we did not find an overall sustainable effect of the studied 
professional as well as patient oriented interventions, which aimed to improve the use 
of a set of national guidelines for comprehensive fertility care. However, an 
evaluation of the patient oriented intervention showed generally positive experiences 
with patient empowerment and doctor-patient communication. Professionals 
appeared quite indifferent to the disseminated implementation materials, raising the 
question whether they should be the only actors responsible for guideline 
implementation. This provides a promising basis for further studies on the effects of 
patient oriented implementation of professional guidelines.
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Summarizing
This thesis focused on improving the implementation of a set of clinical practice 
guidelines on comprehensive fertility care.
First, a set of guideline-based quality indicators was developed by means of a rigorous 
systematic Delphi-method. Such quality indicators are important to assess current care 
and, by repeated assessment, also to monitor changes in care. The indicator-set was 
extensively tested in a practice test based on medical records and questionnaire data, 
to explore its value as an instrument within a quality improvement initiative. 
Additional professional and patient questionnaires were used to get more insight into 
several specific aspects of current fertility care: A determinant study was performed to 
gain knowledge on potential patient and clinic characteristics associated with the 
current practice of information provision. A second determinant study investigated the 
potential patient and clinic characteristics that are related to patient satisfaction and 
experiences with current fertility care. Subsequently, a cluster-randomized controlled 
trial (c-RCT) was performed in which an innovative multi-faceted, tailored, professional 
and patient oriented strategy was tested against a single-faceted professional oriented 
strategy to implement the Dutch fertility guideline programme. The practice test was 
used as a baseline measurement in this c-RCT. Finally, a process evaluation was 
performed to gain insight into the implementation process and degree of effectiveness 
of both strategies.
In this final chapter, we present answers to the research questions posed in the 
general introduction. The main findings from the studies in the previous chapters and 
some methodological considerations are discussed in the light of available literature. 
The chapter will conclude with some implications for future research as well as future 
practice.
Answers to the research questions
The following answers to the research questions posed in chapter 1, can be formulated 
from the studies described in this thesis.
1. What can be regarded as a valid set of quality indicators for comprehensive 
fertility care? (chapter 2, 3, 4)
Chapter two describes the rationale for the types of indicators, i.e. process and 
structure, that were sought after in the presented study in chapter 3. Following a 
systematic, rigorous six-step Delphi method, we were able to develop a guideline- 
based set of 39 process and structure indicators for comprehensive fertility care, 
both evidence and consensus-based. In a practice test, seven quality criteria per 
indicator were evaluated in chapter 4 to explore the validity and feasibility of these 
indicators as instruments to assess clinical care. Those criteria were: measurability, 
applicability, improvement potential, discriminatory capacity, complexity and case- 
mix stability. The proposed indicator set scored variably on the different quality 
criteria; overall, the set proved suitable for assessing and improving comprehensive 
fertility care. However, tailored to a similarly sized and selected patient sample as 
was used in the described practice test, we could clearly distinguish three subsets 
within the original set: a first subset of indicators with high applicability and
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improvement potential proved suitable for monitoring and quality improvement 
purposes; a second subset of indicators with low improvement potential to be used 
for quality monitoring purposes only; lastly, a third subset of indicators which 
requires a different, very specific fertility patient-sample to make them useful for 
quality improvement purposes.
2. What is the quality of current fertility care in the Netherlands, and how is this 
experienced by patients? (chapter 4, 5, 6)
Based on the extensive audit of comprehensive fertility care by means of the 
described set of quality indicators in chapter 4, a large variation between sites in 
the quality of current fertility care in the Netherlands was found. For some 
indicators, the variation between the clinics, ranged up to a 100%. The median 
adherence to guideline recommendations was less than 50% for 14 of the 39 
indicators assessed. Although 100% scores may not be realistic due to practical 
problems in indicator measurement and the need to divert from guideline 
recommendations in specific cases, all clinics should strive to equal the highest 
scoring clinic, which is a goal within reach. From this current care assessment, it can 
be concluded that there is ample room for improvement within Dutch clinical 
fertility care. This is particularly true for the practice of information provision, of 
which we performed an extensive case study in chapter 5, including a determinants 
analysis. It was shown that an alarming number of couples is deprived of sufficient 
or complete information regarding diagnostics, treatment course and concurrent 
risks and complications. However, a huge discrepancy between these findings and 
the way current information provision was experienced by patients was found. The 
vast majority of patients reported that the information they received was sufficient. 
In addition, chapter 6 showed that patients' experiences with fertility care were 
predominantly positive and satisfaction with provided care was high. This was partly 
associated with specific patient characteristics like high education level, achieving 
pregnancy or good mental health. Moreover, both determinant studies showed that 
small and sometimes simple changes in the organization of current care, e.g. the 
use of checklists for information provision, the presence of trained fertility nurses or 
a specialized fertility consultation hour, could effectuate higher quality and higher 
rated fertility care.
3. Does a combined professional and patient oriented intervention strategy prove 
more effective for the implementation of a fertility guideline programme than an 
exclusively professional oriented strategy? (chapter 7)
The cluster-randomized controlled trial described in chapter 7, revealed that neither 
the innovative multi-faceted professional and patient oriented strategy nor the 
single professional oriented strategy improved the actual use of the comprehensive 
Dutch fertility guidelines as a whole. On the one hand, within the subset of 
indicators with high improvement potential, no overall improvement was 
measured. On the other hand, within the subset of indicators with already high 
adherence (i.e. indicators with low improvement potential) it could be seen that 
care remained of comparably high standards.
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4. What are successful elements of the intervention strategies used? (chapter 7)
A process-evaluation of the c-RCT was performed among professionals and patients, 
in order to shed some light on the use and appreciation of the implementation 
tools. Professionals from both intervention arms rated the feedback report as easily 
accessible, comprehensible and reported that the report actually contributed most 
to the implementation of the guidelines in their clinics. In the maximal intervention 
arm, the feedback meeting and 'List of suggested tools for implementation of the 
guidelines at local level' were moreover appreciated, whereas professionals were 
indifferent to the remaining intervention elements. Patients were generally positive 
regarding the distributed leaflets. They reported an increase in knowledge of 
potential causes of the fertility problem, fertility treatment options and fertility 
guidelines. Moreover, they perceived an increased understanding of their doctor's 
treatment policy as well as increased empowerment to influence treatment 
decisions during consultations. However, as distribution of the patient-leaflets was 
poor, other methods of introduction should be sought-after for this kind of 
intervention to be successful.
Discussion of main findings
The studies performed within the span of this thesis taught us that an objective care 
assessment by means of systematically developed quality indicators can identify the 
domains of fertility care in need of improvement. Both professionals and healthcare 
authorities are thus enabled to act upon this gathered knowledge on current care 
performance. Improvement strategies can be developed which are tailored to the 
different care settings and local shortcomings in performance can be addressed.
Assessing and improving fertility care
Defining high quality of fertility care
The first step in each quality improvement initiative should be the definition of 
appropriate outcome measures. Commonly used traditional measures to evaluate the 
quality of care, are mortality and morbidity. For fertility care, the most frequently used 
outcome measures are 'pregnancy rate' or 'life birth rate', and to a much lesser extent 
morbidity, reflected in complication rate. However, a high pregnancy rate does not 
automatically mean that the quality of delivered care is high. For instance, we do not 
consider fertility care to be of high quality when professionals achieve high pregnancy 
rates at the cost of an increased number of potential life-threatening complications 
like OHSS or multiple pregnancies. Moreover, as discussed in chapter 2 and 3, the 
traditional outcome measures do not provide us with information on where exactly 
improvements in care are necessary. Measures that focus on the process and structure 
of care could indeed provide such information. However, an universal definition of 
what exactly should be "high quality fertility care" does not exist yet. Pennings and 
Ombelet proposed for fertility care that all treatment regimens should refer to the 
standards of "patient-friendly ART" \  Van Empel and colleagues redefined this concept 
to "high quality ART", while entrusting the patient with a key position regarding all six 
aspects of high quality care of the Institute of Medicine (IOM): safety, effectiveness, 
patient-centeredness, timeliness, efficiency and equity.2,3 Following the quality 
initiative proposed by the IOM, high quality care should thus be measured by each of
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these six dimensions. Although professionals seem increasingly supportive of the 
central position that patients should have in fertility care, it will require a paradigm 
shift in professionals' sense of quality to replace, or rather complete, the traditional 
outcome measures with these new dimensions. We therefore promote the use of a 
broad set of indicators covering several aspects of care, instead of the rather short­
sighted use of only traditional outcomes measures. As existing national guidelines 
represent a condensed version of widely available scientific evidence and professional 
consensus, they offer a good basis for the definition of such indicators.
Developing quality indicators for fertility care
The specific aim of the study described in chapter 3, was the development of a valid 
indicator set suitable for the assessment of comprehensive clinical fertility care. By 
involving end-users like gynaecologists and fertility clinicians as panel-members in the 
development-process, a solid basis for future implementation activities was created. A 
systematic procedure was performed conform the current 'state of the art' in indicator 
development.4,5 Firstly, a literature search for existing indicator sets was performed 
and the Dutch fertility guideline programme was taken as a starting point for fertility 
indicator development. The literature search showed the rather surprising finding that 
an international equivalent of this indicator-development project was not yet 
performed for clinical fertility care. An initiative that showed the closest resemblance, 
was the proposed set of seven 'key priorities for implementation' accompanying the 
NICE fertility guideline which was issued by the National Health Service (NHS).6 
However, these key priorities were not systematically developed, let alone tested 
before guideline dissemination. The priority topics were explicitly chosen because of 
convenience of data collection by the requested use of existing NHS resources. This 
lack of precedents within clinical fertility care makes the indicator-studies presented 
in this thesis unique to the field and assigns them an explorative and maybe even 
exemplary status.
Our entire indicator development process was performed bearing the specific goal of 
assessing comprehensive clinical fertility care in mind. This does however implicate 
that concessions have been made regarding the total selected number of indicators 
per guideline, to avoid ending up with a far too large indicator set. Such concessions 
are however inherent to any selection procedure. Our six-step method resulted in a 
very well 'weighted' choice of those guideline recommendations that were considered 
most important regarding overall efficacy, health gain and improvement potential for 
the sole purpose of assessing comprehensive fertility care. If however a need is felt for 
better or more extensive monitoring of one of the separate guideline topics, a new 
indicator procedure can, and should be, executed per guideline. As the indicator set 
was primarily developed for internal audit purposes in a research setting, external 
uptake and use of the set or widespread publication of results should be guided 
carefully, as misinterpretation and potential misuse by uneducated media could easily
7,8occur.
if
138 Chapter 8
The status of guideline-based indicators in quality of care assessments 
There are some important issues to keep in mind when using and interpreting quality 
indicators for care assessments, even if they are robustly developed. Foremost, it is 
necessary to realize that quality indicators do not provide a black and white picture of 
assessed care in absolute terms of what's wrong and what's good. The scope of the 
described indicator assessment was primarily the identification of potential 
shortcomings in current care. This does however not mean that shortcomings (i.e. non­
adherence to guideline recommendations) are automatically of clinical significance. 
Therefore, imperfect quality indicator scores need to be seen as a signal that delivered 
care should be evaluated more closely, rather than a statement that delivered care is 
insufficient per se.4
For guideline-based quality indicators in particular, there is another important point of 
attention. In daily practice, there might be good reasons for professionals to divert 
from a guideline, for example when specific treatment circumstances or individual 
patients' profile require so. Here, we come to a frequently heard objection (i.e. from 
the professional's point of view) to guideline-based quality indicator scores. Guidelines 
are developed for the vast majority of patients, and guideline adherence can thus be 
hampered by a professional's need to tend to an individual patient's situation. Such 
'motivated exceptions' are very hard to register or take into account in performance 
assessments, as they are not necessarily written down in medical records, nor 
systematically entered in the concise entries within electronic databases. In our 
current care assessments, we tried to take into account the potentially motivated 
exceptions as much as possible, for example, by calculating per patient a weighed 
indicator score that is computed from, for instance, the sum of various cycles. An 
elaborated example can be given on the calculation of the indicator recommending 
unstimulated IUI in case of idiopathic infertility. It is imaginable that a need for a 
different treatment policy can be felt after performing already four cycles according to 
the guideline recommendation that did not result into a pregnancy. In this case, a 
certain degree of leniency is allowed to the professional regarding a well-considered 
use of ovarian stimulation in the fifth and sixth cycles. The aberrance from the 
guideline recommendation in only two out of 6 cycles will thus not directly influence 
the weighed indicator score, as two-thirds of the cycles were still according to the 
guideline-recommendation.
Guideline and quality indicator dynamics
Guidelines, as well as accompanying quality indicators should be treated as 'living' 
concepts and should therefore be periodically updated. Some of the studied guidelines 
in this thesis were unfortunately quite aged, with a maximum age of nine years for the 
guidelines 'male infertility', 'OHSS' and 'indications for IVF' at the time of the after­
measurement. For example, in case of idiopathic infertility, the Dutch IUI guideline 
(issued in 2000), prescribes stimulated IUI as treatment of choice. In contrast, the NICE 
guideline issued by the NHS in 2004 recommends unstimulated IUI to prevent adverse 
outcomes like multiple pregnancies, although there is evidence stating that stimulated 
IUI has better outcomes in terms of pregnancy rates. Dutch fertility clinicians are 
individually adapting to this recommendation that became available in a newly spread
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NHS best-practice guideline, by switching their policy from stimulated to unstimulated 
IUI. We anticipated upon this by enabling panel members to add new 
recommendations in the first step of the Delphi procedure. We should however bear in 
mind that the most important prerequisite for delivering evidence-based best care, is 
that evidence should become widely available to professionals, by timely or 
continuous updates.
Implementing change into current practice
In general, results of controlled trials and systematic reviews on guideline 
implementation show that efforts are often not very successful. If any improvement is 
achieved at all, these are small-to-moderate (around 5%-10%); however, such changes 
may still be clinically relevant.9-12 The impact on patient outcomes has often not been 
studied at all or could not be evidently demonstrated.13,14 The evaluated interventions 
in the c-RCT described in chapter 7 proved unfortunately not very beneficial in 
improving current fertility care. This of course raises the question about underlying 
causes. We will discuss here as potential causes the currently available evidence of 
implementation techniques, available knowledge of barriers to implementation and 
the actual extent of implementation of the executed strategies.
The Cochrane Effective Practice and Organisation of Care Group (EPOC) aims to 
systematically review the impact of different interventions to promote healthcare 
interventions. Both 'Audit and feedback' and 'educational outreach visits' are reported 
to have a small to modest effect on improving professional practice.15,16 The effect of 
'printed educational materials' (PEM) seems to be beneficial when compared to no 
intervention, although this effectiveness is uncertain when PEM's are compared to 
other interventions.17 Cameron et al. investigated how feedback on clinical 
performance of different intensities (i.e. feedback, feedback plus action planning 
letter, feedback plus facilitated action planning) was received by maternity 
professionals18. Although feedback of increased intensity proved feasible and 
acceptable to clinicians, the authors were unable to demonstrate that clinicians 
actually increased their intention to comply with audit criteria. It thus remains unclear 
whether more intensive strategies should be preferred above simple ones. One of the 
factors that can intuitively be depicted as a contributor to the degree of success of the 
introduced implementation strategies, lies within the local level of 'quality 
improvement attitude', meaning the organizational culture or the team's willingness to 
change. This potential contributor was however not defined as subject for research in 
this thesis, whereas we can predict that the presence of a favourable quality 
improvement culture is an important factor contributing to successful guideline 
implementation. Moreover, we did not evaluate the presence and impact of local 
opinion-leaders who introduce and promote implementation policy, although the 
presence of such a person is previously reported to be important.19 In our c-RCT, 
professionals in the maximal intervention arm had to open up to the idea that patients 
have knowledge of, and could actually utilise professional guidelines to their 
advantage. If patients in general adapted to this, it would definitely change traditional 
doctor-patient roles and interaction. So, opinion leaders could play a substantial role in 
guiding colleagues through this change in doctor and patient culture. As for now, the
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interesting question remains whether both patient as well as doctors are ready yet to 
accept this shift towards a more active patient role in discussing and planning 
treatment policy. The evidence-base for effects of having a 'change culture' or 'change 
promoter' remains unfortunately incomplete and in this field also, further research is
20-23necessary.
For reproductive medicine, quite some efforts have recently been made to expand the 
knowledge on guideline adherence and guideline implementation. The first sporadic 
publications date from the mid-nineties, with a steady surge in the number of
18 24-34publications on several guideline topics from the year 2000 onwards. ' " New 
research projects are increasingly carried out and as a result the number of 
publications is growing as well as the evidence base.
However, for fertility care in particular, evidence on guideline implementation is still 
lacking. One of the core problems of implementation research in general, is that what 
proves to be effective in one setting, may not work at all in another setting. Therefore, 
while formulating interventions for guideline implementation in fertility care, 
researchers should be very cautious in extrapolating results from publications 
regarding neighboring fields of reproductive medicine, for instance obstetrics. This 
does not mean however, that this knowledge can't be used as a starting point for new 
trials in fertility care, as in many settings the same gynaecologists are active in both 
obstetric, gynaecologic as well as fertility care.
A review of evidence-based strategies for implementing guidelines in obstetrics35, 
showed especially positive effects for interventions including audit and feedback, 
reminders, as well as multifaceted strategies. It also clearly demonstrated that the 
prospective identification of barriers to change leads to better adaptation of 
interventions. As previous evidence concerning this barrier identification remained 
unequivocal36, this obstetric review offers an important basis for future studies among 
reproductive health care professionals. A newly published study on barriers among 
gynaecologists dealing with induced abortion care37, identified mainly organizational
25,27,38-barriers, which is not very different from other studies in reproductive medicine
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In summary, literature remains largely inconclusive about the extent of effectiveness 
of the different interventions applied in our c-RCT; moreover, the effectiveness of 
interventions that were of value in one setting, cannot be guaranteed when translated 
to other settings. The lack of any beneficial effect of the interventions in the described 
c-RCT could thus be caused by an imperfect theoretical background, the lack of a 
barrier analysis performed uniquely for this project, or simply inappropriateness of the 
interventions for translation to our particular study setting.
Process-evaluation
A process evaluation was performed to gain more insight into the potential causes of 
ineffectiveness of the interventions by increasing our knowledge of the events during 
the intervention period. For the evaluation of any interventions aimed at healthcare 
improvement, performing a rigorous process evaluation is at least as important as a (c- 
)RCT of interventions, as it clearly shows where exactly an effect was established or 
failed to occur. Although the coverage rate of the patient-oriented intervention was 
imperfect (37% of included patients received one or more leaflets), the evaluation of
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the leaflets by patients was predominantly positive. Due to the leaflets, patients 
reported an increased knowledge of potential causes, treatment and guidelines, an 
increased understanding of their doctor's treatment policy as well as perceived 
increased empowerment for decision making during consultations. Professionals, 
however, appeared quite indifferent to the disseminated implementation materials. It 
could thus very well be possible that the surplus value of the maximal implementation 
strategy was limited when compared to the minimal strategy. This also raises the 
question whether professionals should be the only actors responsible for guideline 
implementation; future efforts to induce practice changes might prove more efficient 
by concentrating on patients or patient associations.
Methodological considerations
Study design
Performing a (c-)RCT to evaluate interventions for healthcare improvement, is 
considered the 'gold standard' in implementation research.41 We chose a clustered 
design with a randomization at clinic level because randomization at patient or 
professional level would be practically impossible without risking contamination of 
both study arms. However, such a design requests many more patients to achieve an 
appropriate study power. This can be effectuated by increasing the number of clusters 
or the number of patients per cluster. As we randomly selected our patient sample 
from an electronic financial database in which treatment or diagnosis was not 
indicated, we could not guarantee sufficient inclusion per indicator beforehand. 
Including more patients or more clusters in order to try to achieve higher statistical 
power, would have considerably decreased overall feasibility of the study, as data 
collection was already an extensive task.
In this thesis, we aimed to assess and improve the quality of comprehensive clinical 
fertility care according to a national guideline programme consisting of ten guidelines, 
in 16 regional clinics. This accounted for an ambitious multi-centre study focusing on a 
complete guideline programme without a precursor within reproductive medicine. 
There is one major advantage of trying to implement a complete guideline programme 
at once. Some of the known barriers for fertility guideline implementation, for 
example 'lack of self-efficacy' 27, are not unique to one guideline. As the same fertility 
professionals are involved for each of the guidelines, the implementation of the entire 
programme can thus be improved by removing this barriers with a single intervention. 
For example, increasing the degree of shared decision-making to overcome the 'lack of 
self-efficacy', can be used for both patients within the 'initial assessment of fertility' 
who turn down an expectative treatment policy, but is also applicable to patients that 
want to pursue a second IVF-cycle even if less than three follicles have grown after 
maximal ovarian hyper stimulation. Introducing an intervention for all guidelines at 
once, could thus prove very cost-effective because different subgroups of patients and 
thus different aspects of fertility care could be improved with a single intervention at 
professional level.
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Study population
Conversely, improvement of so many issues at the same time was probably too 
difficult.
Neither the minimal nor the maximal implementation strategy had an evident 
beneficial effect on the scores of indicators deducted from the ten national guidelines 
on comprehensive fertility care. Shrinking scale size, for example to only one guideline 
or only one subgroup of patients (for instance, only IUI or IVF/ICSI patients) receiving 
care from multiple guidelines, could have some benefits. Not only would it relieve 
practical problems in indicator measurement (e.g. making it less time consuming to 
identify and assess cases) but professionals would also be provided with a clearer focus 
in adapting and using the offered interventions, as one clinical problem or patient 
group could then have their undivided 'quality improvement attention'. An additional 
advantage is that sufficient power for correct statistical analysis of results will be more 
easily achieved if the patient sample is more homogenous in terms of diagnosis or 
treatment type. In brief, achieving optimal results in comparable study settings, could 
be achieved by confinement and aggravation of implementation efforts by focusing 
more on details.
The role of patients in guideline implementation
The rationale to involve patients in fertility guideline implementation derives from the 
hypothesis that fertility patients, who are a relatively young, critical and actively 
participating patient group, have high interests in influencing and understanding their 
treatment policy and might also favor a high degree of shared decision making. Griffin 
and colleagues performed a review on health-related outcomes of interventions 
intended to alter the interaction between patients and professionals 42. They 
concluded that patient targeted approaches were more effective than those targeted 
at professionals. Moreover, providing patients with specific prompt sheets proved 
more effective than providing only generalized information, even without changing the 
length of consultations. Literature from social science reports that opportunities for 
involvement can increase patients' self-confidence, self esteem, and level of social 
contact43. For maternity care, the effect of coaching patients to participate in clinical 
decision making and the use of question prompts for patients, lead to increased 
perception of control and increased involvement in care44: a need for exactly these 
two concepts is a frequently heard preference from focus group interviews among 
fertility patients from the participating clinics. Therefore, it was hypothesized that if 
any patient group could thus be able to influence health care delivery by direct 
interaction with their caregiver, it could very well be fertility patients.
Taking the previous considerations, cited literature and process-evaluation data into 
account, we can conclude that the patient-directed implementation strategy 
developed for our c-RCT could be successful among this patient sample in theory, but 
remains hampered by the limited amount of evidence within implementation 
research. Moreover, if the indicators targeted were for example restricted to a single 
guideline, or if the patient sample would have been more homogenous, this patient- 
directed intervention could have been more elaborated and tailored to those groups. 
Now, we can only conclude that more research is needed to broaden the evidence
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base for patient-oriented guideline implementation interventions in the field of fertility 
care.
Practical execution
From a practical point of view, assessing ten guidelines in one project, proved a 
laborious exercise. Even though participating clinics belonged to one collaborating and 
internally referring region, different registration standards and methods for medical 
data existed at every location, for example different types of electronic or paper charts 
and different levels of completeness of treatment registration. A lot of effort was put 
into gathering medical records at the several locations and training the extra personnel 
(three 5th year medical students and one health care researcher) for data extraction. 
Moreover, practical problems in indicator operationalization could not be fully 
anticipated upon in the study design phase. Poor availability of medical data and the 
lack of adequate data resources are common problems in performance assessment 
efforts45,46 .
Electronic patient files
However, difficulties to properly measure clinical care, or more specifically quality 
indicators, should never be a reason to discard rigorously selected indicators. On the 
contrary, efforts should be undertaken to facilitate measurement initiatives. The 
introduction of a national Electronic Patient File (EPF) in the near future, literally offers 
a blank page for those interested in clinical performance assessments. Professionals 
and professional societies alike should therefore realize that it's time to stop lingering 
and being only a suspicious observer of EPF-progression; the time has come to actively 
join the EPF-movement and seize this great opportunity for future continuous 
monitoring of actual care. In particular, attention should be paid to relatively small 
investments or adjustments to existing databases that can be made for this purpose. 
The routinely monitoring of clinical performance indicators, such as our developed set 
for fertility care, within an EPF will greatly increase our knowledge of current care as 
well as of the practice of indicator assessment.
Level of analysis
Data were gathered and analysed at clinic level and data on the performance of 
individual professionals was therefore not available37. This was done because 
performance data were often only traceable at team level: Sometimes individual 
signatures lack in medical charts or, in particular for teaching clinics, treatment policy 
should be attributed to a supervisor's or joint team decision. In chapter 6 we therefore 
included only hospital characteristics like care infrastructure (e.g. presence of a 
separate fertility consultation hour) and team composition (e.g. presence of trained 
fertility nurses) as potential determinants at the care provider's level. Previous barrier­
research, however, showed that there are also barriers to guideline adherence at the 
individual professional's level27. Assessing indicator scores at the individual 
professional's level would thus provide information on performance that is the closest 
to the care process. However, to disentangle each individual's contribution to a 
complex care performances implicates major methodological challenges: not only is a 
considerable number of patients needed per professional for adequate statistical
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analysis of such 'individualized indicator scores', but attributing each policy decision to 
a traceable individual would be practically utopian.
Ceiling effect
A lack of performance improvement after an intervention might be attributed to a 
failure of the intervention itself or a failure to measure change when levels of 
performance are already high at baseline15. It is possible that, due to motivated 
exceptions to guideline recommendations or practical measurement difficulties, any 
change in the fourth quartile of adherence (75%-100%) is harder to achieve and assess. 
Moreover, there could be a 'ceiling effect' due to age of the guidelines. It is likely that 
the first period after new evidence or guidelines become available is critical for 
adaptation of the contents and thus for changing current care. This implicates that 
adherence to guideline recommendations that is not achieved within the first months 
or years following guideline dissemination, is a priori unlikely to happen anymore. An 
explanation could be that at least part of the non-adherence can be attributed to a 
professional's disagreement with guideline contents and thus unwillingness to change 
current practice. Summarising, chances of successful implementation are likely to 
decrease with an increasing interval of first publication.
Implications for future research and practice
From the above, several implications can be distilled for future research as well as 
future practice.
Implications for future research on fertility guideline implementation
There are some methodological recommendations that emerge from our experience
with the studies performed within this thesis. These involve the following topics:
St u d y  d esig n
Considering a c-RCT design with a formal control group and multiple intervention arms, 
instead of two intervention arms and a historic control group, could give more insight 
into effect of interventions of diverse intensity. An additional advantage would be that 
such a study design lends itself better for a cost-effectiveness comparison of the 
different interventions. However, more clusters or patients are needed for such a 
design, which might decrease feasibility of data-collection.
St u d y  o b jec t
As discussed before, some of the studied guidelines were relatively aged at time of the 
implementation effort. Picking a soon-to-be or newly ratified guideline as subject to a 
follow-up study, could offer a more promising departure point for renewed evaluation 
of (some of) the proposed implementation strategies. This would offer the possibility 
to perform a baseline assessment of current care just before dissemination of the 
guideline, immediately followed by a (cluster randomized controlled) trial of 
implementation policies of different intensity. Aiming to implement such a recently 
issued instead of an aged guideline will (at least partly) prevent discussion on validity 
of guideline contents or status of underlying evidence by the involved professionals.
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St u d y  in str u m e n ts
Including patients in indicator development will contribute to patient-centeredness of 
the quality of care assessment. However, as patients frequently indicate problems with 
the assessment of medical-technical recommendations, or a lack of self-efficacy in a 
panel with professionals, a separate and pre-trained patient panel should be 
considered. Furthermore, it might be necessary to appoint an extra scoring weight to 
those patient-selected recommendations during the overall final indicator selection 
round, to guarantee a high degree of uptake of those patient-selected 
recommendations for indicator-selection.
Collecting data on patients' health care needs is considered to lead to better detection 
of short-comings in care, but we demonstrated that there exists a vast discrepancy 
between patient experiences and satisfaction when assessed by means of 
questionnaires on the one hand, and objective care assessment by means of quality 
indicators on the other hand. The two types of assessment should therefore always be 
combined, to reflect the state of current care as completely as possible.
St u d y  o u tc o m es
Within the scope and design of our project it was unfortunately not possible to make a 
proper outcome assessment regarding pregnancy rates, multiple pregnancy rates or 
life birth rates. Because of the heterogeneity of the patient sample, pregnancy rates 
could not be validly compared between patients; for some patients only had one 
consultation or went through an initial assessment of fertility, whereas other patients 
might have had three consecutive embryo transfers in the study period. This means 
that endpoints in time were often not comparable between subgroups of patients. A 
study design in which a single patient subgroup is subject to study, for example, IUI or 
ovulation induction patients lends itself more properly for such comparisons. Linking 
structure and process measures from the indicator set to patient outcomes like 
pregnancy rate, would provide an interesting insight into the complex relationship 
between the two47.
T h eo r etic a l  b a c k g r o u n d
The above mentioned suggestions for further research aim more or less at a more 
perfect study design to test the proposed interventions. It might, however, very well 
be possible that our focus should be on entirely different interventions. More research 
should for example be conducted to unravel the role of local culture for change, team 
climate and opinion leaders in improving guideline implementation.
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Implications for future policy and practice in fertility care
Based on the topics described in this thesis and discussed in this last chapter, some
implications can be formulated for policy and current practice. We will present these
implications while addressing the relevant stakeholders involved:
Im p lic a tio n s  fo r  p o lic y  of p r o fe s sio n a l  o r g a n iz a t io n s
• Supplying guidelines with sets of quality indicators and creating the (electronic) 
infrastructure to measure them, can help professionals to identify those domains of 
care in need of improvement and moreover enables continuous quality monitoring. 
Letting professionals participate in the development process, creates transparency 
and a supporting base for future implementation activities.
• An important prerequisite for the successful use of clinical practice guidelines or 
sets of quality indicators is that both are kept 'alive', meaning continuously updated 
with newly available evidence.
• Convenient assessment of quality indicators should be facilitated by the uptake of 
those indicators in the future nationwide EPF.
• The effort pays back; guidelines and quality indicators can be tools to achieve high 
quality care. Inability or difficulty to measure an indicator should never be the sole 
reason to abandon this indicator or relent from assessment efforts.
• The use of large, (inter-)national registrations enable solid assessment of less 
frequent conditions and complications by means of quality indicators.
• To achieve high quality care, the major efforts generally put into guideline 
development, should be equalled by efforts put into guideline implementation 
activities and guideline implementation research.
• Providing patients with leaflets on professional guideline contents can increase their 
understanding professional decision-making, improve doctor-patient 
communication and empower patients to influence treatment decisions. All this can 
improve a doctor's perception of self-efficacy and thus lead to better guideline 
adherence.
• Professional organisations should stress the importance of shared decision making, 
and encourage their residents-in-training to implement this concept.
Im p lic a tio n s  fo r  p r o fessio n a ls
• Participating in current care assessments by means of quality indicators is very 
useful as it provides insight into those aspects of current care where local 
improvements are needed.
• Professionals should think of those assessments as an opportunity, not as merely 
another bureaucratic interference. Assessment results can educate and guide 
towards optimal health care delivery.
• Guidelines are as a rule formulated for 'the majority' of patients. Making motivated 
exceptions to these guidelines for individual patients should always be possible, but 
should not result from a lack of self-efficacy concerning doctor-patient interaction.
• In fertility care, the current practice of information provision is insufficient. 
Whether caused by limited information provision by professionals or defective 
memorization by patients, in both cases professionals should take responsibility to
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improve current care. The presence of specialized nursing personnel or the use of 
information checklists by professionals could improve this care.
• As information provision for highly educated, Dutch couples seems already 
insufficient, special attention should be paid to risk-groups that are lowly educated 
or non-Dutch.
Im p lic a tio n s  fo r  p a tien ts  a n d  p a t ien t  a ss o c ia t io n s
• Taking notice of professional guideline contents, either by specialized leaflets or 
visiting the professional society's website, can increase patients' understanding of 
their doctor's decision-making, improve communication with the doctor and 
empower the patient to influence treatment decisions.
• Although occurrence of complications is fortunately infrequent, make sure patients 
are optimally informed about the potential risks and complications of future 
treatment.
• Having an active and well-organised patient association can provide the structure 
for information-exchange between patient and professional stakeholders, for 
example, by clarifying information about professional guidelines.
• Encouraging patients to take up their role in shared decision-making, can trigger 
medical professionals to apply it more often.
• It will probably prove beneficial if patient oriented interventions are not introduced 
by professionals but instead by patient organisations or representatives.
Final conclusion
In conclusion, we developed a valid indicator set that can be used for monitoring and 
improving fertility care. We could not demonstrate an universal benefit of the tested 
strategies for the implementation of the Dutch fertility guidelines in a c-RCT. However, 
the process evaluation among patients of the maximal implementation group, showed 
promising results on the use of patient leaflets explaining professional guideline 
contents, especially regarding understanding of the professional's treatment policy 
and empowerment for participation in clinical decision-making. These are ingredients 
to entrust patients with a central role within guideline implementation in the future. 
However, challenges for further research on the improvement of the quality of current 
fertility care by guideline implementation are manifold, and should be simultaneously 
taken up by the different stakeholders involved.
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Summary
Chapter 1: General Introduction
Chapter 1 describes the rationale for the studies performed within this thesis. 
Infertility is a worldwide problem with high societal impact. To help clinicians provide 
evidence and consensus based healthcare, diverse (inter)national organizations have 
sought to develop guidelines for the provision of fertility care. In the Netherlands, the 
Dutch Society for Obstetrics and Gynaecology (NVOG) has developed a broad guideline 
programme to guide fertility professionals in providing their daily care. However, as 
guidelines do not implement themselves, we describe the background and current 
state of evidence for guideline implementation in general. While evidence for fertility 
guideline implementation is currently lacking, we deduct from the available evidence 
and barrier analyses within general and reproductive medicine two experimental 
strategies to improve implementation of the Dutch fertility guideline programme. As 
fertility patients are in general young and critical about their care, we hypothesize they 
could be just the allies we need in implementing fertility guidelines.
Chapter 2: Debate on outcome measures for fertility care
Monitoring fertility care by the use of quality indicators will facilitate the transparency 
of provided health care as well as comparisons over time and between settings. 
However, what exactly should be the best indicators to assess fertility care is still 
subject to debate. We contribute to this discussion by suggesting the systematic 
development of evidence-based quality indicators, especially process and structure 
indicators, rather than outcome measures, for the monitoring and improvement of 
fertility care.
Chapter 3: Indicator development for fertility care
As none of the existing fertility guideline programmes worldwide is accompanied by a 
satisfactory set of quality indicators, we aimed in chapter 3 to develop a valid, 
guideline-based indicator set. A systematic RAND-modified Delphi method was used to 
develop a set of key recommendations based on 10 national Dutch fertility guidelines, 
international literature and existing international indicators. Experts' opinions were 
used to appraise recommendations regarding specific criteria such as efficacy, level of 
health gain, applicability and potential for care improvement. As a result, a 
representative set of 39 key recommendations was selected from 303 initial 
recommendations. The recommendations covered two structural and 37 procedural 
aspects, the latter encompassing 'indications for treatment', 'diagnostic procedures', 
'treatment procedures' and 'patient information'. These recommendations were, as a
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final step, translated into measureable indicators for monitoring and improving clinical 
fertility care.
Chapter 4: Variation in fertility care
In chapter 4, a practice test was performed to test the previously developed indicator 
set. This study aimed to assess several quality criteria of the indicator-set and to use 
the set to assess current fertility care. For this purpose, a historic cohort study was 
performed in 16 Dutch fertility clinics. In total, 2698 couples were invited to 
participate. Indicator data were gathered by medical record extraction, and patient 
and professional questionnaires. Quality criteria for each indicator (measurability, 
reliability, applicability, improvement potential, discriminatory capacity, complexity 
and case-mix stability) were assessed. Current practice was measured as each clinic's 
adherence to the separate indicators. As a result, 1499 (56%) couples participated. All 
indicators were measurable, but the results for the other quality criteria varied. In 
total, 14 of the 39 indicators scored <50% adherence. There existed a wide variation in 
performance between the clinics, ranging up to 100%. The highest median adherence 
(86%) was found within the guideline 'indications for IVF-treatment'. The lowest 
median adherence is found within the guideline 'initial assessment of fertility' (43%), 
followed closely by the guideline 'anovulation' (44%). Based on the results of our 
practice test, particularly applicability and improvement potential, we can distinguish 
three subsets within our original set of 39 quality indicators. Indicators within the first 
subset score highly for applicability and improvement potential and can therefore be 
used for quality monitoring purposes and as a baseline measurement for quality 
improvement programmes in the involved clinics. A second subset contains indicators 
with low improvement potential, which makes them useless for improvement 
programmes, but with high applicability, which makes them still suitable for 
monitoring purposes, namely to ensure that adherence continues to be high in the 
future. Within the third subset we find indicators with low applicability. They concern 
relatively rare conditions or complications (e.g. premature ovarian failure and severe 
ovarian hyperstimulation syndrome), so inclusion numbers within our random patient 
sample were too small for adequate indicator assessment. In conclusion, this study 
shows that the quality of the developed indicator-set was adequate for the monitoring 
of clinical fertility care. Such objective assessment of care can help professionals to 
identify and subsequently target the domains of care in need of improvement A first 
assessment in the Netherlands reveals large variation between clinics and ample room 
for improvement of care.
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Chapter 5: Information provision in fertility care
In chapter 5, we focused on the current practice of information provision in fertility 
care, as adequate information provision is a crucial dimension of high-quality care. 
Clinical practice guidelines containing consensus-based recommendations may 
standardize practice between settings. The described study was designed for three 
purposes: (i) to assess actual adherence to recommendations on information 
provision, (ii) to measure patient satisfaction with current practice and (iii) to analyse 
how variation in adherence relates to the characteristics of patients and clinics. To do 
so, all recommendations concerning patient information were extracted from the 
national fertility guideline programme and edited into a patient questionnaire. 
Additional questions concerning patient satisfaction and potential determinants of 
information provision at patient level were included (e.g. female age, type of 
infertility). A professional's questionnaire was sent to all gynaecologists to gather 
potential determinants at clinic level (e.g. fertility team size, presence of specialized 
fertility nurses). Multilevel regression analysis was performed to identify the 
determinants of information provision. A total of 1499 couples (56%) participated. The 
percentage of couples who reported to have received complete information varied 
between recommendations from 10 to 96% (mean 57%). Overall, 94% of couples were 
satisfied with fertility services. The use of checklists for information provision, the 
presence of obstetrics/gynaecology residents and specialized nursing personnel, and 
higher patient anxiety scores were significantly associated (P < 0.05) with higher levels 
of information received. We conclude from these results that information provision for 
infertile couples is currently poor and in need of improvement. This could easily be 
procured by, for example, the use of information checklists.
Chapter 6: Patients' experiences with fertility care
Chapter 6 aimed to asses patients' experiences and satisfaction with fertility care as 
well as the determinants associated with these two concepts. The questionnaire that 
was sent to the previously described patient sample included specific questions for this 
purpose.
Waiting times, information provision and emotional support were experienced the 
least positive aspects of care. Determinants of all care aspects were found significant 
(p<0.05) at four different domains. Three at patient level, i.e. demographic 
characteristics, type of received treatment and both general and mental health status, 
and one at clinic level, i.e. organization of care. In general, patients' satisfaction with 
care was rated high (94%).
The results from this study provide us with an increased understanding of the 
determinants of patients' experiences and satisfaction with fertility care. This enables
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professionals to tailor their care to specific subgroups of patients and adjust their 
organization of fertility care where needed. Moreover, the study underlines the need 
to investigate whether case-mix correction is necessary whenever interpreting patient- 
surveys on care experiences, as both patient's and clinic's characteristics can influence 
the way healthcare delivery is experienced.
Chapter 7: A cluster-randomized controlled trial to improve fertility guideline 
implementation
Chapter 7 describes a cluster-randomized controlled trial designed to evaluate the 
effect of two different strategies to improve the implementation of the Dutch fertility 
guideline programme. A single, professional oriented strategy of audit and feedback 
was tested against a multifaceted, tailored professional and patient oriented strategy 
consisting of audit and feedback, dissemination of professional implementation 
material and specific patient leaflets that explain the professional guideline contents in 
lay language. The used outcome measures were the extent of adherence to the 
indicators developed in chapter 3. The data from chapter 3 was taken as a before 
measurement. Neither strategy provided an overall beneficial effect on the 
implementation of the fertility guideline programme. Small effects were seen for 
isolated indicators. However, patient evaluation of the patient leaflets was very 
positive, with reported positive effects on doctor-patient communication and an 
experienced increased empowerment for participation in the clinical decision making 
process. A possible explanation of the lack of effects is the poor dissemination of 
intervention material among patients and poor use of the intervention elements by 
participating professionals. The surplus value of the maximal intervention can be 
questioned as the most highly appreciated intervention elements were the feedback 
report and feedback meeting.
Chapter 8: General discussion
In the final chapter, we present the main findings of the studies from the previous 
chapters. The research questions from the introductory chapter are answered and 
discussed in the light of available literature. The developed set of indicators from 
chapter 3 seems to be a valid instrument for monitoring and improving fertility care. 
However, we might need to use a differently chosen patient sample or convert to 
subgroups of indicators for the different purposes of monitoring and improving care. 
Methodological considerations of the performed studies are taken into account while 
interpreting these results. The lack of an overall effect of the maximal intervention 
does not rule out a role for patients within professional guideline implementation, as
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patient evaluation of the strategy showed promising results concerning 
communication and empowerment.
However, trying to improve an entire guideline programme for comprehensive fertility 
care proved an ambitious task. Suggestions for future research on patient oriented 
guideline implementation are therefore described. As an overall effect of the 
strategies was not found, future research might profit from a different study design in 
which only a subgroup of patients or a single, recently issued guideline is the focus of 
attention. In addition, more research should be conducted to augment our theoretic 
knowledge of for example the role of local culture for change, team climate and 
opinion leaders in improving guideline implementation.
Moreover, practice and policy implications for healthcare providers as well as patients 
are therefore in this final chapter. We state for example that a convenient assessment 
of quality indicators should be facilitated by the uptake of those indicators in the 
future nationwide EPF. Similarly, the use of large, (inter-)national registrations could 
enable solid assessment of less frequent conditions and complications by means of 
quality indicators. And finally, the major efforts generally put into guideline 
development, should be equaled by efforts put into guideline implementation 
activities and guideline implementation research.
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Samenvatting
Hoofdstuk 1: Algemene inleiding
Onvruchtbaarheid (Infertiliteit) wordt omschreven als het uitblijven van zwangerschap 
na 12 maanden regelmatige, onbeschermde geslachtsgemeenschap. Uit studies is 
bekend dat wereldwijd bij 4 tot 30% van de paren in de vruchtbare leeftijd sprake is 
van infertiliteit. Dit betekent dat ongeveer 80 miljoen paren ter wereld te kampen 
hebben met dit probleem. Het is dan ook niet vreemd dat infertiliteit als één van de 
grote gezondheidsproblemen van de 21e eeuw wordt beschouwd. Omdat een 
aanzienlijk deel van de bevolking er vroeg of laat mee te kampen krijgt, heeft 
Infertiliteit als gezondheidsprobleem dan ook grote impact op onze huidige 
maatschappij. Niet alleen wat betreft persoonlijk verdriet en eventuele psychische 
problemen die het oplevert, maar ook omdat de vraag naar nader medisch onderzoek 
of behandeling groot is. Om behandelaren te helpen zorg te leveren die kwalitatief 
gezien zo hoogwaardig mogelijk is (dat wil zeggen zorg die is gebaseerd op de meest 
recente kennis en wetenschappelijke bewijzen of bij gebrek daaraan op door 
behandelaren onderling overeengekomen aanbevelingen), zijn er diverse professionele 
organisaties die richtlijnen voor onderzoek naar of behandeling van 
fertiliteitsproblemen hebben opgesteld. De Nederlandse Vereniging voor Obstetrie en 
Gynaecologie (NVOG) heeft voor Nederland een negental richtlijnen opgesteld; daarbij 
komt de nationale Embryo-wet, waarin de zorg rondom IVF en ICSI behandelingen 
omschreven staat. Door het gebruik van deze richtlijnen kan de variatie in de zorg 
tussen verschillende behandelaren en verschillende locaties zo klein mogelijk 
gehouden worden. Helaas is het hebben van richtlijnen alleen, niet genoeg om goede 
zorg te garanderen; de richtlijnen moeten ook in de dagelijkse praktijk worden 
ingevoerd, het zogenaamde implementeren. We beschrijven in hoofdstuk 1 de kennis 
die momenteel beschikbaar is over het implementeren van richtlijnen in het algemeen 
en in de voortplantingsgeneeskunde in het bijzonder. Ondanks het feit dat de kennis 
over laatstgenoemde slechts spaarzaam beschikbaar is, ontwikkelen we op basis van 
de schaarse kennis die beschikbaar is, twee strategieën waarmee we willen proberen 
de implementatie van de Nederlandse fertiliteitsrichtlijnen te bevorderen. Aangezien 
fertiliteitspatiënten in het algemeen vrij jong en kritisch zijn, is het heel goed mogelijk 
dat zij de cruciale bondgenoot kunnen zijn bij het implementeren van 
fertiliteitsrichtlijnen . H
158 Chapter 9
Hoofdstuk 2: Debat over uitkomstmaten binnen fertiliteitszorg
Het hebben van gedegen kwaliteitsindicatoren als meetinstrumenten om 
fertilliteitszorg te monitoren, zou als voordeel hebben dat de geleverde zorg 
inzichtelijk gemaakt wordt. Bovendien stelt het ons in staat zorg die op verschillende 
tijdstippen en plaatsen geleverd wordt, met elkaar te vergelijken. Desalniettemin is er 
nog discussie wat precies de meest geschikte indicatoren zouden zijn om dergelijke 
zorg te beoordelen. In hoofdstuk 2 dragen wij bij aan deze internationaal gevoerde 
discussie. Wij stellen voor dat er op systematische wijze en zo veel mogelijk op basis 
van wetenschappelijke bewijzen kwaliteits-indicatoren ontwikkeld dienen te worden, 
die niet alleen op uitkomst gericht zijn (zoals bijvoorbeeld zwangerschap of 
levendgeborenen per gestarte IVF cyclus) maar met name ook op de proces en 
structuur van de geleverde zorg (zoals bijvoorbeeld correcte informatievoorziening 
respectievelijk certificering van het laboratorium).
Hoofdstuk 3: Het ontwikkelen van kwaliteitsindicatoren voor fertiliteitszorg
Aangezien geen van de bestaande internationale richtlijnprogramma's met betrekking 
op fertiliteitsproblemen, voorzien is van een set van geschikte kwaliteitsindicatoren, 
hebben wij in hoofdstuk 3 geprobeerd een valide indicatorenset te ontwikkelen die op 
de richtlijnen gebaseerd is. Een zogenaamde RAND-gemodificeerde Delphi methode 
werd toegepast om een set van kern-aanbevelingen samen te stellen gebaseerd op de 
Nederlandse richtlijnen, internationaal beschikbare literatuur en bestaande 
internationale indicatoren. Aan circa 60 nationale experts werd gevraagd om alle 
aanbevelingen uit de richtlijnen te beoordelen op specifieke criteria zoals belang voor 
doelmatigheid van zorg, mate van gezondheidswinst, toepasbaarheid en 
verbeterbaarheid. Door toepassen van deze procedure werd uit een totaal van 303 
aanbevelingen, een definitieve set van 39 kernaanbevelingen geselecteerd. Hiervan 
hadden er 2 betrekking op de structuur en 37 op procesmaten van zorg. Geselecteerde 
procesmaten hadden betrekking op de onderwerpen indicatiestelling, diagnostiek, 
behandeling en informatievoorziening. Als laatste stap werden deze kern- 
aanbevelingen via algoritmen vertaald naar meetbare indicatoren voor het monitoren 
en verbeteren van fertiliteitszorg.
Hoofdstuk 4: Variatie in fertiliteitszorg
Met de ontwikkelde indicatorenset uit het voorgaande hoofdstuk, werd in hoofdstuk 4 
een uitgebreide praktijktest uitgevoerd. Hierbij werden ook enkele kwaliteitscriteria 
van de ontwikkelde indicatoren gemeten. Een historisch cohort van 2698 paren 
fertiliteitspatiënten uit 16 Nederlandse klinieken werd uitgenodigd mee te doen aan 
deze praktijktest. Data om de indicatoren te meten werd verzameld uit vragenlijsten
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naar zowel patiënten en behandelaren als ook uit medische dossiers. Per indicator 
werden de volgende kwaliteitscriteria gemeten: meetbaarheid, reproduceerbaarheid, 
toepasbaarheid, verbeterpotentieel, onder-scheidend vermogen, complexiteit en de 
noodzaak tot correctie voor case-mix. Huidige zorg werd omschreven als de adherentie 
binnen een kliniek aan de voorgestelde indicatoren. In totaal waren 1499 paren (56%) 
bereid mee te doen. Hoewel alle indicatoren meetbaar bleken, varieerden de scores 
op de andere criteria behoorljik. Van de 39 indicatoren werd er voor 14 stuks minder 
dan 50% adherentie gemeten. Bovendien was er een brede variatie in adherentie 
tussen de klinieken, namelijk tot wel 100%. De richtlijn 'indicaties voor IVF' scoorde het 
beste met gemiddeld 86% adherentie, in tegenstelling tot bijvoorbeeld de richtlijn 
'orienterend fertiliteitsonderzoek' (43%) en 'anovulatie (44%).
Op basis van de gemeten kwaliteitscriteria kunnen we de oorspronkelijke 
indicatorenset indelen in drie subgroepen. Een eerste groep indicatoren scoort hoog 
op toepasbaarheid en verbeterpotentieel, waarmee zij uitermate geschikt is voor 
zowel monitoring op verschillende momenten in tijd als voor het initiëren van 
verbeterprogramma's. Dit in tegenstelling tot een tweede groep, met weliswaar hoge 
toepasbaarheid maar een laag verbeterpotentieel, waardoor die groep ongeschikt is 
voor verbeterprogramma's maar wel voor continue monitoring van zorg. Tot slot een 
derde subgroep met slechts een lage toepasbaarheid in de hier onderzochte 
patiëntensteekproef, aangezien het minder frequent voorkomende klinische beelden 
of complicaties betreft, zoals prematuur ovarieel falen of een ovarieel overstimulatie 
syndroom. Om deze indicatorengroep te kunnen meten zou een veel specifiekere 
patiënteninclusie nodig zijn. Concluderend toont deze studie aan dat de initiële 
indicatorenset adequaat is voor het monitoren van klinische fertiliteitszorg. Bovendien 
blijkt er in Nederland sprake van een grote variatie in geleverde fertiliteitszorg tussen 
verschillende klinieken. Een objectieve meting van de huidige zorg, zoals in deze 
praktijktest beschreven, kan behandelaren helpen om die onderdelen van zorg te 
identificeren die verbetering behoeven.
Hoofdstuk 5: Informatievoorziening aan fertiliteitspatiënten
In hoofdstuk 5 hebben we ons toegespitst op de specifieke gang van zaken rond 
informatievoorziening aan paren die een fertiliteitstraject doorlopen, aangezien goede 
informatie een cruciale vereiste is om zorg van hoge kwaliteit te noemen. De in dit 
hoofdstuk beschreven studie concentreerde zich op 3 doelen:
1) het meten van de huidige zorg, dat wil zeggen de mate van adherentie aan richtlijn- 
aanbevelingen die betrekking hebben op patiënteninformatie
2) het meten van patiënttevredenheid met deze huidige zorg
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3) het onderzoeken of variatie in richtlijn-adherentie wellicht te maken heeft met 
bepaalde karakteristieken van de patiënten of kliniek 
Voor dit doel werden alle aanbevelingen met betrekking op informatievoorziening uit 
de richtlijnen geselecteerd en bewerkt tot een patiëntenvragenlijst. Bovendien werden 
vragen gericht op tevredenheid en potentiële voorspellers op patiëntniveau (zoals 
bjivoorbeeld leeftijd van de vrouw) toegevoegd. Daarnaast werd een vragenlijst 
verzonden aan behandelaren, om potentiële voorspellers op kliniekniveau te 
verzamelen (zoals bijvoorbeeld de omvang van het behandelteam). Door middel van 
een multilevel regressie analyse werd geprobeerd voorspellers van kwalitatief goede 
informatievoorziening te ontdekken. In totaal deden 1499 paren mee. Per informatie- 
aanbeveling verschilde het aantal paren dat volledige informatie ontving van 10-96% 
(gemiddeld 56%). Toch was 94% van de paren tevreden met de geleverde zorg. Het 
bleek dat het gebruik van checklists voor het geven van informatie, de aanwezigheid 
van gynaecologen in opleiding en het hebben van specifiek geschoold verpleegkundig 
personeel, evenals angstigere patiënten, geassocieerd waren met het ontvangen van 
complete informatie. Op basis van deze resultaten concluderen wij dat de huidige 
Nederlandse zorg met betrekking op informatievoorziening aan fertiliteitspatiënten 
tekortschiet en voor verbetering vatbaar is. Dit zou gemakkelijk kunnen worden 
bewerkstelligd door bijvoorbeeld systematische checklists te gebruiken.
Hoofdstuk 6: Ervaringen van patiënten met fertiliteitszorg
De studie in hoofdstuk 6 was erop gericht om enerzijds de ervaringen en tevredenheid 
van patiënten met fertiliteitszorg te meten, en anderzijds de voorspellers van deze 
twee begrippen te beschrijven. Dit gebeurde op basis van de reeds eerder beschreven 
vragenlijst. Met betrekking tot wachttijden, informatie-voorziening en emotionele 
ondersteuning werden de minst positieve patiëntenervaringen gemeten. Voorspellers 
van deze ervaringen konden worden gevonden op 4 verschillende domeinen. Drie 
domeinen hadden betrekking op het niveau van de patiënt, te weten: demografische 
kenmerken, het type ontvangen behandeling en de gezondheidsstatus (zowel 
algemeen als mentaal). Het vierde domein werd gevonden op kliniek niveau, en 
omvatte de organisatie van zorg. Opvallend was, dat de tevredenheid van patiënten 
met betrekking tot de ontvangen fertiliteitszorg desondanks hoog was (94%).
De resultaten van deze studie vergroten onze kennis van de voorspellers van 
patiëntenervaringen en -tevredenheid. Deze opgedane kennis stelt behandelaren in 
staat om hun zorg toe te snijden op specifieke subgroepen van patiënten, en 
bovendien hun organisatie van zorg waar nodig aan te passen. Tot slot onderschrijft 
deze studie de noodzaak om correctie van case-mix toe te passen wanneer men
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patiëntenenquêtes evalueert, aangezien zowel patiënt als kliniek karakteristieken de 
wijze waarop geleverde zorg ervaren wordt, kan beïnvloeden.
Hoofdstuk 7: Een cluster-gerandomiseerde gecontroleerde trial om de implementatie 
van fertiliteitsrichtlijnen te bevorderen
Hoofdstuk 7 beschrijft een clustergerandomiseerde gecontroleerde trial die gericht 
was op het evalueren van twee verschillende strategieën om de implementatie van het 
Nederlands richtlijnprogramma van de NVOG met betrekking tot fertiliteits-problemen 
te verbeteren. Een minimale, enkelvoudige en behandelaargerichte strategie van audit 
en feedback (het meten van zorg en het terugkoppelen van de resultaten van die 
meting) werd vergeleken met een maximale, meervoudige strategie die naast op 
behandelaren, ook op patiënten gericht was. Deze laatste strategie bestond eveneens 
uit audit en feedback, maar bovendien uit het verspreiden van implementatiemateriaal 
aan de behandelaren en folders aan patiënten, waarin de inhoud van de professionele 
richtlijnen in simpele taal werd uitgelegd. De gebruikte uitkomstmaat in deze trial, was 
de adherentie aan de indicatorenset die in hoofdstuk 3 werd ontwikkeld. De resultaten 
van de praktijktest uit hoofdstuk drie werd daartoe gebruikt als voormeting. Geen van 
beide strategieën resulteerde in een unaniem voordelig effect op de implementatie 
van de richtlijnen, hoewel kleine effecten werden gezien voor geïsoleerde indicatoren. 
Desalniettemin was het oordeel van patiënten over de folders erg positief; er werd 
naar aanleiding van het gebruik van de folders een verbetering van de arts-patiënt 
communicatie gemeld, evenals een ervaren verlaging van de drempel actief te 
participeren in het tot stand komen van behandelbeslissingen. Een mogelijke 
verklaring van het ontbreken van een effect van de geïmplementeerde strategieën, is 
de incomplete verspreiding van de folders onder patiënten, en een matig gebruik van 
het aangeboden implementatiemateriaal door de behandelaren. De meerwaarde van 
de maximale strategie staat bovendien ter discussie aangezien het door behandelaren 
meest gewaardeerde interventie onderdeel de audit en feedback was, die ook bij de 
minimale strategie ter beschikking werd gesteld.
Hoofdstuk 8: Algemene beschouwing
In het laatste hoofdstuk van dit proefschrift presenteren we de belangrijkste 
bevindingen van de studies in de voorgaande hoofdstukken. Hierbij worden de 
onderzoeksvragen uit hoofdstuk 1 niet alleen beantwoord, maar tevens besproken in 
het licht van de beschikbare en meest recente literatuur. Het blijkt dat de 
indicatorenset die ontwikkeld is in hoofdstuk 3, een valide instrument is om de huidige 
fertiliteitszorg te monitoren en verbeteren. Tegelijkertijd hebben we geleerd dat voor
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elk van deze doelen afzonderlijk, wellicht een andere patiëntensteekproef of zelfs een 
deelselectie van indicatoren nodig is.
Voorts worden enkele methodologische overwegingen genoemd bij het interpreteren 
van de studieresultaten. Het gebrek aan een overtuigend effect van de gepresenteerde 
strategieën, sluit een toekomstige rol van patiënten in de implementatie van 
professionele richtlijnen echter geenszins uit. De patiëntgerichte interventie werd 
immers zeer positief geëvalueerd, met gerapporteerde positieve effecten op arts- 
patiënt communicatie en een ervaren 'empowerment' om actief mee te kunnen doen 
in het maken van behandelbeslissingen.
Het proberen te implementeren van een tienledig richtlijnprogramma bleek hoe dan 
ook een ambitieuze en tijdrovende taak. Dit is dan ook de reden dat we in dit 
slothoofdstuk aanbevelingen doen voor vervolgonderzoek naar patiëntgerichte 
implementatie van richtlijnen. Zo zou toekomstig onderzoek kunnen profiteren van 
een aangepast studie-ontwerp, waarin voor een meer homogene patiëntengroep 
wordt gekozen, of slechts een enkele, recent gepubliceerde richtlijn wordt 
geïmplementeerd. Om bij te dragen aan de theoretische basis van 
richtlijnimplementatie-onderzoek, zouden bijvoorbeeld de veranderingsbereidheid van 
een kliniek, team klimaat en het inzetten van lokale opinieleiders als aandachtspunten 
voor een vervolgstudie kunnen dienen. Tot slot worden enkele implicaties en 
aanbevelingen voor zowel behandelaren als beleidsmakers besproken. Zo propageren 
wij dat het in de nabije toekomst in te voeren Elektronisch Patiënten Dossier bij uitstek 
geschikt is om kwaliteitsindicatoren mee te meten, mits men daar nu reeds 
voorbereidende handelingen voor treft. Evenzo zal het gebruik van grotere, (inter-) 
nationale databases, de structurele monitoring van minder frequent voorkomende 
ziektebeelden of complicaties mogelijk maken. Maar bovenal zijn wij van mening dat 
de enorme inspanningen die heden ten dage wél worden geleverd voor het 
ontwikkelen van richtlijnen, gevolgd moeten worden door minstens zo grote 
inspanningen om die richtlijnen vervolgens te implementeren en uit die 
implementatie, door middel van wetenschappelijk onderzoek, lering te trekken.
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• 'Guideline based development of quality indicators for subfertility care'
Oral presentation at the annual meeting of the Guidelines International Network 
(GIN), Toronto, Canada, augustus 2007.
• 'Actual and desired information provision in subfertility care'
Oral presentation at the annual meeting of the Guidelines International Network 
(GIN), Toronto, Canada, augustus 2007.
• 'Guideline based development of quality indicators for subfertility care'
Oral presentation at the annual meeting of the European Society for Human 
Reproduction and Endocrinology (ESHRE), Lyon, France, juli 2007.
Poster presentations
• 'Variation in clinical subfertility care measured by guideline-based quality 
indicators'
35e Gynaecongres, Utrecht, juni 2009.
'Variation in clinical subfertility care measured by guideline-based quality 
indicators'
Oral poster presentation annual conference of The International Society for Quality 
in Health Care (ISQua) Kopenhagen, oktober 2008.
'Variation in the quality of clinical subfertility care: an assessment by guideline- 
based quality indicators'
Annual meeting of the European Society for Human Reproduction and 
Endocrinology (ESHRE), Barcelona 2008, juli 2008.
□
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Introduction
Ik wil dit proefschrift graag eindigen met het citaat aan het begin; 'Elke knoop heeft 
iemand om hem te ontwarren'. De SPRING-studie bleek een knoop van behoorlijk 
Gordiaanse omvang, en vormde voor dan ook een ware uitdaging. Zonder de hulp van 
vele anderen, was het nooit gelukt deze te ontwarren; iedereen die daaraan heeft 
meegewerkt, daarom hartelijk bedankt!
Patients
In de eerste plaats wil ik de ruim 2600 
patiëntenparen bedanken die 
belangeloos, of liever gezegd, in het 
belang van een betere fertiliteitszorg, 
de moeite en tijd hebben genomen de 
uitgebreide vragenlijsten in te vullen. 
Zonder hulp van patiëntenvereniging 
'Freya' en deze paren was het nooit 
gelukt zo'n goed overzicht van de 
huidige regionale zorg te krijgen.
The 'SPRING' study Group
Veel dank ben ik ook verschuldigd aan 
mijn promotores and copromotores: 
Prof. dr. R.P.T.M. Grol, beste Richard, 
ondanks je drukke agenda en over 
minstens 150 man te verspreiden 
aandacht, wist je toch altijd precies wat 
er speelde in het project. Het is al vele 
malen eerder gezegd, maar je wist 
altijd met frisse blik nieuwe inzichten te 
berde te brengen en op praktische 
wijze sturing te geven aan dwalende 
artikelen. Bedankt voor de begeleiding 
de afgelopen jaren, de introductie in de 
wondere wereld der implementatie en 
met name ook je daadkracht bij de 
afronding van de laatste loodjes. Ik ben 
blij dat ik me nog tot je laatste cohort 
promovendi mag rekenen, want IQ 
healthcare zal je node missen!
Prof. dr. J.A.M. Kremer, beste Jan; ik 
weet nog dat ik op een koude donder­
dagmorgen, vers afgestudeerd, kwam 
solliciteren bij jou en Rosella. Ik geef 
het toe, Nijmegen stond niet écht hoog 
op mijn verlanglijstje. Maar ik was 
gecharmeerd van het project en 
hoewel ik vermoedde dat het nog 
weleens een hele kluif kon zijn, was ik 
ervan overtuigd dat het met twee open 
en vriendelijke begeleiders als jullie 
toch wel goed zou moeten komen! 
Daarin heb ik me gelukkig niet vergist! 
Ik neem in dit dankwoord even de 
vrijheid lekker lang van stof te zijn! Ik 
wil je ontzettend bedanken voor alle 
soepel verlopende donderdagochtend- 
besprekingen, je laagdrempeligheid en 
praktische benadering van alle beren 
die ik op de weg tegenkwam. Fijn dat je 
ons altijd van snelle reply's voorziet en 
altijd tijd voor je promovendi inruimt. 
(Zelfs toen we je aandacht moesten 
delen met je nieuwste iPhone ©! )
Dr. Hermens, beste Rosella; je hebt me 
meer dan eens opgelapt als ik dankzij 
de immense omvang van de data­
verzameling verzoop in de enveloppen 
en, de wanhoop nabij, op het 
spreekwoordelijke randje van de 
Waalbrug stond. Bedankt dan ook voor 
je immer goede humeur en je gave om 
altijd het benodigde geld of mankracht 
te regelen als de nood het hoogst was!
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De bureau-stelling geldt zeker ook voor 
jou!
Dr. Nelen, beste Willianne; dank voor je 
oneindige precisie en het immer secuur 
nakijken van de zoveelste versie van 
mijn artikelen. Mijn beroerde 
typkwaliteiten en jouw altijd op volle 
toeren functionele spellingscheck zijn 
vaak met elkaar gebotst, maar het 
resultaat mag er zijn! Jij en Rosella zijn 
echt alles wat iemand zich als 
begeleiding in een promotie-traject 
wensen kan; laagdrempelig, inhoudelijk 
sterk, praktisch aangelegd en 
bovendien nog gezellig ook. Dat is lang 
niet voor elke promovendus weggelegd 
en mag dus best weleens zwart op wit 
staan! Ik ben daarom niet alleen blij 
maar ook trots dat jullie mijn co- 
promotoren zijn; Jan mag zich gelukkig 
prijzen met zo'n perfect complementair 
onderzoeksduo als jullie!
Prof. dr. Zielhuis, beste Gerhard; dank 
voor het altijd constructief en 
verfrissend meedenken op de 
projectgroepbesprekingen. Ik heb uw 
bijdrage altijd bijzonder waardevol 
gevonden!
Dr. Adang; beste Eddy; hoewel we 
helaas aan jouw vakgebied nooit echt 
zijn toegekomen, was je altijd 
geïnteresseerd in het project en bereid 
mee te denken. Dank daarvoor!
Inclusion
Speciale dank ben ik verschuldigd aan 
de volgende gynaecologen en 
fertiliteitsartsen die contactpersonen 
waren van de 16 deelnemende 
klinieken:
Peter van Dop (St Catharina Ziekenhuis, 
Eindhoven), Ben Willem Mol en Pettie 
Maas (Maxima Medisch Centrum,
Veldhoven), Ton Franssen (Canisius 
Wilhelmina Ziekenhuis, Nijmegen), 
Mirjam van Rozendaal (Ziekenhuis 
Bernhoven, Veghel), Jos Vollebergh 
(Ziekenhuis Bernhoven, Oss), Ineke 
Minkhorst (Maasziekenhuis Pantein, 
Boxmeer), Carl Hamilton en Monique 
Brandes (Jeroen Bosch Ziekenhuis, den 
Bosch), Henk Ruis (behandelcentrum 
stichting Geertgen, Elsendorp), Guido 
Muijsers (Rivierenland Ziekenhuis, Tiel), 
Jules Schagen van Leeuwen en Tessa 
Cox (St Antonius Ziekenhuis, 
Nieuwegein), Bert van Dam en Thecla 
van de Kamp (Gelre Ziekenhuis, 
Apeldoorn), Eduard Scheenjes en 
Caroline Leendertz (Ziekenhuis 
Gelderse Vallei, Ede), Alexander 
Schmoutziguer en Laszló Bancsi 
(Ziekenhuis Rijnstate, Arnhem), Vincent 
Blom (Streekziekenhuis Zevenaar), 
Eveline Tepe, (Slingeland Ziekenhuis, 
Doetinchem).
En uiteraard even zovele secretariaten, 
poli- en archiefmedewerkers en 
fertiliteits-teams ter plaatse voor hulp 
bij dossiers zoeken, dataverzameling en 
distributie van vragenlijsten en 
patiëntenfolders.
Externe co-auteurs, Laszló Bancsi, Jos 
Vollebergh en Tessa Cox, bedankt voor 
jullie bijdrage en correcties bij de 
betreffende artikelen.
Material and Methods
Met stip op nummer één: Janine, 
zonder jouw oneindige hulp en inzet 
was het met de hele inclusie, 
dataverzameling en die kilometers 
syntax nooit gelukt! Ondanks het feit 
dat ik altijd het onmogelijke in veel te 
korte tijd wilde, bleef je altijd even 
precies. Zie figuur 1.
(PS : ...check jij die syntax nog even ?)
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Figuur 1: SPSS syntax dankbetuiging 
C O M P U T E  d an k  =99 .
DO IF object= 'proefschrift' AND  uniekid_1 = 
'se lm a ' A N D  uniekid_2= 'janine' D ank =4 . 
E X E C U T E .
V A L U E  L A B E L  d an k  '0 ' niet aa n w e z ig  ' 1' 
neutraal '2 ' gem iddeld  '3 ' groot 4 'd u izen dm aal' 
99 'ongeld ig '.
V a ria b le  label uniekid_1 ' d e g e n e  d ie dan k  
betuigt' uniekid_2 'd e g e n e  d ie d an k  ontvangt' 
M ISSIN G  V A L U E S  d an k  '(7 thru 9).
Reinier, je hebt de zeldzame gift 
statistiek logisch te laten klinken en het 
begrijpelijk uit te leggen. Dank voor al 
je hulp bij de multilevelanalyses!
Het gehele secretariaat IQ, en met 
name Jeannette van 'sectie 2' voor 
allerhande hulp bij vooral scannen en 
verifiëren van oneindig veel Teleform- 
vragenlijsten en spoed-verzendingen. 
Jolanda, heel erg bedankt voor je hulp 
bij het gereed maken van het 
manuscript en het mij achter de broek 
zitten toen de tijd begon te dringen!
Data collection:
Onderzoeksondersteuning en
onmisbare praktische hulp kreeg ik van 
Annelies, Sabine en Marc: bedankt! 
Studenten Evelyn, Anke,
gezondheidswetenschapper Petra 
hielpen bij de voormeting en studenten 
Jasper en Monica droegen behoorlijk 
wat steentjes bij aan de nameting, 
naast nog enkele bijklussende 
'verzend'-studenten.
Samen worstelden we ons door ruim 
2600 dossiers, en er werden in totaal 
ruim 6000 vragenlijsten en reminders 
verstuurd en dus even zovele brieven 
gevouwen, enveloppen gevuld, 
bestickerd en dichtgeplakt. Dat we er al
met al maar een pijnlijke 50 stuks 
zonder inhoud hebben verzonden, is 
dus hoogstwaarschijnlijk niet significant 
©!
Marc, Mark F en Gilbert, bedankt voor 
frequente, acute ICT-helpdeskerij.
Setting
Co-workers
Alle collega's van de Pijler 
Voortplantingsgeneeskunde van het 
UMCN: Daarbij noem ik natuurlijk de 
VPG gynaecologen Jan, Ina, Wim, Didi 
en Hans voor de leerzame tijd tijdens 
mijn eerste schreden in de kliniek; de 
immer goedgehumeurde en 
goedgeklede dames van het 
Secretariaat voor hulp bij praktische 
zaken; analisten en embryologen van 
het lab waar ik terecht kon voor al m'n 
'zaadvragen' of het bietsen van 
koekjes, alle verpleegkundigen en 
NP'ers Leny en Jolieneke voor de fijne 
samenwerking en eigenlijk altijd 
gezellige weekenddiensten (zeker toen 
het koffie-apparaat eenmaal daar 
was!). Ik heb ruim 4 jaar met veel 
plezier bij én met jullie gewerkt, de 
Freya-award is op zijn plek!
En last, but certainly not leas,t collega 
IVF-artsen Bea, Gwendolyn, Esther, 
Anika en Joyce. Jullie waren fijne 
collega's! Dames, zorg dat de VPG 
minstens een doctoraat-hattrick scoort 
dit jaar!
Alle collega's uit de kantoortuin1 en 
LAT-relatie Emmy, die bezig of net klaar 
zijn met hun eigen promotie. Hoewel ik 
nooit vaker in de tuin heb gezeten dan 
het afgelopen jaar aan zaterdagen en 
zondagen, was daar altijd minstens nog 
één kantoortuiner keiharde 
wetenschap aan het bedrijven2. Maar 
dankzij de frequente publiceren-is- 
trakteren-taart was er vaak genoeg
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reden om over de vloer te komen en 
ook de onderzoekers-weekendjes 
waren ronduit memorabel. Succes met 
het afronden van jullie promoties, ik 
hoop dat we snel weer allemaal 
collega's zijn!!
Collega's IQ, teveel om op te noemen, 
dank voor de hulp, leerzame tijd vol 
printerperikelen, afdelingsuitjes,
refereeractiviteiten. Ik noem speciaal 
de IQ-skitrip en gezamenlijk afzien bij 
de zevenheuvelenloop. De IQ- 
kelderbewoners bedankt voor de 
gezelligheid toen we naar -1 
'verbannen' werden, en specifiek Geert 
voor het vele malen aanhoren van 
onderzoeksgerelateerde stress boven 
het Senseo-apparaat danwel een 
Aesculaafbiertje met Lucy en Marije. 
Lucy, ondanks enige topografische 
dwalingen zouden we het bezoeken 
van watervallen (Howcome, Niagara 
ain't no Kitchener?), vulkanen (no 
puedo ver El Arenal?), bergtoppen 
(porqué ninguna agua caliente?) en 
besneeuwde hellingen (hast du ein 
Eisbär gesehen?) zeker niet voor gezien 
houden;-)
Collega's Rijnstate: Na een leuke tijd in 
het Radboud vroeg ik me af wat me in 
Arnhem te wachten stond. Gelukkig 
was die zorg onterecht! Maatschap 
gynaecologen, bedankt voor de warme 
ontvangst, leerzame tijd en goede 
werksfeer die er in het Rijnstate heerst. 
Collegae A(N)IOS3 : we zijn een leuke 
ploeg! Bedankt voor jullie 
aanhoudende interesse in mijn 
chronisch 'nu echt bijna klaar'- 
levenswerk: snel weer borrelen! Alle 
klinisch verloskundigen, poli- 
medewerkers, verpleegkundigen, 
kraamverzorgsters, bedankt voor de 
fijne samenwerking en geduld met dit
groentje! Han, volgend jaar weer 
gewoon drie keer naar de sneeuw ©!
Various contributors
Lieve clubgenootjes Absoluut4 het moet 
maar weer eens gezegd dat we een 
bijzonder leuk stel zijn! Wat een feest 
dat we elkaar ondanks geografische 
spreiding na 11 jaar nog leuk genoeg 
vinden om regelmatig uitbundige dates 
te maken. Ik hoop dat er nog maar veel 
dr's, weekendjes weg, hilarische 
lustrumfotoboeken en 'over-the-top' 
etentjes mogen volgen!
Klaar, Tamaar en Diek, succes met jullie 
proefschriften! Ier en Klaar, ik ben blij 
dat de onovertroffen alfabetische 
volgorde ons in 1997 in hetzelfde 
introductiegroepje deed belanden! Snel 
weer samen fietsen en feesten! 
Oud-ploeggenoten Hille, Mirthe, coach 
Eva en andere Njordvriendjes en 
vriendinnetjes. De 'Head of the River 
Amstel' bij windkracht 6 tegen is niets 
vergeleken met een
promotietraject...Maar na de finish is 
het nog altijd goed bieren, dus trek de 
agenda's maar!
NMHC dames 11 en 8, het is nog steeds 
lekker rondjes rennen met jullie! Lon, 
superbedankt voor je grafische hulp bij 
het ontwerp van de mooie kaft en 
tussenbladen!
Dames van de Nieuwe Rijn 80, dat 
waren tijden, wat is het toch altijd leuk 
met jullie! Hopelijk tot snel op een oud- 
HG-event!
Location
De Legendarische kamer 1.04 op het 
WOK later KWAZO tegenwoordig IQ, 
was de reden dat ik de kantoortuin 
links liet liggen. Hier werd niet alleen 
hardcore wetenschap bedreven, maar 
ook toekomst- en vakantieplannen 
bedacht, afwijzingen en publicaties
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gevierd, afterlunch gedipped, ge-brand- 
een-kaarsje-punt-NL-ed en vanaf dag 
één 'stellingen voor als het ooit zover 
is' verzonnen.
Lieve Marije, Bosschie, 1.04-roomie 
nummer 1; zonder de andere dames 
nimfen teniet te doen, jij had natuurlijk 
aan mijn zijde moeten staan .. M'n 
liefste 'Nijmeegse' vriendinnetje, die zo 
verdomd goed haar best doet zover 
mogelijk uit de buurt van Nijmegen te 
blijven! Gelukkig heb je met een 
gloedvolle nieuwe carrière (én een 
riant logeerbed) in Melbourne, de 
enige goede reden om te ontbreken. 
Dat gezegd hebbende, moet je wel 
beseffen dat het je nog heel wat 
bierella's en vrijdagavond-kipsaté gaat 
kosten om dít weer goed te maken! 
Misjoetoe;-)
Paranimfen
Dan natuurlijk mijn allerliefste 
paranimfen die mij met raad, daad en 
hun sprankelende verschijning zullen 
bijstaan:
Lieve Esther, 1.04-roomie nummer 2; Af 
en toe deelden we ook 4 muren op 
spannender locaties zoals Lyon en 
Barcelona, of op de lange VPG- 
woensdagmiddagen 'poli met z'n twee 
op min één'. In elk geval was het met 
jou altijd leuk! M aarre.had je ze nou 
niet even kunnen overtuigen in dit 
project alleen die IUI richtlijn te 
implementeren;-)? Super dat je mijn 
paranimf wil zijn! Veel succes bij je 
eigen 'laatste loodjes' en afronding van 
je proefschrift, almost there!
Lieve Jakkes, inmiddels zijn we zo 
ongeveer langer samen op vakantie 
geweest dan dat we eigenlijk samen 
gewoond hebben; en toch ben je m'n 
favoriete NR80-huisgenoot! Zet hem op
bij je eigen promotie-onderzoek en blijf 
vooral de wereld zien in rebussen en 
expressieve mandarijntjes;-). Oja, en nu 
wil Snel snel weer een weekendje met 
je weg!
Acknowledgements
Lieve papa en mama, nummertje drie is 
ook eindelijk drs-o/. Daar mogen jullie 
nu ook eens wat credits voor krijgen, 
want die goede genen komen heus 
ergens vandaan! Daarbij hebben jullie 
ons de brede interesse voor cultuur en 
natuur bijgebracht en ons, hoe 
eigenwijs ook, nooit een strobreed in 
de weg gelegd als het ging om studie of 
talrijke buitenschoolse activiteiten. Pap, 
nu drie doctors en twee dokters onder 
1 dak, met bijbehorende ego's en 
praatjes; je moet er maar tegen 
kunnen! Gelukkig is je humeur 
onverwoestbaar en je geduld oneindig. 
Ik denk dat ik nu wel weer tijd heb voor 
een gezamenlijke Sudoku! Mam, 'Three 
down, one more to go '; Nu is het mijn 
beurt om te kunnen zeuren wanneer 
die promotie, als kroon op je carrière, 
nou eindelijk eens afkomt ©, zet hem 
op!
Daniël en Maurice, jullie 'HBO'-zusje 
staat weer op gelijke voet. En tja, het 
dankwoord is langer dan twee pagina 
geworden, who cares!
En nu; tijd voor vakantie, een boek en 
een andere knoop!
References
1 Gwendolyn, Willianne, Wouter, Joyce, Suzan, Refika, 
Roosmarie, Bea, Eva, Anne, Angèle, Thijs, Suzan, Hedwig, 
Irene, Ineke, Charlotte (2x), Sabine, Inge, Annemijn, Elvira, 
Marian, Ralph, Channa, Linda, Arno, Esther, Anika 
Irene, alle weekends@work waren gezellig!
Suzanne, Jantien, Marieke J en Marieke S, Tjitske, Anne, 
Hanneke, Sanne, Moniek, Marjolijn, Dorus, Jet, Josine, 
Colette, Eva, Kim
4Klara, Iris, Steph, Steef, Dieke, Isa,Tamara, Ilena, Vanessa, 
Jennifer, Ingrid (2x), Cecile
Curriculum Vitae
174 CurricuIum Vitae
Curriculum Vitae 175
Curriculum Vitae
Selma Mourad werd geboren op 1 maart 1980 te Leiden en groeide op in het 
nabijgelegen Leiderdorp. Bij gebrek aan duidelijke toekomstplannen volgde zij op het 
Stedelijk Gymnasium Leiden zoveel mogelijk talen alsook exacte vakken, waarop zij in 
1997 het VWO-diploma behaalde. Direct daarna werd aangevangen met de studie 
Geneeskunde aan de Universiteit Leiden. Tijdens haar studententijd woonde zij 6 jaar 
met veel plezier met 20 andere dames, 1 gezamenlijke TV en kat Harrie op de Nieuwe 
Rijn 80. Daarnaast werd er gelezen, gehockeyd, hardgelopen, geborreld, geroeid en 
vele malen het Rondje Ringvaart gefietst. In het seizoen 1999-2000 nam zij als ab-actis 
plaats in het bestuur van de Koninklijke Studenten Roei Vereniging 'Njord', waarna zij 
nog twee jaar actief was als wedstrijdroeier, en tot op heden als Bestuurslid van 
oudleden-vereniging 'Oud Njord'.
In 2001 vertrok Selma voor 4 maanden in het kader van een wetenschappelijke stage 
naar de Verenigde Staten, waar zij in Portland (Oregon) bij het Rosenfeld Lab, 
verbonden aan het Doernbecher's Children's Hospital van de Oregon Health and 
Science University (OHSU), onderzoek deed naar de rol van Insuline Like Growthfactors 
en bijbehorende Binding Proteins op geprogrammeerde celdood (begeleiders dr. Junko 
Tsubaki, dr. Vivian Hwa, Prof dr. Ron Rosenfeld). Vele Western, Northern blot's en de 
onfortuinlijke dood van met liefde verzorgde celkweken verder, was het duidelijk dat 
er, ondanks de schoonheid van the Pacific Northwest, zeker geen lab-carrière voor 
haar in het verschiet lag. Vervolgens begon Selma aan de co-assistentschappen, en 
verbleef onder andere 3 maanden in Beirut, Libanon, voor het volgen van de 
coschappen Dermatologie en Keel-, Neus- en Oorheelkunde aan de American 
University of Beirut Medical Centre (AUBMC). Eind 2004 behaalde zij het artsexamen 
en werd direct aangesteld in het UMC st Radboud als artsonderzoeker op de door 
ZonMw gesubsidieerde 'SPRING-studie', geïnitieerd door het Scientific Institute for 
Quality of Healthcare (IQ healthcare, voorheen afdeling Kwaliteit van Zorg) en de 
afdeling Verloskunde en Gynaecologie van het UMCN. Een vruchtbare samenwerking 
tussen deze twee afdelingen in de personen van enerzijds Prof dr. Richard Grol en dr. 
Rosella Hermens en anderzijds Prof dr. Jan Kremer en dr. Willianne Nelen, resulteerde 
in de studies beschreven in dit proefschrift. Naast het doen van onderzoek, was Selma 
bovendien enkele dagen per week werkzaam als IVF-arts bij de pijler 
Voortplantingsgeneeskunde. In mei 2009 begon zij als ANIOS te werken op de afdeling 
Verloskunde en Gynaecologie van het Rijnstate Ziekenhuis (opleider dr. F.P. 
Dijkhuizen). In juli 2010 zal zij officieel met de opleiding tot Gynaecoloog starten in het 
Nijmeegse cluster, en wel in het Ziekenhuis Gelderse Vallei te Ede (opleiders Prof. dr. 
D.D. Braat en dr. E. Scheenjes).
